0001437749-23-033487 | F-4 | XBRL Viewer

Disaggregation of Revenue [Table Text Block]

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Revenue by timing
Over time	$	413	$	—	$	1,236	$	1,524
Point-in time		783		2,158		3,144		3,022
Total revenue	$	1,196	$	2,158	$	4,380	$	4,546

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Revenue by geography ^{(1) (2)}
Asia Pacific	$	82	$	232	$	351	$	1,946
Europe		513		43		1,506		80
North America		588		1,817		2,467		2,435
South America		13		66		56		85
Total revenue	$	1,196	$	2,158	$	4,380	$	4,546

	Year Ended December 31,
	2022		2021
Revenue by geography ⁽¹⁾
Asia Pacific	$	1,531	$	3,988
North America		3,438		201
Other		1,043		58
Total revenue	$	6,012	$	4,247

Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]

	September 30,		December 31,
	2023		2022
Non-current	$	1,000	$	1,000
Current		3,286		1,941
Total	$	4,286	$	2,941

	December 31,
	2022		2021
Non-current	$	1,000	$	1,000
Current		1,941		935
Total	$	2,941	$	1,935

Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]

		Within 1 Year				Years 2				Years 3				Thereafter
Remaining performance obligations		$	6,852			$	5,648			$	5,005			$	1,000

		Within 1 Year				Years 1-2				Years 2-3				Thereafter
Remaining performance obligations		$	6,422			$	11,296			$	3,860			$	—

Note 11 - Stockholders' Equity

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Equity [Text Block]

11. Stockholders’ Equity

Reverse Recapitalization

The Condensed Consolidated Statements of Redeemable Preferred Stock and Stockholders’ Equity reflect the Merger and reverse recapitalization as of January 2022 as discussed in Note 4 (Reverse Recapitalization). Since it was determined that Satellogic Inc. was the accounting acquirer in the reverse recapitalization, all periods prior to the consummation of the Merger reflect the balances and activity of Satellogic Inc. (other than shares which were retroactively restated in connection with the Merger).

Preferred Stock

Prior to the Merger, the Company’s authorized and issued preferred stock consisted of the following:

	Authorized Shares (prior to Merger)		Issued and Outstanding Shares (as of December 31, 2021)
Series A preferred stock		4,723,330		2,547,330
Series B preferred stock		3,117,915		1,392,131
Series B-1 preferred stock		899,153		672,524
Total preferred stock		8,740,398		4,611,985

In connection with the Merger, all shares of preferred stock were converted to shares of Class A ordinary shares.

Preferred Stockholder Transaction

In March 2021, we signed an Exchange Agreement (the “Exchange Agreement”) in conjunction with a Loan and Security Agreement and warrant with Columbia River Investment Limited, a holder of preferred stock and convertible notes (the “Investor”), requiring the Investor to sell back to us all its outstanding shares and Notes debt (as part of the sale of such notes to Nettar Group Inc.

The Columbia Warrant was initially recognized as a liability. The fair value of the Columbia Warrant was reclassified to additional paid-in capital in connection with the Merger.

Common Stock

We are authorized to issue unlimited Class A ordinary shares with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. As of September 30, 2023, there were 76,292,604 shares of Class A common stock issued and outstanding.

In addition, we are authorized to issue unlimited shares of Class B ordinary shares with a par value of $0.0001 per share. Holders of Class B ordinary shares are entitled to 1.472467906 votes per share. Satellogic’s founder and Chief Executive Officer owns 13,582,642 Class B ordinary shares, representing 100% of the voting power of the Class B ordinary shares and 20.8% of the voting power of Satellogic’s common stock.

Holders of Class B ordinary shares have a number of votes per share equal to the number of votes controlled by the Liberty Investor. Class B ordinary shares will automatically convert to Class A ordinary shares at the five-year anniversary of the Closing Date unless otherwise converted, generally at the holder’s option.

Treasury Stock

On February 14, 2022, our board of directors approved an initial $5 million share repurchase program. Repurchases under the program may be made in the open market, in privately negotiated transactions or otherwise, with the timing of repurchases depending on market conditions.

We repurchased 516,123 Class A ordinary shares for $2.7 million during the nine months ended September 30, 2022. The Company did not repurchase any shares during the nine months ended September 30, 2023.

Hannover Holdings Transaction

We repurchased 51,700 Class A ordinary shares, 134,735 shares of Series A preferred stock, and 15,082 shares of Series B-1 preferred stock from Hannover Holdings S.A. prior to the consummation of the Merger for an aggregate of $5.9 million (the “Hannover Holdings Transaction”).

11. Stockholders’ Equity (Deficit)

Reverse Recapitalization

The Consolidated Statements of Redeemable Preferred Stock and Stockholders’ Equity (Deficit) reflect the Merger and reverse recapitalization as of January 2022 as discussed in Note 4 (Reverse Recapitalization). Since Satellogic Inc. was determined to be the accounting acquirer in the reverse recapitalization, all periods prior to the consummation of the Merger reflect the balances and activity of Satellogic Inc. (other than shares which were retroactively restated in connection with the Merger).

Preferred Stock

Prior to the Merger, our authorized and issued preferred stock consisted of the following:

	Authorized Shares (prior to Merger)		Issued and Outstanding Shares (as of December 31, 2021)
Series A preferred stock		4,723,330		2,547,330
Series B preferred stock		3,117,915		1,392,131
Series B-1 preferred stock		899,153		672,524
Total preferred stock		8,740,398		4,611,985

In connection with the Merger, all shares of preferred stock were converted to shares of Class A ordinary shares.

Preferred Stockholder Transaction

The Columbia Warrant was initially recognized as a liability. The fair value of the Columbia Warrant was reclassified to additional paid-in capital in connection with the Merger. See Note 6 (Warrant Liabilities) for further information relating to the Columbia Warrant.

Common Stock

Our registration statement was filed on May 2, 2022 and was declared effective on May 9, 2022.

We are authorized to issue unlimited Class A ordinary shares with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. As of December 31, 2022, there were 75,612,795 Class A ordinary shares issued and outstanding.

In addition, we are authorized to issue unlimited Class B ordinary shares with a par value of $0.0001 per share. Holders of Class B ordinary shares are entitled to 1.472467906 votes per share. Satellogic’s founder and Chief Executive Officer owns 13,582,642 Class B ordinary shares, representing 100% of the voting power of the Class B ordinary shares and 20.9% of the voting power of Satellogic’s common stock.

Treasury Stock

We repurchased 516,123 Class A ordinary shares for $2.7 million during the year ended December 31, 2022.

Hannover Holdings Transaction

The entire disclosure for equity.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481004/946-505-50-6

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480237/815-40-50-6

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//505/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-13

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-14

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 16
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-16

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-18

Note 10 - Income Tax - Schedule of Operating Loss and Tax Credit Carryforwards (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Carried Forward	$ 1,365	$ 6,245
Net Operating Loss	13,300	$ 20,900
The Argentine Tax Authority (AFIP) [Member]
Carried Forward	7,864
Net Operating Loss	0
Tax and Customs Administration, Netherlands [Member]
Carried Forward	2,856
Net Operating Loss	0
State Administration of Taxation, China [Member]
Carried Forward	2,258
Net Operating Loss	0
Internal Revenue Service (IRS) [Member]
Carried Forward	280
Net Operating Loss	0
General Taxation Directorate in Uruguay [Member]
Carried Forward	19
Net Operating Loss	$ 0

Note 4 - Reverse Recapitalization 1 (Details Textual) $ / shares in Units, $ in Thousands				1 Months Ended	9 Months Ended	12 Months Ended
	Feb. 10, 2022 USD ($) $ / shares shares	Jan. 25, 2022 USD ($) $ / shares shares	Jan. 18, 2022 USD ($) $ / shares shares	Jul. 31, 2021 USD ($) $ / shares shares	Sep. 30, 2023	Dec. 31, 2022 USD ($)	Dec. 23, 2021 USD ($)
Proceeds From Reverse Recapitalization \| $		$ 168,000				$ 168,000
Conversion of Stock, Shares Issued (in shares)		2,140,340
Recapitalization Exchange Ratio					3.3028	3.3028
C F V [Member] \| Liberty Subscription Agreement [Member]
Proceeds from Issuance or Sale of Equity \| $			$ 150,000
Canter Loan [Member] \| Class A Common Stock Issued for Conversion of Promissory Note [Member]
Debt Conversion, Converted Instrument, Shares Issued (in shares)			788,021
Canter Loan [Member] \| CF Securities [Member]
Debt Instrument, Face Amount \| $							$ 7,500
Pipe Warrant [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)		2,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) \| $ / shares		$ 20
Proceeds from Issuance or Sale of Equity \| $		$ 58,200
Forward Purchase Warrant [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)				333,333
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) \| $ / shares				$ 11.5
Proceeds from Issuance or Sale of Equity \| $				$ 10,000
The 10 Dollar Liberty Warrant [Member] \| C F V [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)			5,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) \| $ / shares			$ 10
The 15 Dollar Liberty Warrant [Member] \| C F V [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)			15,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) \| $ / shares			$ 15
Advisory Fee Warrant [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)	2,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) \| $ / shares	$ 10
Class of Warrant or Right, Cash Portion of Advisory Fee \| $	$ 1,250					$ 7,500
Class of Warrant or Right, Anniversary Period (Year)	18 years
Common Class A [Member]
Stock Issued During Period, Shares, New Issues (in shares)		5,816,770		1,250,000
Conversion of Stock, Shares Issued (in shares)		2,140,340
Common Class A [Member] \| Transaction Fee Payment [Member]
Sale of Stock, Number of Shares Issued in Transaction (in shares)			2,058,229
Sale of Stock, Consideration Received on Transaction \| $			$ 5,000
Common Class A [Member] \| C F V [Member] \| Liberty Subscription Agreement [Member]
Sale of Stock, Number of Shares Issued in Transaction (in shares)			20,000,000
Series X Preferred Stock [Member]
Conversion of Stock, Shares Converted (in shares)		2,033,230
Conversion of Stock, Amount Converted \| $		$ 21,400

Note 16 - Related Parties 1 (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Use of Estimates, Policy [Policy Text Block]

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Convertible notes from related parties
Interest expense on amounts owed to related parties	$	—	$	—	$	—	$	44

	December 31,
	2022		2021		2020
Convertible notes debt from related parties
Amounts owed to related parties	$	—	$	13,028	$	—
Interest expense	$	554	$	620	$	591

Note 9 - Additional Financial Statement Information - Schule of Prepaid and Other Current Assets 1 (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Prepaid expenses	$ 2,604	$ 1,767	$ 1,153
Advances to suppliers	228	588	829
Other current assets	413	843	713
Total	$ 3,245	$ 3,198	$ 2,695

Note 5 - Revenue from Contracts with Customers - Schedule of Contract Liabilities 1 (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Contract liabilities	$ 1,000	$ 1,000	$ 1,000
Current	3,286	1,941	935
Total	$ 4,286	$ 2,941	$ 1,935

Note 11 - Stockholder's Equity - Schedule of Preferred Stock 1 (Details)	Dec. 31, 2021 shares
Preferred stock, authorized (in shares)	8,740,398
Preferred stock, issued (in shares)	4,611,985
Series A Preferred Stock [Member]
Preferred stock, authorized (in shares)	4,723,330
Preferred stock, issued (in shares)	2,547,330
Series B Preferred Stock [Member]
Preferred stock, authorized (in shares)	3,117,915
Preferred stock, issued (in shares)	1,392,131
Series B-1 Preferred Stock [Member]
Preferred stock, authorized (in shares)	899,153
Preferred stock, issued (in shares)	672,524

Note 11 - Stockholders' Equity (Details Textual) - USD ($) $ / shares in Units, $ in Thousands		9 Months Ended		12 Months Ended
	Apr. 06, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Feb. 14, 2022	Jan. 18, 2022	Jan. 17, 2022
Common Stock, Par or Stated Value Per Share (in dollars per share)		$ 0.0001		$ 0.0001	$ 0.0001
Common Stock, Shares, Outstanding (in shares)								88,824,647	17,215,336
Stock Repurchase Program, Authorized Amount							$ 5,000
Payments for Repurchase of Common Stock		$ (0)	$ 8,603	$ 8,603	$ (0)	$ (0)
Hanover Holdings S A [Member]
Payments for Repurchase of Common Stock	$ 5,853
Common Class A [Member]
Common Stock, Par or Stated Value Per Share (in dollars per share)		$ 0.0001		$ 0.0001
Common Stock, Shares, Issued (in shares)		76,292,604		75,612,795
Common Stock, Shares, Outstanding (in shares)		76,292,604		75,612,795
Treasury Stock, Shares, Acquired (in shares)		0	516,123	516,123
Payments for Repurchase of Common Stock			$ 2,700	$ 2,700
Common Class A [Member] \| Hanover Holdings S A [Member]
Treasury Stock, Shares, Acquired (in shares)	51,700
Common Class B [Member]
Common Stock, Par or Stated Value Per Share (in dollars per share)		$ 0.0001		$ 0.0001
Common Stock, Shares, Issued (in shares)		13,582,642		13,582,642
Common Stock, Shares, Outstanding (in shares)		13,582,642		13,582,642
Common Stock, Voting Interest		100.00%		100.00%
Common Class B [Member] \| Chief Executive Officer [Member]
Common Stock, Shares, Outstanding (in shares)		13,582,642		13,582,642
Common Stock, Voting Interest		20.80%
Common Stock [Member]
Common Stock, Voting Interest				20.90%
Series A Preferred Stock [Member] \| Hanover Holdings S A [Member]
Treasury Stock, Shares, Acquired (in shares)	134,735
Series B-1 Preferred Stock [Member] \| Hanover Holdings S A [Member]
Treasury Stock, Shares, Acquired (in shares)	15,082

Significant Accounting Policies (Policies)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Accounting Policies [Abstract]

Use of Estimates

The preparation of the Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant estimates and assumptions reflected in these Condensed Consolidated Financial Statements include, but are not limited to, revenue recognition; determination of useful lives of property and equipment; valuation of warrant liabilities, earnout liabilities, stock options; and determination of income tax. We evaluate our estimates and assumptions on an ongoing basis. Actual results could differ from those estimates and such differences may be material to the Condensed Consolidated Financial Statements.

Use of Estimates

The preparation of the Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant estimates and assumptions reflected in these Consolidated Financial Statements include, but are not limited to, revenue recognition; determination of useful lives of property and equipment; valuation of warrant liabilities, earnout liabilities, stock options; and determination of income tax. We evaluate our estimates and assumptions on an ongoing basis. Actual results could differ from those estimates and such differences may be material to the Consolidated Financial Statements.

Revenue from Contract with Customer [Policy Text Block]

Revenue Recognition

We recognize revenue in accordance with Topic 606, Revenue from contracts with customers. Revenue is recognized when a customer obtains control of promised goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that we expect to receive in exchange for goods or services provided under such contracts. We apply the following five-step model in order to determine this amount: (i) identification of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) we satisfy each performance obligation.

Our main revenue stream is from services. We recognize as revenues, the amount of the transaction price that is allocated to the respective performance obligation when or as the performance obligation is satisfied. Revenue is recognized ratably over the subscription period or at the point in time upon delivery. Our satellite imagery can be delivered to customers in two ways: either by providing access via our platform or via electronic delivery.

The nature of our contracts does not currently give rise to variable consideration related to returns or refunds as those are not offered.

We evaluate contracts with a minimum purchase commitment to determine whether we expect to be entitled to a breakage amount. We consider the requirements on constraining estimates variable consideration. The following factors are evaluated when assessing the increased likelihood of a significant revenue reversal: (i) the amount of consideration is highly susceptible to factors outside our influence or control (e.g., volatility in a market, judgment of action of third parties, weather conditions), (ii) uncertainty about the amount of consideration is not expected to be resolved for a long period of time, (iii) our experience with similar types of contracts is limited, or that experience has limited predictive value, (iv) we have a practice of either offering a broad range of price concessions or changing the payment terms and conditions of similar contracts in similar circumstances, and (v) the contract has a large number and broad range of possible consideration amounts.

We exclude amounts collected on behalf of third parties, such as sales taxes, when determining transaction price.

Contract liabilities consist of payments received from customers, or such consideration that is contractually due, in advance of providing the product or performing services.

We generally do not enter into long-term financing arrangements or payment plans with customers. Although our business practice is not to enter into contracts with non-cash consideration, at times this may occur. In these instances, we determine the fair value of the non-cash consideration at contract inception and includes this value as part of the total arrangement consideration. In instances where we cannot reasonably estimate the fair value of the non-cash consideration, we will measure the consideration indirectly by reference to its stand-alone selling price of the goods promised to the customer in exchange for consideration.

Revenue Recognition

We recognize revenue in accordance with Topic 606 Revenue from contracts with customers. Revenue is recognized when a customer obtains control of promised goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that we expect to receive in exchange for goods or services provided under such contracts. We apply the following five-step model in order to determine this amount: (i) identification of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) we satisfy each performance obligation.

Our main revenue stream is from services. We recognize as revenues the amount of the transaction price that is allocated to the respective performance obligation when or as the performance obligation is satisfied. Generally, our performance obligations are transferred to customers at a point in time, typically upon delivery. Our satellite imagery can be delivered to customers in two ways, either by providing access via our platform or via electronic delivery.

The nature of our contracts does not currently give rise to variable consideration related to returns or refunds as those are not offered.

We evaluate contracts with a minimum purchase commitment to determine whether we expect to be entitled to a breakage amount. We consider the requirements on constraining estimates variable consideration. The following factors are evaluated when assessing the increased likelihood of a significant revenue reversal: (i) the amount of consideration is highly susceptible to factors outside our influence or control (e.g., volatility in a market, judgment of action of third parties, weather conditions), (ii) uncertainty about the amount of consideration is not expected to be resolved for a long period of time, (iii) our experience with similar types of contracts is limited, or that experience has limited predictive value, (iv) we have a practice of either offering a broad range of price concessions or changing the payment terms and conditions of similar contracts in similar circumstances, and (v) the contract has a large number and broad range of possible consideration amounts.

We exclude amounts collected on behalf of third parties, such as sales taxes, when determining transaction price.

Contract liabilities consist of payments received from customers, or such consideration that is contractually due, in advance of providing the product or performing services.

Fair Value Measurement, Policy [Policy Text Block]

Fair Value Measurement

Certain assets and liabilities are carried at fair value in accordance with U.S. GAAP.

Valuation techniques used to measure fair value requires us to utilize observable and unobservable inputs. The hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Financial instruments carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:

•

Level 1: Quoted prices in active markets for identical assets or liabilities.

•

Level 2: Valuation techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable.

•

Level 3: Valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable.

Assets and liabilities recognized at fair value on a recurring basis in the Condensed Consolidated Financial Statements are re-assessed at the end of each reporting period to determine whether any transfers have occurred between levels in the hierarchy.

For fair value disclosures, classes of assets and liabilities are based on the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy.

Fair Value Measurement

Certain assets and liabilities are carried at fair value in accordance with U.S. GAAP.

•

Level 1: Quoted prices in active markets for identical assets or liabilities.

•

Level 2: Valuation techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable.

•

Level 3: Valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable.

Assets and liabilities recognized at fair value on a recurring basis in the Consolidated Financial Statements are re-assessed at the end of each reporting period to determine whether any transfers have occurred between levels in the hierarchy.

For fair value disclosures, classes of assets and liabilities are based on the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy.

Concentration Risk, Credit Risk, Policy [Policy Text Block]

Credit risk management

Credit risk is the risk that a counterparty fails to discharge an obligation to us. We are exposed to credit risk from financial assets including cash, cash equivalents and restricted cash held at banks, trade and other receivables.

The credit risk is managed based on our credit risk management policies and procedures. Credit risk of any entity doing business with us is systematically analyzed, including aspects of a qualitative nature. The measurement and assessment of our total exposure to credit risk covers all financial instruments involving any counterparty risk.

The credit risk in respect of cash balances held with banks and deposits with banks are managed via diversification of bank deposits and are only with major reputable financial institutions.

As our risk exposure is mainly influenced by the individual characteristics of each customer, we continuously analyze the creditworthiness of significant debtors. Accounts receivable are non-interest bearing and generally on terms of 30 to 90 days. As of September 30, 2023 two customers, accounted for 84% of accounts receivable, net of allowance. As of December 31, 2022, one customer accounted for 72% of our accounts receivable net of allowance.

Two customers accounted for more than 10% of our revenue totaling $0.9 million for the three months ended September 30, 2023 and one customer accounted for more than 10% of our revenue totaling $1.7 million for the three months ended September 30, 2022. Two customers each accounted for more than 10% of our revenue totaling $4.4 million for the nine months ended September 30, 2023 and $3.8 million for the nine months ended September 30, 2022.

The Company contracts with certain third-party service providers to launch satellites and others for cloud-based computing infrastructure. Service providers who provide these services are limited. The inability of launch service providers and cloud based computing providers to perform under their contracts with the Company could materially impact future operating results.

Credit risk management

The credit risk in respect of cash balances held with banks and deposits with banks are managed via diversification of bank deposits and are only with major reputable financial institutions.

Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]

Impairment of Assets

We assess potential impairments to long-lived assets whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable. An impairment is considered to exist if the total estimated future cash flows on an undiscounted basis are less than the carrying amount of the assets or asset group. We performed an impairment test as of September 30, 2023 due to our net loss for the period and concluded that the asset group is not impaired.

Estimates of future cash flows are highly subjective judgments based on management’s experience and knowledge of the Company's operations. These estimates can be significantly impacted by many factors, including changes in global economic conditions, operating costs, obsolescence of technology and competition.

If estimates or underlying assumptions change in the future, we may be required to record impairment charges. If the fair value of an asset group is less than its carrying amount, then the carrying amount of the asset group would be reduced to its fair value. That reduction is an impairment loss that would be recognized in the Condensed Consolidated Statements of Operations and Comprehensive Loss.

Impairment of Assets

We assess potential impairments to long-lived assets whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable. An impairment is considered to exist if the total estimated future cash flows on an undiscounted basis are less than the carrying amount of the assets or asset group. We performed an impairment test as of December 31, 2022, 2021 and 2020 due to our net loss for those years and concluded that the asset group is not impaired.

If estimates or underlying assumptions change in the future, we may be required to record impairment charges. If the fair value of an asset group is less than its carrying amount, then the carrying amount of the asset group would be reduced to its fair value. That reduction is an impairment loss that would be recognized in the Consolidated Statements of Operations and Comprehensive Loss.

Equity Method Investments [Policy Text Block]

Equity Method Investments

We account for equity investments in which we have significant influence, but not a controlling financial interest, using the equity method of accounting. Under the equity method of accounting, investments are initially recorded at cost, less impairment, and subsequently adjusted to recognize our share of earnings or losses as a component of Other income (expense), net in the Condensed Consolidated Statements of Operations and Comprehensive Loss. Our equity method investments are required to be reviewed for impairment when it is determined there may be an other-than-temporary loss in value. We have not recorded any impairment losses related to our equity method investments during the period ended September 30, 2023.

Equity Method Investments

We account for equity investments in which we have significant influence, but not a controlling financial interest, using the equity method of accounting. Under the equity method of accounting, investments are initially recorded at cost, less impairment, and subsequently adjusted to recognize our share of earnings or losses as a component of Other income (expense), net in the Consolidated Statements of Operations and Comprehensive Loss. Our equity method investments are required to be reviewed for impairment when it is determined there may be an other-than-temporary loss in value. We have not recorded any impairment losses related to our equity method investments during the year ended December 31, 2022. We did not hold any equity investments in 2021 or 2020.

Share-Based Payment Arrangement [Policy Text Block]

Stock-Based Compensation

We measure and recognize all stock-based compensation expense based on estimated fair values for all stock-based awards made to employees and non-employees. Compensation cost is recognized over the requisite service period for each separate tranche, as though each tranche of the award is, in substance, a separate award. The expense calculation includes estimated forfeiture rates, which have been developed based upon historical experience.

The fair values for stock options are calculated using the Black-Scholes option pricing model using the following inputs:

Expected term - The simplified method is used to calculate the expected term.

Expected volatility - We determine the expected stock price volatility based on the historical volatilities of guideline companies from comparable industries.

Expected dividend yield - We do not use a dividend rate due to the fact that we have never declared or paid cash dividends on the Company’s common stock and we do not anticipate doing so in the foreseeable future.

Risk-free interest rate - We base our interest rate on a treasury instrument for which the term is commensurate with the maximum expected life of the stock options.

The fair values for restricted stock units ("RSUs") with service-based vesting conditions are calculated based upon our closing stock price on the date of the grant.

Stock-Based Compensation

The fair values for stock options are calculated using the Black-Scholes option pricing model using the following inputs:

Expected term - The simplified method is used to calculate the expected term.

Expected volatility - We determine the expected stock price volatility based on the historical volatilities of guideline companies from comparable industries.

Expected dividend yield - We do not use a dividend rate due to the fact that we have never declared or paid cash dividends on the Company’s common stock and we do not anticipate doing so in the foreseeable future.

Risk-free interest rate - We base our interest rate on a treasury instrument for which the term is commensurate with the maximum expected life of the stock options.

The fair values for restricted stock units ("RSUs") with service-based vesting conditions are calculated based upon our closing stock price on the date of the grant.

Foreign Currency Transactions and Translations Policy [Policy Text Block]

Foreign Currencies

The financial position and results of operations of certain of our foreign subsidiaries are measured using the local currency as the functional currency. Revenues and expenses of these subsidiaries have been translated into U.S. dollars at average exchange rates prevailing during the period. Assets and liabilities of these subsidiaries have been translated at the exchange rates as of the balance sheet date. Translation gains and losses are recorded in accumulated other comprehensive loss.

Aggregate foreign currency gains and losses, such as those resulting from the settlement of receivables or payables, foreign currency contracts and short-term intercompany advances in a currency other than the relevant subsidiary’s functional currency, are recorded currently in the Condensed Consolidated Statements of Operations and Comprehensive Loss (included in other income, net) and resulted in gains of $1.8 million and $1.1 million during the three months ended September 30, 2023 and 2022, respectively and $3.7 million and $1.6 million during the nine-month periods ended September 30, 2023 and 2022, respectively.

Foreign Currencies

Aggregate foreign currency gains and losses, such as those resulting from the settlement of receivables or payables, foreign currency contracts and short-term intercompany advances in a currency other than the relevant subsidiary’s functional currency, are recorded currently in the Consolidated Statements of Operations and Comprehensive Loss (included in other income, net) and resulted in gains of $1,576, $1,022, and $594 during the years ended December 31, 2022, 2021, and 2020, respectively.

Lessee, Leases [Policy Text Block]

Leases

We determine if a contract is a lease or contains a lease at inception. On the lease commencement date, we recognize a right-of-use (“ROU”) asset and lease liability related to operating type leases. The cost of ROU assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Operating lease liabilities are recorded based on the present value of the future lease fixed payments. In determining the present value of future lease payments, we use our incremental borrowing rate applicable to the economic environment and the duration of the lease based on the information available at the commencement date as the majority of leases do not provide an implicit rate. For real estate and equipment contracts, we generally account for the lease and non-lease components as a single lease component. In assessing the lease term, we include options to renew only when we are reasonably certain that such option(s) will be exercised; a determination which is at our sole discretion. Variable lease payments are recognized as expenses in the period incurred. For leases with an initial term of 12 months or less, we have elected to not record an ROU asset and lease liability. We record lease expense on a straight-line basis over the shorter of the lease term and estimated useful lives of the assets, beginning on the commencement date.

We remeasure and reallocate the consideration in a lease when there is a modification of the lease that is not accounted for as a separate contract. The lease liability is remeasured when there is a change in the lease term or in the assessment of whether we will exercise a lease option. We assess ROU assets for impairment in accordance with our long-lived asset impairment policy.

We account for lease agreements with contractually required lease and non-lease components on a combined basis. Lease payments made for cancellable leases, variable amounts that are not based on an observable index and lease agreements with an original duration of less than 12 months are recorded directly to lease expense.

For the periods presented, the Company does not have any financing type leases.

For the three months ended September 30, 2023 and 2022, lease expense was $0.6 million and $0.5 million, respectively and for the nine months ended September 30, 2023 and 2022, lease expense was $1.9 million and $1.4 million, respectively. Lease obligations and right of use assets increased as of September 30, 2023 compared to December 31, 2022 due primarily to inflation adjustments to lease payments in certain facility leases, which were accounted for as lease modifications in the nine months ended September 30, 2023.

Leases

We determine if a contract is a lease or contains a lease at inception. On the lease commencement date, we recognize a right-of-use (“ROU”) asset and lease liability related to operating type leases. The cost of ROU assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Operating lease liabilities are recorded based on the present value of the future lease fixed payments. In determining the present value of future lease payments, we use our incremental borrowing rate applicable to the economic environment and the duration of the lease based on the information available at the commencement date as the majority of leases do not provide an implicit rate. For real estate and equipment contracts, we generally account for the lease and non-lease components as a single lease component. In assessing the lease term, we include options to renew only when we are reasonably certain that such option(s) will be exercised; a determination which is at our sole discretion. Variable lease payments are recognized as expenses in the period incurred. For leases with an initial term of 12 months or less, we have elected to not record an ROU asset and lease liability. We record lease expense on a straight-line basis over the shorter of the lease term and the estimated useful lives of the assets, beginning on the commencement date.

For the periods presented, we do not have any financing type leases.

Accounts Receivable [Policy Text Block]

Accounts Receivable and Allowance for Credit Losses

Trade accounts receivable are stated at the amount owed by the customer, net of allowances for estimated credit losses, discounts, returns and rebates. We measure the allowance for credit losses based on the estimated loss.

In calculating an allowance for credit losses, we use our historical experience, external indicators and an aging method. We assess impairment of trade accounts receivable on a collective basis as they possess shared credit risk characteristics, which have been grouped based on customer industry type. The Company also considers account size in its groupings and the days past due in its analysis.

Accounts are written off against the allowance account when they are determined to be no longer collectible. The following table shows the activity in the allowance for credit losses for the nine months ended September 30, 2023 and 2022:

	Nine Months Ended September 30,
	2023		2022
Allowance for credit losses as of beginning of period	$	3,237	$	1,794
Provision		80		1,736
Allowance for credit losses as of end of period	$	3,317	$	3,530

Accounts Receivable and Allowance for Doubtful Accounts

Trade accounts receivable are stated at the amount owed by the customer, net of allowances for estimated doubtful accounts, discounts, returns and rebates. We measure the allowance for doubtful accounts based on the estimated loss.

In calculating an allowance for doubtful accounts, we use our historical experience, external indicators and an aging method. We assess impairment of trade accounts receivable on a collective basis as they possess shared credit risk characteristics which have been grouped based on the days past due.

Accounts are written off against the allowance account when they are determined to be no longer collectible. The following table shows the activity in the allowance for doubtful accounts for the years ended December 31, 2022 and 2021:

	December 31,
	2022			2021
Allowance for doubtful accounts as of beginning of period	$	1,794		$	—
Provision		1,736			1,794
Write-offs		—			—
Foreign exchange and other		(293	)		—
Allowance for doubtful accounts as of end of period	$	3,237		$	1,794

Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]

Cash, Cash Equivalents and Restricted Cash

Cash and cash equivalents include deposits in banks and short-term (original maturities of three months or less at the time of purchase), highly liquid investments that are readily convertible to known amounts of cash with a maturity of three months or less at the time of purchase.

Restricted cash, including amounts in Other non-current assets, represents amounts pledged as guarantees for sales and lease agreements as contractually required.

	September 30, 2023		December 31, 2022
Cash and cash equivalents	$	30,971	$	76,528
Restricted cash		—		126
Restricted cash included in Other non-current assets		1,151		1,138
Total cash, cash equivalents and restricted cash	$	32,122	$	77,792

Cash, Cash Equivalents and Restricted Cash

Restricted cash, including amounts in Other non-current assets, represents amounts pledged as guarantees for sales and lease agreements as contractually required.

	December 31,
	2022		2021
Cash and cash equivalents	$	76,528	$	8,533
Restricted cash		126		—
Restricted cash included in Other non-current assets		1,138		—
Total cash, cash equivalents and restricted cash	$	77,792	$	8,533

Cash Flow Information

	Year Ended December 31,
	2022		2021		2020
Cash paid during the period for:
Income tax, net of refunds	$	758	$	96	$	59
Interest	$	3,520	$	49,283	$	27,286

Note 11 - Stockholders' Equity 1 (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Schedule of Stock by Class [Table Text Block]

	Authorized Shares (prior to Merger)		Issued and Outstanding Shares (as of December 31, 2021)
Series A preferred stock		4,723,330		2,547,330
Series B preferred stock		3,117,915		1,392,131
Series B-1 preferred stock		899,153		672,524
Total preferred stock		8,740,398		4,611,985

	Authorized Shares (prior to Merger)		Issued and Outstanding Shares (as of December 31, 2021)
Series A preferred stock		4,723,330		2,547,330
Series B preferred stock		3,117,915		1,392,131
Series B-1 preferred stock		899,153		672,524
Total preferred stock		8,740,398		4,611,985

Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(27))
-SubTopic 10
-Topic 210
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-3

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-4

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-5

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481142/505-10-45-2

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-10

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-8

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480244/480-10-S99-1

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-6

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-7

Note 5 - Revenue from Contract with Customer - Schedule of Remaining Performance Obligations 2 (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Remaining performance obligations		$ 6,422
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Remaining performance obligations	$ 6,852
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Remaining performance obligations	5,648	11,296
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Remaining performance obligations	5,005	3,860
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Remaining performance obligations	$ 1,000	$ 0

Note 9 - Additional Financial Statement Information (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]

	September 30,		December 31,
	2023		2022
Prepaid expenses and other current assets
Prepaid expenses	$	2,604	$	1,767
Advances to suppliers		228		588
Other current assets		413		843
Total	$	3,245	$	3,198

	December 31,
	2022		2021
Prepaid expenses and other current assets
Prepaid expenses	$	1,767	$	1,153
Advances to suppliers		588		829
Other current assets		843		713
Total	$	3,198	$	2,695

Schedule of Accrued Liabilities [Table Text Block]

	September 30,		December 31,
	2023		2022
Accrued expenses and other liabilities
Provisions		66		71
Payroll and benefits payable		2,111		3,289
Other taxes payable		5,373		3,128
Other		430		451
Total	$	7,980	$	6,939

Total current	$	7,481	$	6,417
Total non-current	$	499	$	522

	December 31,
	2022		2021
Accrued expenses and other liabilities
Accrued professional fees related to Merger⁽¹⁾	$	—	$	16,263
Provisions		71		2,934
Payroll and benefits payable		3,289		2,545
Other taxes payable		3,128		2,045
Other		451		2,200
Total	$	6,939	$	25,987

Total current	$	6,417	$	23,435
Total non-current	$	522	$	2,552

Schedule of Finance Costs, Net and Other Financial Income (Expense) [Table Text Block]

	Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022
Finance income (expense), net
Interest expense	$	—		$	(9	)	$	(3	)	$	(1,597	)
Redeemable Series X preferred stock dividends		—			—			—			(97	)
Other finance costs		(38	)		(29	)		(103	)		(99	)
Interest income		427			419			1,577			568
Total	$	389		$	381		$	1,471		$	(1,225	)

	Year Ended December 31,
	2022			2021			2020
Finance costs, net
Interest expense	$	(1,596	)	$	(8,729	)	$	(43	)
Redeemable Series X preferred stock dividends		(97	)		(974	)		—
Other finance costs		(123	)		(71	)		—
Interest income		1,164			36			78
Total	$	(652	)	$	(9,738	)	$	35

Note 3 - Accounting Standards Updates (ASU)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Accounting Standards Update and Change in Accounting Principle [Text Block]

3. Accounting Standards Updates (“ASU”)

Accounting Standard Recently Adopted

In June 2016, the FASB issued ASU No. 2016-13, Credit Losses - Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires entities to use a forward-looking approach based on current expected credit losses to estimate credit losses on certain types of financial instruments, including trade receivables, resulting in an earlier recognition of losses than under the current incurred loss approach, which requires waiting to recognize a loss until it is probable of being incurred. We adopted this guidance as of January 1, 2023. The impact of adopting this new guidance was not material to the consolidated financial statements.

3. Accounting Standards Updates (“ASU”)

Accounting Standards Recently Adopted

In May 2021, the FASB issued ASU 2021-04, Earnings per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), which clarifies and reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified upon modification or exchange. This ASU is effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity applies the amendments prospectively to modifications or exchanges occurring on or after the effective date of the amendments. We adopted this guidance as of January 1, 2022. The impact of adopting this new guidance was not material to the consolidated financial statements.

In January 2020, the FASB issued ASU 2020-01, Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)—Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force), which clarifies the interaction of accounting for equity securities, investments accounted for under the equity method of accounting, and the accounting for certain forward contracts and purchase options, under the aforementioned topics. This ASU is effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity applies the amendments prospectively to modifications or exchanges occurring on or after the effective date of the amendments. We adopted this guidance as of January 1, 2022. The impact of adopting this new guidance was not material to the consolidated financial statements.

In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”) which is part of the FASB’s overall simplification initiative to reduce the costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. ASU 2019-12 simplifies accounting guidance for intra-period allocations, deferred tax liabilities, year-to-date losses in interim periods, franchise taxes, step-up in tax basis of goodwill, separate entity financial statements, and interim recognition of tax laws or rate changes. ASU 2019-12 is effective for emerging growth companies following private company adoption dates in fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted. We adopted this guidance as of January 1, 2022. The impact of adopting this new guidance was not material to the consolidated financial statements.

Accounting Standards Not Yet Adopted

In June 2016, the FASB issued ASU No. 2016-13, Credit Losses - Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires entities to use a forward-looking approach based on current expected credit losses to estimate credit losses on certain types of financial instruments, including trade receivables, resulting in an earlier recognition of losses than under the current incurred loss approach, which requires waiting to recognize a loss until it is probable of being incurred. This standard is effective for us beginning January 1, 2023 and will be adopted using the modified retrospective transition method through a cumulative-effect adjustment to retained earnings as of the effective date. Upon adoption, the standard is expected to only impact our account for credit losses related to accounts receivable. In preparation for the adoption of the new standard, we have updated certain policies and related processes, but we do not expect the adoption of this new guidance will have a material impact on the Consolidated Financial Statements.

The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480016/944-40-65-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480016/944-40-65-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480016/944-40-65-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(iv)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480016/944-40-65-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (h)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480016/944-40-65-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 5
-Subparagraph (SAB Topic 11.M.Q2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480530/250-10-S99-5

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (i)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480528/815-20-65-6

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 842
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 5
-Subparagraph (f)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479832/842-10-65-5

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 842
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 5
-Subparagraph (f)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479832/842-10-65-5

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (c)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 848
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483550/848-10-65-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 105
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479343/105-10-65-6

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 8
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482615/740-10-65-8

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 8
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482615/740-10-65-8

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 8
-Subparagraph (e)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482615/740-10-65-8

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482833/825-10-65-6

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482833/825-10-65-6

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 6
-Subparagraph (e)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482833/825-10-65-6

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479654/326-10-65-4

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 326
-SubTopic 10
-Name Accounting Standards Codification
-Section 65
-Paragraph 4
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479654/326-10-65-4

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 926
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (f)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483194/926-20-65-2

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 926
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (f)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483194/926-20-65-2

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 926
-SubTopic 20
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (f)(3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483194/926-20-65-2

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480530/250-10-S99-6

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-1

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-1

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 250
-Publisher FASB
-URI https://asc.fasb.org//250/tableOfContent

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (d)(1)
-SubTopic 20
-Topic 310
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481925/310-20-65-2

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 65
-Paragraph 2
-Subparagraph (d)(2)
-SubTopic 20
-Topic 310
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481925/310-20-65-2

Note 10 - Income Tax - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Stock-based compensation	$ 3,023	$ 2,053
Bad debt expense	415	407
Deferred financing costs	806	0
Other	193	419
Carried Forward	1,365	6,245
Total deferred income tax assets	5,802	9,124
Valuation allowance	(5,802)	(7,484)
Total deferred income tax assets (liabilities), net	$ 0	$ 1,640

Note 14 - Net Loss Per Share - Schedule of Antidilutive Securities (Details) - shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Antidilutive Securities (in shares)	58,487,423	29,441,138	13,434,712
Warrant [Member]
Antidilutive Securities (in shares)	49,184,868	15,931,360	0
Sponsor Earnout Shares [Member]
Antidilutive Securities (in shares)	1,775,962	0	0
Stock Options [Member]
Antidilutive Securities (in shares)	6,067,313	6,864,563	4,694,314
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities (in shares)	1,459,280	0	0
Redeemable Convertible Preferred Stock [Member]
Antidilutive Securities (in shares)	0	6,645,215	8,740,398

Note 18 - Leases - Changes in Operating Lease ROU Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Balance as of beginning of period	$ 2,955	$ 1,403
Lease expense	(1,701)	(494)	$ (247)
Foreign exchange differences	115	(48)
Additions	7,171	2,119
Disposals	(322)	0
Transfers	(47)	(25)
Balance as of end of period	$ 8,171	$ 2,955	$ 1,403

Note 16 - Related Parties - Schedule of Related Party Transactions 1 (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Related Party [Member] \| Interest Expense [Member]
Related Party Transaction, Amounts of Transaction	$ 0	$ 0	$ 0	$ 44	$ 554	$ 620	$ 591

Note 4 - Reverse Recapitalization 1

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Reverse Recapitalization Disclosure [Text Block]

4. Reverse Recapitalization

On January 25, 2022 and pursuant to the Merger Agreement, the Merger was accounted for as a reverse recapitalization in accordance with U.S. GAAP. Under this method of accounting, CF V was treated as the “acquired” company and Satellogic was treated as the acquirer for financial reporting purposes. Accordingly, for accounting purposes, the reverse recapitalization was treated as the equivalent of the Company issuing stock for the net assets of CF V, accompanied by a recapitalization. The net assets of CF V were stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Merger represent those of the Company.

The transaction resulted in net cash proceeds of $168 million, after transaction expenses and debt repayment, through the contribution of cash held in CF V’s trust account, net of redemptions by CF V’s public stockholders, and a concurrent private placement offering led by SoftBank’s SBLA Advisers Corp. and Cantor Fitzgerald & Co. (“CF&Co.”), among other institutional investors, and the Liberty Investment, as defined and described further below.

On the Closing Date, the Company consummated the Merger contemplated by the Merger Agreement, including the following:

Private Placement (“PIPE”) Investment

Pursuant to the relevant subscription agreement, the Company issued 5,816,770 Class A ordinary shares and a non-redeemable warrant (“PIPE Warrant”) to purchase 2,500,000 Class A ordinary shares to a PIPE investor at an exercise price of $20.00 per share, for an aggregate purchase price of $58.2 million.

Forward Purchase Agreement

In July 2021, CFAC Holdings V, LLC (the “Sponsor”), CF V, and Satellogic entered into the Amended and Restated Forward Purchase Agreement (“FPA”), pursuant to which Satellogic issued to the Sponsor 1,250,000 Class A ordinary shares, and warrants to purchase an additional 333,333 Class A ordinary shares at an exercise price of $11.50 per share (“Forward Purchase Warrant”), for an aggregate purchase price of $10 million.

Cantor Loan

Satellogic and Cantor Fitzgerald Securities (“CF Securities”) entered into a Secured Promissory Note, dated December 23, 2021 (the “Promissory Note”), pursuant to which CF Securities agreed to loan $7.5 million to Satellogic (the “Cantor Loan”). On January 18, 2022, CF Securities, Satellogic and Nettar entered into the Promissory Note Waiver Letter (the “Promissory Note Waiver Letter”) pursuant to which Satellogic and CF Securities agreed that the Company would repay the Cantor Loan, including all principal and interest by the issuance of 788,021 Class A ordinary shares. Such repayment occurred on the Closing Date.

Redeemable Series X Preferred Stock

Per the transaction, the 2,033,230 outstanding shares of redeemable Series X preferred stock and accrued dividends in the combined amount of $21.4 million were converted to 2,140,340 shares of Class A common stock.

Liberty Investment

On January 18, 2022, Satellogic and CF V entered into the Liberty Subscription Agreement with an investor (the “Liberty Investor”). Satellogic agreed to issue and sell to the Liberty Investor (i) 20,000,000 shares of Class A ordinary shares, (ii) a warrant to purchase up to 5,000,000 of Satellogic’s Class A ordinary shares at an exercise price of $10.00 per share (the “$10.00 Liberty Warrant”), and (iii) a warrant to purchase up to 15,000,000 of Satellogic’s Class A ordinary shares at an exercise price of $15.00 per share (the “$15.00 Liberty Warrant,” and together with the $10.00 Liberty Warrant, the “Liberty Warrants”), in a private placement for an aggregate purchase price of $150.0 million. The transaction closed on February 10, 2022 (the “Liberty Closing” and the transaction collectively, the “Liberty Investment”).

An advisory fee is payable by Satellogic in exchange for advisory services to be provided to Satellogic from time to time until a Cessation Event (as defined in the Liberty Subscription Agreement). The advisory fee includes a warrant to purchase 2,500,000 of Satellogic’s Class A ordinary shares at an exercise price of $10.00 per share (the “Liberty Advisory Fee Warrant”), which was issued at the Liberty Closing, and for so long as a Cessation Event has not occurred, $1.25 million to be paid in cash on the 18-month anniversary of the Liberty Closing and on the last day (or, if not a business day, the immediately following business day) of each of the following five successive three-month anniversaries of such 18-month anniversary (each, an “Advisory Fee Cash Payment” and together, the “Advisory Fee Cash Payments”), representing an aggregate of up to $7.5 million in Advisory Fee Cash Payments.

The Liberty Advisory Fee Warrant became exercisable as of and from February 10, 2023, and will expire on the fifth anniversary of the Liberty Closing (i.e., February 10, 2027). The Liberty Advisory Fee Warrant is subject to substantially the same terms as the Liberty Warrants.

Transaction Fees

On January 18, 2022, CF V, the Company and CF&Co. entered into the CF Fee Letter, pursuant to which they agreed to pay cash of $5.0 million and issue an aggregate of 2,058,229 of Satellogic’s Class A ordinary shares in payment of certain Merger-related transaction fees. Such payments were made on the Closing Date.

Company Stockholders

In connection with the Merger Transaction:

•

the ordinary shares and preferred shares of Nettar that were issued and outstanding immediately prior to the Merger were automatically cancelled and ceased to exist in exchange for Satellogic’s Class A ordinary shares, as determined in accordance with the Merger Agreement;

•

all Convertible Notes of Nettar converted into Nettar Preferred Shares which were exchanged for shares of Satellogic’s Class A ordinary shares as determined in the Merger Agreement;

•

all options to purchase ordinary shares of Nettar were assumed by the Company and became options to purchase Satellogic’s Class A ordinary shares as determined in accordance with the Merger Agreement;

•

the Columbia Warrant (as defined below) outstanding immediately prior to the Merger became exercisable for that number of Satellogic’s Class A ordinary shares as determined in accordance with the Merger Agreement.

The following table illustrates the shares issued to our stockholders after giving effect to the 3.3028 Exchange Ratio in accordance with the transactions contemplated by the Merger Agreement as of the Closing Date and the issuance of shares pursuant to the transactions described above:

Company stockholders	Shares
Class A stockholders immediately prior to merger		17,215,336
Series A preferred stockholders		7,968,316
Series B preferred stockholders		4,597,928
Series B-1 preferred stockholders		2,171,399
2018 convertible noteholders		5,581,416
2019 convertible noteholders		7,846,333
2020 convertible noteholders		4,553,205
Redeemable Series X preferred stockholders		2,140,340
Liberty investors		20,000,000
PIPE investors		5,816,770
Shares issued for Cantor loan repayment		788,021
Shares issued to Sponsor under Forward Purchase Securities Agreement		1,250,000
Issuance of shares for transaction fees		2,058,229
CF V shares		6,837,354
		88,824,647

4. Reverse Recapitalization

On January 25, 2022, and pursuant to the Merger Agreement, the Merger was accounted for as a reverse recapitalization (the “Reverse Recapitalization”) in accordance with U.S. GAAP. Under this method of accounting, CF V was treated as the “acquired” company and Satellogic was treated as the acquirer for financial reporting purposes. Accordingly, for accounting purposes, the reverse recapitalization was treated as the equivalent of the Company issuing stock for the net assets of CF V, accompanied by a recapitalization. The net assets of CF V were stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Merger represent those of the Company.

On the Closing Date, the Company consummated the Merger contemplated by the Merger Agreement, including the following:

Private Placement (“PIPE”) Investment

Pursuant to the relevant subscription agreement, Satellogic issued 5,816,770 Class A ordinary shares and a non-redeemable warrant (“PIPE Warrant”) to purchase 2,500,000 Class A ordinary shares to a PIPE investor at an exercise price of $20.00 per share, for an aggregate purchase price of $58.2 million.

Forward Purchase Agreement

Cantor Loan

Redeemable Series X Preferred Stock

Per the transaction, the 2,033,230 outstanding shares of redeemable Series X preferred stock and accrued dividends in the amount of $21.4 million were converted to 2,140,340 Class A ordinary shares.

Liberty Investment

On January 18, 2022, Satellogic and CF V entered into the Liberty Subscription Agreement with an investor (the “Liberty Investor”). Satellogic agreed to issue and sell to the Liberty Investor (i) 20,000,000 of Satellogic’s Class A ordinary shares (the “Liberty Shares”), (ii) a warrant to purchase up to 5,000,000 Satellogic’s Class A ordinary shares at an exercise price of $10.00 per share (the “$10.00 Liberty Warrant”), and (iii) a warrant to purchase up to 15,000,000 of Satellogic’s Class A ordinary shares at an exercise price of $15.00 per share (the “$15.00 Liberty Warrant”, and together with the $10.00 Liberty Warrant, the “Liberty Warrants”), in a private placement for an aggregate purchase price of $150.0 million. The transaction closed on February 10, 2022 (the “Liberty Closing” and the transaction collectively, the “Liberty Investment”).

Transaction Fees

On January 18, 2022, CF V, Satellogic and CF&Co. entered into the CF Fee Letter, pursuant to which Satellogic agreed to pay cash of $5.0 million and issue an aggregate of 2,058,229 of Satellogic’s Class A ordinary shares in payment of certain Merger-related transaction fees. Such payments were made on the Closing Date.

Company Stockholders

In connection with the Merger transaction:

•

the common stock and preferred stock of Nettar that were issued and outstanding immediately prior to the Merger were automatically canceled and ceased to exist in exchange for Satellogic’s Class A ordinary shares, as determined in accordance with the Merger Agreement;

•

all Convertible Notes of Nettar converted into Nettar Preferred Shares which were exchanged for shares of Satellogic’s Class A ordinary shares as determined in the Merger Agreement;

•

all options to purchase common stock of Nettar were assumed by the Company and became options to purchase Satellogic’s Class A ordinary shares as determined in accordance with the Merger Agreement;

•

Company stockholders	Shares
Class A stockholders immediately prior to merger		17,215,336
Series A preferred stockholders		7,968,316
Series B preferred stockholders		4,597,928
Series B-1 preferred stockholders		2,171,399
2018 convertible noteholders		5,581,416
2019 convertible noteholders		7,846,333
2020 convertible noteholders		4,553,205
Redeemable Series X preferred stockholders		2,140,340
Liberty investors		20,000,000
PIPE investors		5,816,770
Shares issued for Cantor loan repayment		788,021
Shares issued to Sponsor under Forward Purchase Securities Agreement		1,250,000
Issuance of shares for transaction fees		2,058,229
CF V shares		6,837,354
		88,824,647

Note 7 - Earnout Liabilities (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Schedule of Earnout Liability [Table Text Block]

	Sponsor Earnout
As of December 31, 2022	$	1,353
Change in fair value of financial instruments		(1,130	)
As of September 30, 2023	$	223

	Sponsor Earnout			Forfeiture Earnout			Total Earnout Liabilities
As of December 31, 2021	$	—		$	—		$	—
Additions	$	8,022		$	6,135		$	14,157
Change in fair value of financial instruments		(6,669	)		(5,130	)		(11,799	)
Reclassification to equity		—			(1,005	)		(1,005	)
As of December 31, 2022	$	1,353		$	—		$	1,353

Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]

	September 30, 2023			December 31, 2022
Expected term (in years)		3.32			4.07
Dividend yield (%)		—	%		—	%
Expected volatility		67.3	%		50.4	%
Risk-free interest rate		4.8	%		4.1	%
Expected number of shares		1,775,962			1,775,962

	January 25,			December 31,
	2022			2022
Expected term (in years)		5.00			4.07
Dividend yield (%)		—			—
Expected volatility		30	%		50.4	%
Risk-free interest rate		1.6	%		4.1	%
Expected number of shares		1,842,759			1,775,962

Note 7 - Earnout Liabilities - Schedule of Earnout Liabilities (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Balance	$ 1,353	$ 0
Additions		14,157
Change in fair value of financial instruments		(11,799)
Reclassification to equity		(1,005)
Balance	223	1,353
Sponsor Earnout [Member]
Balance	1,353	0
Additions		8,022
Change in fair value of financial instruments	(1,130)	(6,669)
Reclassification to equity		0
Balance	223	1,353
Forfeiture Earnout [Member]
Balance	1,000	0
Additions		6,135
Change in fair value of financial instruments		(5,130)
Reclassification to equity		(1,005)
Balance	$ 1,000	$ 1,000

Note 15 - Fair Value Measurement and Financial Instruments (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

As of September 30, 2023	Fair value measurement using
Financial instruments	Quoted prices in active markets (Level 1)		Significant observable inputs (Level 2)		Significant unobservable inputs (Level 3)
$8.63 Warrants liability	$	704	$	—	$	—
PIPE Warrant liability		—		—		59
Liberty Warrants and Liberty Advisory Fee Warrant liability		—		—		1,182
Total Warrant Liabilities	$	704	$	—	$	1,241
Sponsor Earnout Liability	$	—	$	—	$	223

As of December 31, 2022	Fair value measurement using
Financial instruments	Quoted prices in active markets (Level 1)		Significant observable inputs (Level 2)		Significant unobservable inputs (Level 3)
$8.63 Warrants liability	$	1,833	$	—	$	—
PIPE Warrant liability		—		—		311
Liberty Warrants and Liberty Advisory Fee Warrant liability		—		—		6,191
Total Warrant Liabilities	$	1,833	$	—	$	6,502
Sponsor Earnout Liability	$	—	$	—	$	1,353

As of December 31, 2022	Fair value measurement using
Financial instruments	Quoted prices in active markets (Level 1)		Significant observable inputs (Level 2)		Significant unobservable inputs (Level 3)
$8.63 Warrants liability	$	1,833	$	—	$	—
PIPE Warrant liability		—		—		311
Liberty Warrants and Liberty Advisory Fee Warrant liability		—		—		6,191
Total Warrant Liabilities	$	1,833	$	—	$	6,502
Sponsor Earnout liability	$	—	$	—	$	1,353

As of December 31, 2021	Fair value measurement using
Financial instruments	Quoted prices in active markets (Level 1)		Significant observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Liabilities measured at fair value
Cantor Loan	$	—	$	—	$	7,522
Columbia Warrant liability		—		—		143,237
Liabilities for which fair values are disclosed
Notes	$	—	$	180,356	$	—
Promissory notes		—		40,925		—

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

	Liberty Warrants and Liberty Advisory Fee Warrant			PIPE Warrant			Columbia Warrant		Sponsor Earnout			Forfeiture Earnout		Cantor Loan
At June 30, 2022	$	15,377		$	952		$	—	$	3,111		$	—	$	—
Issues		—			—			—		—			—		—
Remeasurement (gain)/loss		(4,026	)		(415	)		—		(537	)		—		—
Write-off of deferred costs		—			—			—		—			—		—
Settlements		—			—			—		—			—		—
At September 30, 2022	$	11,351		$	537		$	—	$	2,574		$	—	$	—

At June 30, 2023	$	2,339		$	109		$	—	$	504		$	—	$	—
Remeasurement (gain)/loss		(1,157	)		(50	)		—		(281	)		—		—
At September 30, 2023	$	1,182		$	59		$	—	$	223		$	—	$	—

	Liberty Warrants and Liberty Advisory Fee Warrant			PIPE Warrant			Columbia Warrant			Sponsor Earnout			Forfeiture Earnout			Cantor Loan
At January 1, 2022	$	—		$	—		$	143,237		$	—		$	—		$	7,522
Issues		30,853			1,312			—			8,022			6,135			—
Remeasurement (gain)/loss⁽¹⁾		(19,502	)		(775	)		(18,635	)		(5,448	)		(5,130	)		489
Write-off of deferred costs		—			—			203			—			—			—
Settlements ⁽²⁾		—			—			(124,805	)		—			(1,005	)		(8,011	)
At September 30, 2022	$	11,351		$	537		$	—		$	2,574		$	—		$	—

At January 1, 2023	$	6,191		$	311		$	—		$	1,353		$	—		$	—
Remeasurement (gain)/loss ⁽¹⁾		(5,009	)		(252	)		—			(1,130	)		—			—
At September 30, 2023	$	1,182		$	59		$	—		$	223		$	—		$	—

	Liberty Warrants and Liberty Advisory Fee Warrant			PIPE Warrant			Columbia Warrant			Sponsor Earnout			Forfeiture Earnout			Cantor Loan
At January 1, 2021	$	—		$	—		$	—		$	—		$	—		$	—
Issues		—			—			161,432			—			—			7,513
Remeasurement (gain)/loss⁽¹⁾		—			—			(17,992	)		—			—			9
Amortization of deferred costs		—			—			(203	)		—			—			—
At December 31, 2021		—			—			143,237			—			—			7,522
Issues		30,853			1,312			—			8,022			6,135			—
Remeasurement (gain)/loss⁽¹⁾		(24,662	)		(1,001	)		(18,635	)		(6,669	)		(5,130	)		488
Write-off of deferred costs		—			—			203			—			—			—
Settlements ⁽²⁾		—			—			(124,805	)		—			(1,005	)		(8,010	)
At December 31, 2022	$	6,191		$	311		$	—		$	1,353		$	—		$	—

Note 21 - Equity Method Investment (Details Textual) - USD ($) $ in Thousands		9 Months Ended		12 Months Ended
	May 06, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Payments to Acquire Equity Method Investments		$ (0)	$ 3,604	$ 3,653	$ 0	$ 0
Warrants and Rights Outstanding, Term (Year)	36 months
OS [Member]
Equity Method Investment, Ownership Percentage	5.00%
Payments to Acquire Equity Method Investments	$ 3,700
OS [Member] \| Warrant [Member]
Class of Warrant or Right, Outstanding (in shares)	524,715

Note 7 - Earnout Liabilities (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2022	Jan. 25, 2022	Dec. 31, 2021	Jul. 05, 2021
Earnout Liability		$ 223	$ 1,353		$ 0
Sponsor Earnout [Member]
Earnout Liability		$ 223	1,353		0
Sponsor Earnout [Member] \| Closing Price 1 [Member]
Contingent Consideration, Liability, Earnout Period, Stock Price Trigger (in dollars per share)						$ 12.5
Sponsor Earnout [Member] \| Closing Price 2 [Member]
Contingent Consideration, Liability, Earnout Period, Stock Price Trigger (in dollars per share)						15
Sponsor Earnout [Member] \| Closing Price 3 [Member]
Contingent Consideration, Liability, Earnout Period, Stock Price Trigger (in dollars per share)						$ 20
Sponsor Earnout [Member] \| Common Class A [Member]
Contingent Consideration, Liability, Shares (in shares)						1,869,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number (in shares)	1,775,962	1,775,962
Forfeiture Earnout [Member]
Earnout Liability		$ 1,000	$ 1,000	$ 6,100	$ 0
Forfeiture Earnout [Member] \| Closing Price 1 [Member]
Contingent Consideration, Liability, Earnout Period, Stock Price Trigger (in dollars per share)				$ 10
Forfeiture Earnout [Member] \| Closing Price 2 [Member]
Contingent Consideration, Liability, Earnout Period, Stock Price Trigger (in dollars per share)				$ 15
Forfeiture Earnout [Member] \| Common Class A [Member]
Contingent Consideration, Shares in Escrow (in shares)				310,127

Note 2 - Summary of Significant Accounting Policies

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Significant Accounting Policies [Text Block]

2. Summary of Significant Accounting Policies

Use of Estimates

Revenue Recognition

The nature of our contracts does not currently give rise to variable consideration related to returns or refunds as those are not offered.

We exclude amounts collected on behalf of third parties, such as sales taxes, when determining transaction price.

Contract liabilities consist of payments received from customers, or such consideration that is contractually due, in advance of providing the product or performing services.

Fair Value Measurement

Certain assets and liabilities are carried at fair value in accordance with U.S. GAAP.

•

Level 1: Quoted prices in active markets for identical assets or liabilities.

•

Level 2: Valuation techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable.

•

Level 3: Valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable.

For fair value disclosures, classes of assets and liabilities are based on the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy.

Credit risk management

The credit risk in respect of cash balances held with banks and deposits with banks are managed via diversification of bank deposits and are only with major reputable financial institutions.

Impairment of Assets

Equity Method Investments

Stock-Based Compensation

The fair values for stock options are calculated using the Black-Scholes option pricing model using the following inputs:

Expected term - The simplified method is used to calculate the expected term.

Expected volatility - We determine the expected stock price volatility based on the historical volatilities of guideline companies from comparable industries.

Risk-free interest rate - We base our interest rate on a treasury instrument for which the term is commensurate with the maximum expected life of the stock options.

The fair values for restricted stock units ("RSUs") with service-based vesting conditions are calculated based upon our closing stock price on the date of the grant.

Foreign Currencies

Leases

For the periods presented, the Company does not have any financing type leases.

Accounts Receivable and Allowance for Credit Losses

	Nine Months Ended September 30,
	2023		2022
Allowance for credit losses as of beginning of period	$	3,237	$	1,794
Provision		80		1,736
Allowance for credit losses as of end of period	$	3,317	$	3,530

Cash, Cash Equivalents and Restricted Cash

Restricted cash, including amounts in Other non-current assets, represents amounts pledged as guarantees for sales and lease agreements as contractually required.

	September 30, 2023		December 31, 2022
Cash and cash equivalents	$	30,971	$	76,528
Restricted cash		—		126
Restricted cash included in Other non-current assets		1,151		1,138
Total cash, cash equivalents and restricted cash	$	32,122	$	77,792

2. Summary of Significant Accounting Policies

Use of Estimates

Revenue Recognition

The nature of our contracts does not currently give rise to variable consideration related to returns or refunds as those are not offered.

We evaluate contracts with a minimum purchase commitment to determine whether we expect to be entitled to a breakage amount. We consider the requirements on constraining estimates variable consideration. The following factors are evaluated when assessing the increased likelihood of a significant revenue reversal: (i) the amount of consideration is highly susceptible to factors outside our influence or control (e.g., volatility in a market, judgment of action of third parties, weather conditions), (ii) uncertainty about the amount of consideration is not expected to be resolved for a long period of time, (iii) our experience with similar types of contracts is limited, or that experience has limited predictive value, (iv) we have a practice of either offering a broad range of price concessions or changing the payment terms and conditions of similar contracts in similar circumstances, and (v) the contract has a large number and broad range of possible consideration amounts.

We exclude amounts collected on behalf of third parties, such as sales taxes, when determining transaction price.

Contract liabilities consist of payments received from customers, or such consideration that is contractually due, in advance of providing the product or performing services.

Fair Value Measurement

Certain assets and liabilities are carried at fair value in accordance with U.S. GAAP.

•

Level 1: Quoted prices in active markets for identical assets or liabilities.

•

Level 2: Valuation techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable.

•

Level 3: Valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable.

For fair value disclosures, classes of assets and liabilities are based on the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy.

Credit risk management

The credit risk in respect of cash balances held with banks and deposits with banks are managed via diversification of bank deposits and are only with major reputable financial institutions.

Impairment of Assets

We assess potential impairments to long-lived assets whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable. An impairment is considered to exist if the total estimated future cash flows on an undiscounted basis are less than the carrying amount of the assets or asset group. We performed an impairment test as of December 31, 2022, 2021 and 2020 due to our net loss for those years and concluded that the asset group is not impaired.

If estimates or underlying assumptions change in the future, we may be required to record impairment charges. If the fair value of an asset group is less than its carrying amount, then the carrying amount of the asset group would be reduced to its fair value. That reduction is an impairment loss that would be recognized in the Consolidated Statements of Operations and Comprehensive Loss.

Equity Method Investments

We account for equity investments in which we have significant influence, but not a controlling financial interest, using the equity method of accounting. Under the equity method of accounting, investments are initially recorded at cost, less impairment, and subsequently adjusted to recognize our share of earnings or losses as a component of Other income (expense), net in the Consolidated Statements of Operations and Comprehensive Loss. Our equity method investments are required to be reviewed for impairment when it is determined there may be an other-than-temporary loss in value. We have not recorded any impairment losses related to our equity method investments during the year ended December 31, 2022. We did not hold any equity investments in 2021 or 2020.

Stock-Based Compensation

The fair values for stock options are calculated using the Black-Scholes option pricing model using the following inputs:

Expected term - The simplified method is used to calculate the expected term.

Expected volatility - We determine the expected stock price volatility based on the historical volatilities of guideline companies from comparable industries.

Risk-free interest rate - We base our interest rate on a treasury instrument for which the term is commensurate with the maximum expected life of the stock options.

The fair values for restricted stock units ("RSUs") with service-based vesting conditions are calculated based upon our closing stock price on the date of the grant.

Foreign Currencies

Aggregate foreign currency gains and losses, such as those resulting from the settlement of receivables or payables, foreign currency contracts and short-term intercompany advances in a currency other than the relevant subsidiary’s functional currency, are recorded currently in the Consolidated Statements of Operations and Comprehensive Loss (included in other income, net) and resulted in gains of $1,576, $1,022, and $594 during the years ended December 31, 2022, 2021, and 2020, respectively.

Leases

We determine if a contract is a lease or contains a lease at inception. On the lease commencement date, we recognize a right-of-use (“ROU”) asset and lease liability related to operating type leases. The cost of ROU assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Operating lease liabilities are recorded based on the present value of the future lease fixed payments. In determining the present value of future lease payments, we use our incremental borrowing rate applicable to the economic environment and the duration of the lease based on the information available at the commencement date as the majority of leases do not provide an implicit rate. For real estate and equipment contracts, we generally account for the lease and non-lease components as a single lease component. In assessing the lease term, we include options to renew only when we are reasonably certain that such option(s) will be exercised; a determination which is at our sole discretion. Variable lease payments are recognized as expenses in the period incurred. For leases with an initial term of 12 months or less, we have elected to not record an ROU asset and lease liability. We record lease expense on a straight-line basis over the shorter of the lease term and the estimated useful lives of the assets, beginning on the commencement date.

For the periods presented, we do not have any financing type leases.

Accounts Receivable and Allowance for Doubtful Accounts

	December 31,
	2022			2021
Allowance for doubtful accounts as of beginning of period	$	1,794		$	—
Provision		1,736			1,794
Write-offs		—			—
Foreign exchange and other		(293	)		—
Allowance for doubtful accounts as of end of period	$	3,237		$	1,794

Cash, Cash Equivalents and Restricted Cash

Restricted cash, including amounts in Other non-current assets, represents amounts pledged as guarantees for sales and lease agreements as contractually required.

	December 31,
	2022		2021
Cash and cash equivalents	$	76,528	$	8,533
Restricted cash		126		—
Restricted cash included in Other non-current assets		1,138		—
Total cash, cash equivalents and restricted cash	$	77,792	$	8,533

Cash Flow Information

	Year Ended December 31,
	2022		2021		2020
Cash paid during the period for:
Income tax, net of refunds	$	758	$	96	$	59
Interest	$	3,520	$	49,283	$	27,286

Note 10 - Income Tax (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]

	Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022
Loss before income tax	$	(13,550	)	$	(11,840	)	$	(41,277	)	$	(17,818	)
Provision for income tax		4,069			2,983		$	6,193		$	5,126
Effective tax rate		(30.0	%)		(25.2	%)		(15.0	%)		(28.8	%)

	Year Ended December 31,
	2022		2021			2020
Current	$	2,972	$	1,387		$	186
Deferred		1,601		(1,619	)		(38	)
Total provision for (benefit from) income tax	$	4,573	$	(232	)	$	148

Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]

	Nine Months Ended September 30,
	2023
Balance at January 1, 2023	$	3,889
Increases (decreases) in tax positions related to prior periods		(1,974	)
Balance at September 30, 2023	$	1,915

	Year Ended December 31,
	2022
Balance at January 1	$	—
Increases (decreases) in tax positions related to the current period		—
Increases (decreases) in tax positions related to prior periods		3,889
Increases (decreases) related to prior year tax positions as a result of lapse of statute		—
Balance at December 31	$	3,889

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

	Year Ended December 31,
	2022			2021			2020
Loss before income tax	$	(32,068	)	$	(96,537	)	$	(21,381	)

Provision for (benefit from) income tax at weighted-average statutory rates		—			—			—
U.S. state and local income tax, net of federal benefit		(3	)		5			(4	)
U.S. foreign-derived intangible income deduction		(141	)		(200	)		—
Argentina Tax Inflation Adjustment		239			(381	)		(198	)
Change in valuation allowances		4,283			3,648			1,198
Uncertain tax positions		2,293			—			—
Change in carryforward attributes		(1,740	)		—			—
Effect of rates different than statutory		(423	)		(3,300	)		(828	)
Tax credits		(112	)		—			—
Other		177			(4	)		(20	)
Total	$	4,573		$	(232	)	$	148

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

	December 31,
	2022			2021
Deferred income tax assets:
Stock-based compensation	$	3,023		$	2,053
Bad debt expense		415			407
Deferred financing costs		806			—
Other		193			419
Net operating loss carryforwards		1,365			6,245
Total deferred income tax assets		5,802			9,124
Valuation allowance		(5,802	)		(7,484	)
Total deferred income tax assets (liabilities), net	$	—		$	1,640

Summary of Operating Loss Carryforwards [Table Text Block]

Net Operating Loss	Expiration	Gross Amount Carried Forward		Net Amount Recognized as of December 31, 2022
Argentina	December 31, 2023 - December 31, 2027	$	7,864	$	—
Netherlands	Indefinite		2,856		—
China	December 31, 2026 - December 31, 2027		2,258		—
United States	Indefinite		280		—
Uruguay	December 31, 2026 - December 31, 2027		19		—

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands

3 Months Ended

9 Months Ended

12 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Sep. 30, 2023

Sep. 30, 2022

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Cost of sales, exclusive of depreciation shown separately below

$ 1,196

$ 2,158

$ 4,380

$ 4,546

$ 6,012

$ 4,247

$ 0

Costs and expenses

1,046

969

3,159

2,298

3,284

1,876

5,865

6,308

15,732

30,917

37,191

36,640

^[1],[2]

8,003

^[1],[2]

2,169

3,941

7,996

9,657

13,055

9,636

^[3]

5,924

^[3]

5,420

4,031

14,030

10,516

14,326

10,728

^[3]

3,031

^[3]

4,852

6,992

17,930

20,728

29,023

14,002

5,449

19,352

22,241

58,847

74,116

96,879

72,882

22,407

(18,156)

(20,083)

(54,467)

(69,570)

(90,867)

(68,635)

(22,407)

Other income (expense), net

389

381

1,471

(1,225)

(652)

(9,738)

^[2],[4]

1,940

6,270

7,520

50,866

58,311

17,983

^[4]

9,637

^[4]

2,277

1,592

4,199

2,111

1,140

1,069

^[2]

594

^[2]

4,606

8,243

13,190

51,752

58,799

(27,902)

1,026

Income tax (expense) benefit

(13,550)

(11,840)

(41,277)

(17,818)

(32,068)

(96,537)

(21,381)

(4,069)

(2,983)

(6,193)

(5,126)

(4,573)

232

(148)

(17,619)

(14,823)

(47,470)

(22,944)

(36,641)

(96,305)

(21,529)

Other comprehensive loss

(294)

(373)

(218)

(695)

(226)

(86)

Basic loss per share for the period attributable to common stockholders (in dollars per share)

$ (17,913)

$ (15,196)

$ (47,688)

$ (23,639)

$ (36,867)

$ (96,391)

$ (21,529)

$ (0.2)

$ (0.17)

$ (0.53)

$ (0.28)

$ (0.44)

$ (5.78)

^[5]

$ (1.34)

^[5]

Basic weighted-average common shares outstanding (in shares)

89,739,310

89,002,430

89,476,065

81,221,550

83,188,276

^[6]

16,655,634

^[5],[6]

16,029,826

^[5],[6]

Diluted loss per share for the period attributable to common stockholders (in dollars per share)

$ (0.2)

$ (0.37)

$ (0.53)

$ (0.5)

$ (0.66)

$ (5.78)

^[5]

$ (1.34)

^[5]

Diluted weighted-average common shares outstanding (in shares)

89,739,310

90,413,087

89,476,065

82,632,207

83,798,149

16,655,634

^[5]

16,029,826

^[5]

[1]	Certain awards granted by us have a service inception date preceding the grant date. Under IFRS, this resulted in the recognition of stock-based compensation expense prior to the grant date. Under U.S. GAAP, the stock-based compensation expense shall not be recognized until authorization at the grant date.
[2]	Under IFRS, all recognized leases are accounted for similarly to finance leases. Under U.S. GAAP, there is a dual classification on-balance sheet lease accounting model for lessees: finance and operating leases. Operating leases create a straight-line expense, and no interest expense is recognized on the lease liability.
[3]	Under IFRS, certain development expenditures may be capitalized. Under U.S. GAAP, all of our costs relating to R&D activities are expensed as incurred.
[4]	Under IFRS, the redeemable Series X preferred shares and convertible notes contained conversion features that resulted in a bifurcated derivative component with changes in fair value recognized as gain or (loss). Under U.S. GAAP, the conversion features did not result in a material bifurcated embedded derivative, resulting in the elimination of the change in fair value of financial instruments, reduction in interest expense and preferred dividends expense, and increase in the gain (loss) on extinguishment of debt. Under IFRS, it was determined that the redeemable Series X preferred shares should be classified as a liability since there is a contractual obligation to deliver cash or another financial asset and certain conversion events being beyond our control. Under U.S. GAAP, it was determined that the redeemable Series X preferred shares should be classified as mezzanine equity since the shares are redeemable based on events outside of our control. Under IFRS, it was determined that the Columbia Warrant should be classified as equity since settlement would only occur by exchanging a fixed amount of cash for a fixed number of our own equity instruments. Changes in fair value are not recognized. Under U.S. GAAP, it was determined that the Columbia Warrant should be classified as a liability since the number and type of shares received could be different pre- and post- Merger. The Columbia Warrant is recorded at fair value with changes recognized in the Consolidated Statement of Operations and Comprehensive Loss. Additionally, the resulting gain (loss) on extinguishment of the amended convertible notes differed under IFRS versus U.S. GAAP.
[5]	The change in net loss in the adoption of U.S. GAAP as described in items a-d above impacted net loss per share as follows:
[6]	After applying the 3.3028 Exchange Ratio as described in Note 4 (Reverse Recapitalization).

Note 17 - Debt - Summary of Debt (Details) $ in Thousands	Dec. 31, 2021 USD ($)
Long-Term Debt, Gross	$ 108,473
Less deferred financing costs	0
Total debt less deferred financing fees	108,473
Less: Current portion	0
Total non-current debt, net of deferred financing fees	108,473
Convertible Debt [Member] \| A2018 Convertible Notes [Member]
Long-Term Debt, Gross	19,862
Convertible Debt [Member] \| A2019 Convertible Notes [Member]
Long-Term Debt, Gross	27,498
Convertible Debt [Member] \| A2020 Convertible Notes [Member]
Long-Term Debt, Gross	15,294
Loans Payable [Member] \| Cantor Loan [Member]
Long-Term Debt, Gross	7,522
Notes Payable, Other Payables [Member]
Long-Term Debt, Gross	$ 38,297

Note 6 - Warrant Liabilities

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Warrant Liabilities Disclosure [Text Block]

6. Warrant Liabilities

	Liberty Warrants and Liberty Advisory Fee Warrant			PIPE Warrant			*$8.63* Warrants			Total Warrants
As of December 31, 2022	$	6,191		$	311		$	1,833		$	8,335
Warrants issued	$	—		$	—		$	—		$	—
Change in fair value of financial instruments		(5,009	)		(252	)		(1,129	)		(6,390	)
As of September 30, 2023	$	1,182		$	59		$	704		$	1,945

Liberty Warrants and Liberty Advisory Fee Warrant

The Liberty Warrants and the Liberty Advisory Fee Warrant were initially recognized as a liability with a fair value of $30.9 million. The Liberty Warrants and the Liberty Advisory Fee Warrant remain unexercised and were remeasured to fair value of $1.2 million as of September 30, 2023.

PIPE Warrant

The PIPE Warrant was initially recognized as a liability with a fair value of $1.3 million. The PIPE Warrant remains unexercised and was remeasured to fair value of $59 thousand as of September 30, 2023.

$8.63 Warrants

In connection with the Merger, we entered into an Assignment, Assumption and Amendment Agreement (the “Amended Warrant Agreement”), dated January 25, 2022 with the Sponsor and CF V that amends the Warrant Agreement (the “Existing Warrant Agreement”), dated January 28, 2021.

Pursuant to the Existing Warrant Agreement we issued Public Warrants to purchase 8,333,333 Class A ordinary shares and 200,000 Private Placement Warrants. Additionally, we agreed to issue the Forward Purchase Warrant to purchase 333,333 Class A ordinary shares pursuant to the Amended and Restated Forward Purchase Agreement (together, with the Public Warrants and the Private Placement Warrants, the “$8.63 Warrants”).

All of the $8.63 Warrants are governed by the Existing Warrant Agreement. The $8.63 Warrants became exercisable 30 days after the Closing Date, or February 25, 2022, and will expire five years after the Closing Date ( January 25, 2027), or earlier upon redemption or liquidation.

The $8.63 Warrants were initially recognized as a liability with a fair value of $4.9 million. On April 1, 2022, we determined pursuant to a warrant agreement executed by CF V on January 28, 2021, as modified and assumed by an assignment and assumption agreement executed on January 25, 2022, that the warrant price with respect to the warrants issued and outstanding was adjusted from $11.50 to $8.63 and the redemption price was adjusted from $18.00 to $13.50.

Public Warrants to purchase 613,111 shares of Class A ordinary shares were exercised during the nine months ended September 30, 2022.

6. Warrant Liabilities

	Liberty Warrants and Liberty Advisory Fee Warrant			PIPE Warrant			Columbia Warrant			$8.63 Warrants			Total Warrant Liabilities
As of December 31, 2021	$	—		$	—		$	143,237		$	—		$	143,237
Warrants issued	$	30,853		$	1,312		$	—		$	4,872		$	37,037
Change in fair value of financial instruments		(24,662	)		(1,001	)		(18,635	)		(2,702	)		(47,000	)
Write-off of deferred costs		—			—			203			—			203
Settlements		—			—			—			(337	)		(337	)
Reclassification to equity		—			—			(124,805	)		—			(124,805	)
As of December 31, 2022	$	6,191		$	311		$	—		$	1,833		$	8,335

Liberty Warrants and Liberty Advisory Fee Warrant

PIPE Warrant

The PIPE Warrant was initially recognized as a liability with a fair value of $1.3 million. The PIPE Warrant remains unexercised and was remeasured to fair value of $0.3 million as of December 31, 2022.

Columbia Warrant

In March 2021, we issued a warrant to purchase up to 15,931,360 shares of our common stock (“Columbia Warrant”) at an exercise price of $2.51635975 per share, or an aggregate of $40.1 million, in connection with the loan agreement between us and Columbia River Investment Limited (“Columbia”).

The Columbia Warrant is exercisable the earlier of 25 years from the effective date or the date in which the warrant is exercised in full.

The Columbia Warrant was initially recognized on March 8, 2021 as a liability with a fair value of $161.2 million, and was remeasured to a fair value of $143.2 million as of December 31, 2021. We recognized a gain from the remeasurement of the Columbia Warrant of $18.6 million for the year ended December 31, 2022. The fair value of the Columbia Warrant of $124.8 million was reclassified to additional paid-in capital in connection with the Merger.

$8.63 Warrants

In connection with the Merger, we entered into an Assignment, Assumption and Amendment Agreement (the “Amended Warrant Agreement”), dated January 25, 2022, with the Sponsor and CF V that amends the Warrant Agreement (the “Existing Warrant Agreement”), dated January 28, 2021.

Pursuant to the Existing Warrant Agreement, we issued Public Warrants to purchase 8,333,333 Class A ordinary shares and 200,000 private placement Warrants. Additionally, we agreed to issue the Forward Purchase Warrant to purchase 333,333 Class A ordinary shares pursuant to the Amended and Restated Forward Purchase Agreement (together, with the Public Warrants and the private placement Warrants, the “$8.63 Warrants”).

Public Warrants to purchase 613,111 Class A ordinary shares were exercised during the year ended December 31, 2022.

Note 2 - Summary of Significant Accounting Policies - Summary of Allowance for Credit Losses 1 (Details) - USD ($) $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Allowance for doubtful accounts as of beginning of period	$ 3,237	$ 1,794	$ 1,794	$ 0
Bad debt expense	80	1,736	1,736	1,794	$ 0
Allowance for doubtful accounts as of end of period	$ 3,317	$ 3,530	$ 3,237	$ 1,794	$ 0

Note 17 - Debt (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands

1 Months Ended

12 Months Ended

May 09, 2022

Jan. 25, 2022

Jul. 31, 2021

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

^[1]

Mar. 08, 2021

Gain (Loss) on Extinguishment of Debt

$ 0

$ (37,216)

^[1]

$ (9,240)

Treasury Stock, Value, Reacquired

$ 170,900

Columbia Warrants [Member]

Warrant Liability, Reclassifications To Equity

$ 124,800

Cantor Loan [Member]

Debt Conversion, Converted Instrument, Shares Issued (in shares)

26,050

Debt Instrument, Conversion Feature, Volume-Weighted Average Price (in dollars per share)

$ 8

Debt Instrument, Converted Instrument, Additional Shares Issued or Issuable (in shares)

197,005

Columbia Loan [Member]

Loans Payable

$ 40,100

Common Class A [Member]

Stock Issued During Period, Shares, Conversion of Convertible Securities (in shares)

1,250,000

Common Class A [Member] | Cantor Loan [Member]

Stock Issued During Period, Shares, Conversion of Convertible Securities (in shares)

788,021

Debt Instrument, Conversion Feature, Volume-Weighted Average Price (in dollars per share)

$ 10

Convertible Debt [Member]

Gain (Loss) on Extinguishment of Debt

$ 37,216

Convertible Debt [Member] | Common Class A [Member]

Debt Conversion, Converted Instrument, Shares Issued (in shares)

17,980,954

[1]

Under IFRS, the redeemable Series X preferred shares and convertible notes contained conversion features that resulted in a bifurcated derivative component with changes in fair value recognized as gain or (loss). Under U.S. GAAP, the conversion features did not result in a material bifurcated embedded derivative, resulting in the elimination of the change in fair value of financial instruments, reduction in interest expense and preferred dividends expense, and increase in the gain (loss) on extinguishment of debt. Under IFRS, it was determined that the redeemable Series X preferred shares should be classified as a liability since there is a contractual obligation to deliver cash or another financial asset and certain conversion events being beyond our control. Under U.S. GAAP, it was determined that the redeemable Series X preferred shares should be classified as mezzanine equity since the shares are redeemable based on events outside of our control. Under IFRS, it was determined that the Columbia Warrant should be classified as equity since settlement would only occur by exchanging a fixed amount of cash for a fixed number of our own equity instruments. Changes in fair value are not recognized. Under U.S. GAAP, it was determined that the Columbia Warrant should be classified as a liability since the number and type of shares received could be different pre- and post- Merger. The Columbia Warrant is recorded at fair value with changes recognized in the Consolidated Statement of Operations and Comprehensive Loss. Additionally, the resulting gain (loss) on extinguishment of the amended convertible notes differed under IFRS versus U.S. GAAP.

Note 21 - Equity Method Investment

12 Months Ended

Dec. 31, 2022

Equity Method Investments and Joint Ventures Disclosure [Text Block]

21. Equity Method Investment

On May 6, 2022, we entered into an Investment Agreement with OS, a company engaged in the design and production of telescopes and opto-mechanical and aerospace instrumentation for ground and space-based applications, to purchase 5% of OS’s outstanding common shares for $3.7 million. Additionally, OS issued 524,715 stock warrants to us, giving us the right to convert each warrant into a single common share over a period of up to 36 months. Emiliano Kargieman, our Chief Executive Officer, was appointed to OS’s board of directors. The investment was completed on September 30, 2022.

Note 4 - Reverse Recapitalization - Schedule of Reverse Recapitalization (Details)	Jan. 18, 2022 shares
Shares outstanding (in shares)	17,215,336
Issuance of shares for transaction fees (in shares)	2,058,229
Shares outstanding (in shares)	88,824,647
Forward Purchase Securities Agreement [Member]
Shares issued (in shares)	1,250,000
Cantor Loan Repayment [Member]
Shares issued (in shares)	788,021
Series A Preferred Stockholders [Member]
Shares issued (in shares)	7,968,316
Series B Preferred Stockholders [Member]
Shares issued (in shares)	4,597,928
Series B-1 Preferred Stockholders [Member]
Shares issued (in shares)	2,171,399
The 2018 Convertible Noteholders [Member]
Shares issued (in shares)	5,581,416
The 2019 Convertible Noteholders [Member]
Shares issued (in shares)	7,846,333
The 2020 Convertible Noteholders [Member]
Shares issued (in shares)	4,553,205
Redeemable Series X Preferred Stockholders [Member]
Shares issued (in shares)	2,140,340
Liberty Investors [Member]
Shares issued (in shares)	20,000,000
PIPE Investors [Member]
Shares issued (in shares)	5,816,770
CF V Sponsor [Member]
Shares issued (in shares)	6,837,354

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (47,470)	$ (22,944)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	14,030	10,516
Operating lease expense	2,112	1,475
Deferred tax expense (benefit)	0	5,126
Stock-based compensation	4,254	6,624
Interest expense	0	1,685
Change in fair value of financial instruments	(7,520)	(50,866)
Expenses related to Merger	0	10,937
Foreign exchange differences	(5,507)	(5,511)
Property and equipment impairments	379	0
Loss on disposal of property and equipment and right of use assets	24	128
Bad debt expense	80	1,736
Loss on equity-method investment	66	0
Non-cash change in contract liabilities	771	0
Changes in operating assets and liabilities:
Accounts receivable	(508)	(2,129)
Prepaid expenses and other current assets	1,035	(3,765)
Accounts payable	(290)	(3,687)
Contract liabilities	574	1,162
Accrued expenses and other liabilities	3,534	(3,938)
Operating lease liabilities	(1,696)	(1,312)
Net cash used in operating activities	(36,132)	(54,763)
Cash flows from investing activities:
Acquisitions of property and equipment	(12,304)	(19,862)
Equity investment in OS	0	(3,604)
Other	0	(30)
Net cash used in investing activities	(12,304)	(23,496)
Cash flows from financing activities:
Repurchase of stock	0	(8,603)
Tax withholding payments for vested equity-based compensation awards	(272)	0
Proceeds from exercise of Public Warrants	0	5,291
Proceeds from sale of common stock	0	166,675
Proceeds from exercise of stock options	249	37
Net cash provided by financing activities	(23)	163,400
Net increase in cash, cash equivalents and restricted cash	(48,459)	85,141
Effect of foreign exchange rate changes	2,789	3,633
Cash, cash equivalents and restricted cash - beginning of period	77,792	8,533
Cash, cash equivalents and restricted cash - end of period	$ 32,122	$ 97,307

Note 19 - Adoption of U.S. GAAP - Accounting Standards Update and Change in Accounting Principle (Details) - USD ($)
$ / shares in Units, $ in Thousands

3 Months Ended

9 Months Ended

12 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Sep. 30, 2023

Sep. 30, 2022

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Jun. 30, 2023

Jun. 30, 2022

Dec. 31, 2019

$ 1,196

$ 2,158

$ 4,380

$ 4,546

$ 6,012

$ 4,247

$ 0

Cost of sales

1,046

969

3,159

2,298

3,284

1,876

5,865

6,308

15,732

30,917

37,191

36,640

^[1],[2]

8,003

^[1],[2]

2,169

3,941

7,996

9,657

13,055

9,636

^[3]

5,924

^[3]

5,420

4,031

14,030

10,516

14,326

10,728

^[3]

3,031

^[3]

4,852

6,992

17,930

20,728

29,023

14,002

5,449

19,352

22,241

58,847

74,116

96,879

72,882

22,407

(18,156)

(20,083)

(54,467)

(69,570)

(90,867)

(68,635)

(22,407)

389

381

1,471

(1,225)

(652)

(9,738)

^[2],[4]

1,940

6,270

7,520

50,866

58,311

17,983

^[4]

9,637

^[4]

(37,216)

^[4]

(9,240)

^[4]

2,277

1,592

4,199

2,111

1,140

1,069

^[2]

594

^[2]

4,606

8,243

13,190

51,752

58,799

(27,902)

1,026

(13,550)

(11,840)

(41,277)

(17,818)

(32,068)

(96,537)

(21,381)

Income tax

4,069

2,983

6,193

5,126

4,573

(232)

148

(17,619)

(14,823)

(47,470)

(22,944)

(36,641)

(96,305)

(21,529)

(294)

(373)

(218)

(695)

(226)

(86)

Basic loss for the period attributable to common stockholders (in dollars per share)

$ (17,913)

$ (15,196)

$ (47,688)

$ (23,639)

$ (36,867)

$ (96,391)

$ (21,529)

$ (0.2)

$ (0.17)

$ (0.53)

$ (0.28)

$ (0.44)

$ (5.78)

^[5]

$ (1.34)

^[5]

Basic weighted-average common shares outstanding (in shares)

89,739,310

89,002,430

89,476,065

81,221,550

83,188,276

^[6]

16,655,634

^[5],[6]

16,029,826

^[5],[6]

Diluted loss for the period attributable to common stockholders (in dollars per share)

$ (0.2)

$ (0.37)

$ (0.53)

$ (0.5)

$ (0.66)

$ (5.78)

^[5]

$ (1.34)

^[5]

Diluted weighted-average common shares outstanding (in shares)

89,739,310

90,413,087

89,476,065

82,632,207

83,798,149

16,655,634

^[5]

16,029,826

^[5]

Cash and cash equivalents

$ 30,971

$ 76,528

$ 8,533

Accounts receivable, net of allowance of $3,317 and $3,237, respectively

1,718

1,388

1,196

3,245

3,198

2,695

Total current assets

35,934

81,240

12,424

42,728

47,981

32,530

Deferred income tax assets

9,331

8,171

2,955

$ 1,403

1,640

Other non-current assets

5,349

6,463

369

Total assets

93,342

143,855

49,918

Accounts payable

9,850

6,650

Debt

108,473

Warrant liabilities

1,945

8,335

143,237

2,034

2,176

985

3,286

1,941

935

Total current liabilities

7,481

6,417

23,435

21,461

30,072

283,715

7,641

6,063

2,083

1,000

499

522

2,552

Total liabilities

30,601

37,657

289,350

Treasury stock, at cost: 516,123 shares at September 30, 2023, and 516,123 shares at December 31, 2022

21,306

(8,603)

(170,949)

Accumulated other comprehensive loss

342,159

337,928

96,471

(530)

(312)

(86)

Total stockholders’ equity (deficit)

(270,285)

(222,815)

(186,174)

62,741

$ 118,129

62,741

$ 118,129

106,198

(260,738)

(25,828)

$ 79,245

$ 132,000

$ (5,449)

Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)

93,342

143,855

49,918

2,169

3,941

7,996

9,657

13,055

9,636

^[3]

5,924

^[3]

4,852

6,992

17,930

20,728

29,023

14,002

5,449

(13,550)

(11,840)

(41,277)

(17,818)

(32,068)

(96,537)

(21,381)

2,169

3,941

7,996

9,657

13,055

9,636

^[3]

5,924

^[3]

5,420

4,031

14,030

10,516

14,326

10,728

^[3]

3,031

^[3]

4,852

6,992

17,930

20,728

29,023

14,002

5,449

(13,550)

(11,840)

(41,277)

(17,818)

(32,068)

(96,537)

(21,381)

5,865

6,308

15,732

30,917

37,191

36,640

^[1],[2]

8,003

^[1],[2]

389

381

1,471

(1,225)

(652)

(9,738)

^[2],[4]

2,277

1,592

4,199

2,111

1,140

1,069

^[2]

594

^[2]

8,239

3,068

1,415

7,641

6,063

2,083

1,940

6,270

7,520

50,866

58,311

17,983

^[4]

9,637

^[4]

(37,216)

^[4]

(9,240)

^[4]

Basic weighted-average common shares outstanding (in shares)

$ (17,619)

$ (14,823)

$ (47,470)

$ (22,944)

$ (36,641)

$ (96,305)

$ (21,529)

89,739,310

89,002,430

89,476,065

81,221,550

83,188,276

^[6]

16,655,634

^[5],[6]

16,029,826

^[5],[6]

Basic loss per share for the period attributable to common stockholders (in dollars per share)

$ (0.2)

$ (0.17)

$ (0.53)

$ (0.28)

$ (0.44)

$ (5.78)

^[5]

$ (1.34)

^[5]

Diluted loss per share for the period attributable to common stockholders (in dollars per share)

$ (17,619)

$ (33,458)

$ (47,470)

$ (41,579)

$ (55,276)

$ (96,305)

$ (21,529)

$ (0.2)

$ (0.37)

$ (0.53)

$ (0.5)

$ (0.66)

$ (5.78)

^[5]

$ (1.34)

^[5]

Previously Reported [Member]

$ 4,247

$ 0

Cost of sales

1,876

^[1],[2]

36,649

8,127

^[3]

9,640

5,878

^[3]

10,825

3,182

14,002

5,476

72,992

22,663

(68,745)

(22,663)

^[2],[4]

(11,769)

(22)

^[4]

(42,102)

(84,224)

^[4]

3,576

(7,466)

^[2]

1,067

597

(49,228)

(91,115)

(117,973)

(113,778)

Income tax

(232)

148

(117,741)

(113,926)

(86)

Basic loss for the period attributable to common stockholders (in dollars per share)

$ (117,827)

$ (113,926)

^[5]

$ (7.07)

$ (7.11)

Basic weighted-average common shares outstanding (in shares)

^[5]

16,655,634

16,029,826

Diluted loss for the period attributable to common stockholders (in dollars per share)

^[5]

$ (7.07)

$ (7.11)

Diluted weighted-average common shares outstanding (in shares)

^[5]

16,655,634

16,029,826

Cash and cash equivalents

$ 8,533

Accounts receivable, net of allowance of $3,317 and $3,237, respectively

1,196

2,695

Total current assets

12,424

33,586

Deferred income tax assets

2,663

1,640

Other non-current assets

369

50,682

6,650

246,189

891

935

Total current liabilities

23,435

278,100

1,908

1,000

2,552

Total liabilities

283,560

Treasury stock, at cost: 516,123 shares at September 30, 2023, and 516,123 shares at December 31, 2022

(170,949)

Accumulated other comprehensive loss

235,909

(86)

Total stockholders’ equity (deficit)

(297,752)

(232,878)

Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)

50,682

^[3]

9,640

$ 5,878

14,002

5,476

(117,973)

(113,778)

^[3]

9,640

5,878

^[3]

10,825

3,182

14,002

5,476

(117,973)

(113,778)

^[1],[2]

36,649

8,127

^[2],[4]

(11,769)

(22)

^[2]

1,067

597

1,908

^[4]

(42,102)

(84,224)

^[4]

3,576

(7,466)

Basic weighted-average common shares outstanding (in shares)

$ (117,741)

$ (113,926)

^[5]

16,655,634

16,029,826

Basic loss per share for the period attributable to common stockholders (in dollars per share)

^[5]

$ (7.07)

$ (7.11)

Diluted loss per share for the period attributable to common stockholders (in dollars per share)

^[5]

$ (7.07)

$ (7.11)

Revision of Prior Period, Adjustment [Member]

$ 0

Cost of sales

^[1],[2]

(9)

(124)

^[3]

(4)

^[3]

(97)

(151)

(27)

(110)

(256)

110

256

^[2],[4]

2,031

^[4]

60,085

93,861

^[4]

(40,792)

(1,774)

^[2]

(3)

21,326

92,141

21,436

92,397

Income tax

(0)

21,436

92,397

Basic loss for the period attributable to common stockholders (in dollars per share)

$ 21,436

$ 92,397

^[5]

$ 1.29

$ 5.76

Basic weighted-average common shares outstanding (in shares)

^[5]

Diluted loss for the period attributable to common stockholders (in dollars per share)

^[5]

$ 1.29

$ 5.76

Diluted weighted-average common shares outstanding (in shares)

^[5]

Cash and cash equivalents

$ 0

Accounts receivable, net of allowance of $3,317 and $3,237, respectively

Total current assets

(1,056)

Deferred income tax assets

292

Other non-current assets

(764)

(137,716)

143,237

Total current liabilities

5,615

175

Total liabilities

5,790

Treasury stock, at cost: 516,123 shares at September 30, 2023, and 516,123 shares at December 31, 2022

21,306

Accumulated other comprehensive loss

(139,438)

Total stockholders’ equity (deficit)

111,578

(27,860)

Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)

(764)

^[3]

(4)

$ 46

(27)

21,436

92,397

^[3]

(4)

^[3]

(97)

(151)

(27)

21,436

92,397

^[1],[2]

(9)

(124)

^[2],[4]

2,031

^[2]

(3)

175

^[4]

60,085

93,861

^[4]

(40,792)

(1,774)

Basic weighted-average common shares outstanding (in shares)

$ 21,436

$ 92,397

^[5]

Basic loss per share for the period attributable to common stockholders (in dollars per share)

^[5]

$ 1.29

$ 5.76

Diluted loss per share for the period attributable to common stockholders (in dollars per share)

^[5]

$ 1.29

$ 5.76

Revision of Prior Period, Adjustment [Member] | I F R S Impact on Share Based Compensation [Member]

$ 0

$ (89)

(27)

(80)

(252)

542

Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)

(542)

(80)

(136)

(89)

(27)

(80)

(252)

(89)

(27)

Revision of Prior Period, Adjustment [Member] | I F R S Impact on Research and Development [Member]

(80)

(252)

(4)

135

(97)

(151)

(101)

(16)

(1,056)

Total assets

(1,056)

Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)

(1,056)

(1,056)

(4)

135

(101)

(16)

(4)

135

(97)

(151)

Revision of Prior Period, Adjustment [Member] | I F R S Impact on Leases [Member]

(101)

(16)

(49)

(57)

(2)

(42)

292

Total assets

292

175

Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)

292

(42)

(42)

(49)

(57)

(2)

Revision of Prior Period, Adjustment [Member] | I F R S Impact on Financial Instruments [Member]

175

(1,982)

(60,085)

(93,861)

40,792

1,774

(21,275)

(92,087)

Debt

(137,716)

Warrant liabilities

143,237

21,306

(139,980)

Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)

113,153

(21,275)

(92,087)

(21,275)

(92,087)

(1,982)

(60,085)

(93,861)

Revision of Prior Period, Adjustment [Member] | I F R S Impact on Earnings Per Share [Member]

40,792

1,774

Basic loss for the period attributable to common stockholders (in dollars per share)

$ (96,305)

$ (21,529)

$ (5.78)

$ (1.34)

Basic weighted-average common shares outstanding (in shares)

16,655,634

16,029,826

Diluted loss for the period attributable to common stockholders (in dollars per share)

$ (5.78)

$ (1.34)

Basic weighted-average common shares outstanding (in shares)

$ (96,305)

$ (21,529)

16,655,634

16,029,826

Basic loss per share for the period attributable to common stockholders (in dollars per share)

$ (5.78)

$ (1.34)

Diluted weighted-average common shares outstanding (in shares)

$ (96,305)

$ (21,529)

16,655,634

16,029,826

Diluted loss per share for the period attributable to common stockholders (in dollars per share)

$ (5.78)

$ (1.34)

[1]	Certain awards granted by us have a service inception date preceding the grant date. Under IFRS, this resulted in the recognition of stock-based compensation expense prior to the grant date. Under U.S. GAAP, the stock-based compensation expense shall not be recognized until authorization at the grant date.
[2]	Under IFRS, all recognized leases are accounted for similarly to finance leases. Under U.S. GAAP, there is a dual classification on-balance sheet lease accounting model for lessees: finance and operating leases. Operating leases create a straight-line expense, and no interest expense is recognized on the lease liability.
[3]	Under IFRS, certain development expenditures may be capitalized. Under U.S. GAAP, all of our costs relating to R&D activities are expensed as incurred.
[4]	Under IFRS, the redeemable Series X preferred shares and convertible notes contained conversion features that resulted in a bifurcated derivative component with changes in fair value recognized as gain or (loss). Under U.S. GAAP, the conversion features did not result in a material bifurcated embedded derivative, resulting in the elimination of the change in fair value of financial instruments, reduction in interest expense and preferred dividends expense, and increase in the gain (loss) on extinguishment of debt. Under IFRS, it was determined that the redeemable Series X preferred shares should be classified as a liability since there is a contractual obligation to deliver cash or another financial asset and certain conversion events being beyond our control. Under U.S. GAAP, it was determined that the redeemable Series X preferred shares should be classified as mezzanine equity since the shares are redeemable based on events outside of our control. Under IFRS, it was determined that the Columbia Warrant should be classified as equity since settlement would only occur by exchanging a fixed amount of cash for a fixed number of our own equity instruments. Changes in fair value are not recognized. Under U.S. GAAP, it was determined that the Columbia Warrant should be classified as a liability since the number and type of shares received could be different pre- and post- Merger. The Columbia Warrant is recorded at fair value with changes recognized in the Consolidated Statement of Operations and Comprehensive Loss. Additionally, the resulting gain (loss) on extinguishment of the amended convertible notes differed under IFRS versus U.S. GAAP.
[5]	The change in net loss in the adoption of U.S. GAAP as described in items a-d above impacted net loss per share as follows:
[6]	After applying the 3.3028 Exchange Ratio as described in Note 4 (Reverse Recapitalization).

Note 12 - Stock-based Compensation - RSU Activity 1 (Details) - Restricted Stock Units (RSUs) [Member] - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Outstanding unvested RSUs (in shares)	1,459,280	0
Granted during the year (in shares)	3,369,167	1,640,496
Forfeited during the year (in shares)	(559,809)	(60,823)
Vested during the year (in shares)	(494,287)	(120,393)
Outstanding unvested RSUs (in shares)	3,774,351	1,459,280
Outstanding unvested RSUs at December 31, 2022	$ 4,416	$ 1,940

Note 9 - Additional Financial Statement Information - Schedule of Accrued Expenses and Other Liabilities (Details) - USD ($)
$ in Thousands

Sep. 30, 2023

Dec. 31, 2022

Dec. 31, 2021

Accrued professional fees related to Merger(1)

^[1]

$ 0

$ 16,263

Provisions

$ 66

2,934

Payroll and benefits payable

2,111

3,289

2,545

Other taxes payable

5,373

3,128

2,045

Other

430

451

2,200

Total

7,980

6,939

25,987

7,481

6,417

23,435

$ 499

$ 522

$ 2,552

[1]	Refer to Note 4 (Reverse Recapitalization) for further details on the Merger.

Note 12 - Stock-based Compensation (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Share-Based Payment Arrangement, Option, Activity [Table Text Block]

	Number of Options			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (years)		Intrinsic Value (in thousands)
Balance as of December 31, 2022		6,067,313		$	1.83		2.07
Forfeited		(425,178	)		3.98
Exercised		(186,307	)		1.13
Expired		(177,430	)		2.27
Outstanding at September 30, 2023		5,278,398		$	1.61		1.78	$	1,041
Exercisable at September 30, 2023		4,594,898		$	1.40		1.71	$	1,000

	Number of Options			Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (years)		Intrinsic Value (in thousands)
Balance as of December 31, 2021		6,864,563		$	2.05		2.36
Granted		—			—
Forfeited		(574,299	)		4.56
Exercised		(102,825	)		1.12
Expired		(120,126	)		2.60
Outstanding at December 31, 2022		6,067,313		$	1.83		2.07	$	10,818
Exercisable at December 31, 2022		4,449,152		$	1.31		1.92	$	8,832

Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	Year Ended December 31,
	2022			2021			2020
Weighted-average fair value of options at the measurement date (grant date)	$	—			$23.36			$6.31
Dividend yield (%)		—			—			—
Expected volatility (%)		—	%	61	-	72	59	-	61
Risk-free interest rate (%)		—	%	0.5	-	1.4	0.4	-	0.5
Weighted average share price	$	—			$6.79			$2.75

Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]

	Number of RSUs			Intrinsic value (in thousands)
Outstanding unvested RSUs at December 31, 2022		1,459,280
Granted during the year		3,369,167
Forfeited during the year		(559,809	)
Vested during the year		(494,287	)
Outstanding unvested RSUs at September 30, 2023		3,774,351		$	4,416

	Number of RSUs			Intrinsic Value (in thousands)
Outstanding unvested RSUs at December 31, 2021		—
Granted during the year		1,640,496
Forfeited during the year		(60,823	)
Vested during the year		(120,393	)
Expired during the year		—
Outstanding unvested RSUs at December 31, 2022		1,459,280		$	1,940

Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
General and administrative expenses	$	884	$	554	$	2,714	$	2,240
Research and development expenses		312		781		933		1,753
Other operating expenses		218		804		607		2,631
Total	$	1,414	$	2,139	$	4,254	$	6,624

	Year Ended December 31,
	2022		2021		2020
General and administrative expenses	$	2,406	$	5,274	$	1,235
Research and development		3,631		1,968		382
Other operating expenses		2,331		3,639		115
Total	$	8,368	$	10,881	$	1,732

Note 18 - Leases (Details Textual)	Dec. 31, 2022
Operating Lease, Weighted Average Remaining Lease Term (Year)	5 years 7 months 28 days
Operating Lease, Weighted Average Discount Rate, Percent	4.60%
Minimum [Member]
Lessee, Operating Lease, Term of Contract (Year)	2 years
Maximum [Member]
Lessee, Operating Lease, Term of Contract (Year)	10 years

Consolidated Statements of Cash Flows - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Cash flows from operating activities:

Adjustments to reconcile net loss to net cash used in operating activities:

$ (36,641)

$ (96,305)

$ (21,529)

Deferred tax expense (benefit)

14,326

10,728

^[1]

3,031

^[1]

Operating lease expense

2,015

548

298

1,601

(1,619)

(38)

Stock-based compensation

8,368

10,881

1,732

Interest expense

1,693

9,703

Loss on debt extinguishment

(58,311)

(17,983)

^[2]

(9,637)

^[2]

37,216

^[2]

9,240

^[2]

Expenses related to Merger

9,859

Foreign exchange differences

(4,578)

(2,385)

(1,507)

Loss on disposal of property and equipment and right of use assets

996

579

372

Bad debt expense

1,736

1,794

Changes in operating assets and liabilities:

Accounts receivable

(1,928)

(4,691)

(221)

(1,855)

(14)

Accounts payable

(3,202)

1,421

6,474

1,006

480

455

(1,562)

21,622

497

Net cash used in operating activities

(1,985)

(449)

(370)

(68,462)

(28,439)

(11,174)

Cash flows from investing activities:

Acquisitions of property and equipment

(27,252)

(11,233)

(15,787)

Equity investment in OS

(3,653)

Other

Net cash used in investing activities

(30,852)

(11,230)

(15,773)

Cash flows from financing activities:

Proceeds from issuance of redeemable Series X preferred stock

20,332

Proceeds from issuance of debt

7,513

17,348

Repurchase of stock

(8,603)

Proceeds from exercise of Public Warrants

5,291

Proceeds from sale of common stock

167,504

Proceeds from exercise of stock options

144

791

802

Net cash provided by financing activities

164,336

28,636

18,150

Net increase in cash, cash equivalents and restricted cash

65,022

(11,033)

(8,797)

Effect of foreign exchange rate changes

4,237

2,299

1,507

Cash, cash equivalents and restricted cash - beginning of period

8,533

17,267

24,557

Cash, cash equivalents and restricted cash - end of period

$ 77,792

$ 8,533

$ 17,267

[1]

Under IFRS, certain development expenditures may be capitalized. Under U.S. GAAP, all of our costs relating to R&D activities are expensed as incurred.

[2]

Note 1 - Nature of the Business and Basis of Presentation (Details Textual) $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Number of Operating Segments	1		1
Retained Earnings (Accumulated Deficit)	$ (270,285)		$ (222,815)	$ (186,174)
Net Cash Provided by (Used in) Operating Activities	(36,132)	$ (54,763)	(68,462)	(28,439)	$ (11,174)
Cash and Cash Equivalents, at Carrying Value	$ 30,971		$ 76,528	$ 8,533

Amount of accumulated undistributed earnings (deficit).

Note 14 - Net Loss Per Share - Schedule of Net Loss Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands

3 Months Ended

9 Months Ended

12 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Sep. 30, 2023

Sep. 30, 2022

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Basic weighted-average common shares outstanding (in shares)

$ (17,619)

$ (14,823)

$ (47,470)

$ (22,944)

$ (36,641)

$ (96,305)

$ (21,529)

89,739,310

89,002,430

89,476,065

81,221,550

83,188,276

^[1]

16,655,634

^[1],[2]

16,029,826

^[1],[2]

Basic loss per share for the period attributable to common stockholders (in dollars per share)

$ (0.2)

$ (0.17)

$ (0.53)

$ (0.28)

$ (0.44)

$ (5.78)

^[2]

$ (1.34)

^[2]

Adjustment to numerator - Change in fair value of Columbia Warrant liability

$ 0

$ (18,635)

$ 0

$ (18,635)

$ 0

Columbia Warrant (in shares)

$ (17,619)

$ (33,458)

$ (47,470)

$ (41,579)

$ (55,276)

$ (96,305)

$ (21,529)

1,410,657

609,873

Diluted weighted-average common shares outstanding (in shares)

89,739,310

90,413,087

89,476,065

82,632,207

83,798,149

16,655,634

^[2]

16,029,826

^[2]

Diluted loss per share for the period attributable to common stockholders (in dollars per share)

$ (0.2)

$ (0.37)

$ (0.53)

$ (0.5)

$ (0.66)

$ (5.78)

^[2]

$ (1.34)

^[2]

[1]	After applying the 3.3028 Exchange Ratio as described in Note 4 (Reverse Recapitalization).
[2]	The change in net loss in the adoption of U.S. GAAP as described in items a-d above impacted net loss per share as follows:

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482635/260-10-55-15

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-7

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-4

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-10

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 16: http://www.xbrl.org/2003/role/exampleRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 52
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482635/260-10-55-52

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-7

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482635/260-10-55-15

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-7

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-4

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 52
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482635/260-10-55-52

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-7

Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-4

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 5
-Subparagraph (SAB Topic 6.B)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-10

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-31

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-11

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B

Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.

Note 13 - Redeemable Preferred Stock

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Redeemable Preferred Stock [Text Block]

13. Redeemable Preferred Stock

Reverse Recapitalization

The redeemable Series X preferred stock, par value of $0.0001, carried an annual 7% cumulative dividend, payable upon a liquidation, dissolution, winding up or, upon the election of the stockholders, upon redemption. Due to the contractual provisions of the redeemable Series X preferred stock, the Series X preferred stock was accounted for as mezzanine equity.

Upon the closing of the Merger (“Closing”), we cancelled and converted all 2,033,230 shares of issued and outstanding redeemable Series X preferred stock and preferred dividends amounting to $21.4 million into 2,140,340 shares of Satellogic Class A ordinary shares, based on the conversion price of $10.00 per share, at the time the Merger became effective.

As of September 30, 2023, there were no issued and outstanding shares of redeemable Series X preferred stock.

13. Redeemable Preferred Stock

Reverse Recapitalization

Upon Closing, we canceled and converted all 2,033,230 shares of issued and outstanding redeemable Series X preferred stock and preferred dividends amounting to $21.4 million into 2,140,340 shares of Satellogic Class A ordinary shares, based on the conversion price of $10.00 per share, at the time the Merger became effective.

As of December 31, 2022, there were no issued and outstanding shares of redeemable Series X preferred stock.

Note 14 - Net Loss Per Share (Details Textual)	9 Months Ended	12 Months Ended
Note 14 - Net Loss Per Share (Details Textual)	Sep. 30, 2023	Dec. 31, 2022
Recapitalization Exchange Ratio	3.3028	3.3028

Note 13 - Redeemable Preferred Stock 1

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Redeemable Preferred Stock [Text Block]

13. Redeemable Preferred Stock

Reverse Recapitalization

As of September 30, 2023, there were no issued and outstanding shares of redeemable Series X preferred stock.

13. Redeemable Preferred Stock

Reverse Recapitalization

As of December 31, 2022, there were no issued and outstanding shares of redeemable Series X preferred stock.

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 30,971	$ 76,528
Restricted cash	0	126
Accounts receivable, net of allowance of $3,317 and $3,237, respectively	1,718	1,388
Prepaid expenses and other current assets	3,245	3,198
Total current assets	35,934	81,240
Property and equipment, net	42,728	47,981
Operating lease right-of-use assets	9,331	8,171
Other non-current assets	5,349	6,463
Total assets	93,342	143,855
Current liabilities
Accounts payable	6,492	9,850
Warrant liabilities	1,945	8,335
Earnout liabilities	223	1,353
Operating lease liabilities	2,034	2,176
Contract liabilities	3,286	1,941
Accrued expenses and other liabilities	7,481	6,417
Total current liabilities	21,461	30,072
Operating lease liabilities	7,641	6,063
Contract liabilities	1,000	1,000
Other non-current liabilities	499	522
Total liabilities	30,601	37,657
Commitments and contingencies (Note 17)
Stockholders' equity
Preferred stock, $0.0001 par value	0	0
Common stock, $0.0001 par value, unlimited shares authorized; 76,292,604 Class A shares issued and outstanding; and 13,582,642 Class B shares issued and outstanding as of September 30, 2023 and 75,612,795 Class A shares issued and outstanding and 13,582,642 Class B shares issued and outstanding as of December 31, 2022	0	0
Treasury stock, at cost: 516,123 shares at September 30, 2023, and 516,123 shares at December 31, 2022	(8,603)	(8,603)
Additional paid-in capital	342,159	337,928
Accumulated other comprehensive loss	(530)	(312)
Accumulated deficit	(270,285)	(222,815)
Total stockholders’ equity	62,741	106,198
Total liabilities, redeemable preferred stock and stockholders’ equity	$ 93,342	$ 143,855

Note 3 - Accounting Standards Updates (ASU) 1

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Accounting Standards Update and Change in Accounting Principle [Text Block]

3. Accounting Standards Updates (“ASU”)

Accounting Standard Recently Adopted

3. Accounting Standards Updates (“ASU”)

Accounting Standards Recently Adopted

Accounting Standards Not Yet Adopted

Note 14 - Net Loss Per Share 1 (Details Textual)	9 Months Ended	12 Months Ended
Note 14 - Net Loss Per Share 1 (Details Textual)	Sep. 30, 2023	Dec. 31, 2022
Recapitalization Exchange Ratio	3.3028	3.3028

Note 10 - Income Tax - Schedule of Provision (Benefit) Income Tax (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Current					$ 2,972	$ 1,387	$ 186
Deferred tax expense (benefit)			$ 0	$ 5,126	1,601	(1,619)	(38)
Total provision for (benefit from) income tax	$ 4,069	$ 2,983	$ 6,193	$ 5,126	$ 4,573	$ (232)	$ 148

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

Note 7 - Earnout Liabilities 1

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Earnout Liability [Text Block]

7. Earnout Liabilities

	Sponsor Earnout
As of December 31, 2022	$	1,353
Change in fair value of financial instruments		(1,130	)
As of September 30, 2023	$	223

Sponsor Earnout

Pursuant to that certain Sponsor Support Agreement, dated as of July 5, 2021, by and among us, the Sponsor and Nettar, the Sponsor has agreed that during the period between the Closing and the five-year anniversary of the Closing, the Sponsor shall not sell, transfer or otherwise dispose of Class A ordinary shares equal to 1,869,000 less 30% of Forfeiture Escrow Shares retired and cancelled (“Sponsor Earnout”). The Sponsor Earnout is subject to potential forfeiture to us for no consideration until the occurrence of each tranche’s respective earnout triggering event. The earnout triggering events related to achieving a closing price at or above $12.50, $15.00 and $20.00 per share, respectively, for any 10 trading days over a 20 trading day period were not satisfied during the nine months ended September 30, 2023. As a result, the 1,775,962 Class A ordinary shares were not vested and are subject to transfer restrictions and contingent forfeiture provisions.

The estimated fair value of the Sponsor Earnout liability is based on a Monte Carlo simulation valuation model using a distribution of potential outcomes on a semi-annual basis over the earnout period, using the most reliable information available. Assumptions used in the valuation are as follows:

	September 30, 2023			December 31, 2022
Expected term (in years)		3.32			4.07
Dividend yield (%)		—	%		—	%
Expected volatility		67.3	%		50.4	%
Risk-free interest rate		4.8	%		4.1	%
Expected number of shares		1,775,962			1,775,962

Forfeiture Earnout

In connection with the closing of the Merger (the “Closing”), we delivered 310,127 shares of our Class A ordinary shares to an escrow account (“Forfeiture Escrow Shares”). The Forfeiture Escrow Shares were held in escrow for a 30-day adjustment period subsequent to the Closing Date, subject to forfeiture, depending on the VWAP. If the VWAP during the adjustment period was $10.00 or more, all Forfeiture Escrow Shares would be released. For the five-year period following the adjustment period, if the closing price of the shares on the principal exchange or securities market on which such securities are listed or quoted is at or above $15.00 for 10 out of 20 trading days, which do not have to be consecutive, the stockholders will have the right to receive their respective portions of shares back.

The shares were forfeited because the VWAP was below $10.00. The Forfeiture Earnout was initially recognized as a liability with a fair value of $6.1 million. The liability was remeasured to a fair value of $1.0 million at the end of the adjustment period and reclassified as an equity instrument.

7. Earnout Liabilities

	Sponsor Earnout			Forfeiture Earnout			Total Earnout Liabilities
As of December 31, 2021	$	—		$	—		$	—
Additions	$	8,022		$	6,135		$	14,157
Change in fair value of financial instruments		(6,669	)		(5,130	)		(11,799	)
Reclassification to equity		—			(1,005	)		(1,005	)
As of December 31, 2022	$	1,353		$	—		$	1,353

Sponsor Earnout

Pursuant to that certain Sponsor Support Agreement, dated as of July 5, 2021, by and among us, the Sponsor and Nettar, the Sponsor has agreed that during the period between the Closing and the five-year anniversary of the Closing, the Sponsor shall not sell, transfer or otherwise dispose of Class A ordinary shares equal to 1,869,000 less 30% of Forfeiture Escrow Shares retired and canceled (“Sponsor Earnout”). The Sponsor Earnout is subject to potential forfeiture to us for no consideration until the occurrence of each tranche’s respective earnout triggering event. The earnout triggering events related to achieving a closing price at or above $12.50, $15.00 and $20.00 per share, respectively, for any 10 trading days over a 20 trading day period were not satisfied during the year ended December 31, 2022. As a result, the 1,775,962 Class A ordinary shares were not vested and are subject to transfer restrictions and contingent forfeiture provisions.

	January 25,			December 31,
	2022			2022
Expected term (in years)		5.00			4.07
Dividend yield (%)		—			—
Expected volatility		30	%		50.4	%
Risk-free interest rate		1.6	%		4.1	%
Expected number of shares		1,842,759			1,775,962

Forfeiture Earnout

SATELLOGIC INC.

Notes to Consolidated Financial Statements

(in thousands of U.S. dollars, except share and per share information, unless otherwise stated)

Note 5 - Revenue from Contracts with Customers

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Revenue from Contract with Customer [Text Block]

5. Revenue from Contracts with Customers

As described below, during the three months ended September 30, 2023 and 2022, the Company recognized revenue of $1.2 million and $2.2 million, respectively, and during the nine months ended September 30, 2023 and 2022, the Company recognized revenue of $4.4 million and $4.5 million, respectively.

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Revenue by timing
Over time	$	413	$	—	$	1,236	$	1,524
Point-in time		783		2,158		3,144		3,022
Total revenue	$	1,196	$	2,158	$	4,380	$	4,546

Information about the Company’s revenue by geography is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Revenue by geography ^{(1) (2)}
Asia Pacific	$	82	$	232	$	351	$	1,946
Europe		513		43		1,506		80
North America		588		1,817		2,467		2,435
South America		13		66		56		85
Total revenue	$	1,196	$	2,158	$	4,380	$	4,546

⁽¹⁾	Revenue by geography is based on the geographical location of the customer.
⁽²⁾	Certain comparative figures have been reclassified to conform to the current year presentation.

Contract liabilities and Remaining Performance Obligations

Our contract liabilities consist of payments received from customers, or such consideration contractually due, in advance of providing the relevant satellite imagery or related service. Amounts included in Contract liabilities are as follows:

	September 30,		December 31,
	2023		2022
Non-current	$	1,000	$	1,000
Current		3,286		1,941
Total	$	4,286	$	2,941

During the nine months ended September 30, 2023, we recognized revenue of $1.5 million that was included as a Contract liability as of December 31, 2022. During the nine months ended September 30, 2022, we recognized revenue of $0.9 million that was included as a Contract liability as of December 31, 2021.

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. The following table represents the total transaction price for the remaining performance obligations as of September 30, 2023 related to non-cancellable contracts longer than 12-months in duration that is expected to be recognized over future periods.

		Within 1 Year				Years 2				Years 3				Thereafter
Remaining performance obligations		$	6,852			$	5,648			$	5,005			$	1,000

5. Revenue from Contracts with Customers

During the year ended December 31, 2022, we recognized revenue of $6.0 million, of which $1.6 million was recognized over time and $4.4 million was recognized at a point-in-time. During the year ended December 31, 2021, we recognized revenue of $4.2 million, of which $3.8 million was recognized over time and $0.4 million was recognized at a point-in-time. We did not recognize any revenue in 2020.

Information about our revenue by geography is as follows:

	Year Ended December 31,
	2022		2021
Revenue by geography ⁽¹⁾
Asia Pacific	$	1,531	$	3,988
North America		3,438		201
Other		1,043		58
Total revenue	$	6,012	$	4,247

⁽¹⁾	Revenue by geography is based on the geographical location of the customer.

Two customers each accounted for more than 10% of our revenue totaling $4.8 million for the year ended December 31, 2022. One customer accounted for more than 10% of our revenue totaling $3.9 million for the year ended December 31, 2021.

Contract Liabilities and Remaining Performance Obligations

	December 31,
	2022		2021
Non-current	$	1,000	$	1,000
Current		1,941		935
Total	$	2,941	$	1,935

During the year ended December 31, 2022, we recognized revenue of $0.9 million that was included as a Contract liability as of December 31, 2021. During the year ended December 31, 2021, we recognized revenue of $0.5 million that was included as a Contract liability as of December 31, 2020.

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. The following table represents the total transaction price for the remaining performance obligations as of December 31, 2022 related to non-cancellable contracts longer than 12 months in duration that is expected to be recognized over future periods.

		Within 1 Year				Years 1-2				Years 2-3				Thereafter
Remaining performance obligations		$	6,422			$	11,296			$	3,860			$	—

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-9

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-10

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-15

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-12

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-13

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Topic 606
-Publisher FASB
-URI https://asc.fasb.org//606/tableOfContent

Note 7 - Earnout Liabilities 1 (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Schedule of Earnout Liability [Table Text Block]

	Sponsor Earnout
As of December 31, 2022	$	1,353
Change in fair value of financial instruments		(1,130	)
As of September 30, 2023	$	223

	Sponsor Earnout			Forfeiture Earnout			Total Earnout Liabilities
As of December 31, 2021	$	—		$	—		$	—
Additions	$	8,022		$	6,135		$	14,157
Change in fair value of financial instruments		(6,669	)		(5,130	)		(11,799	)
Reclassification to equity		—			(1,005	)		(1,005	)
As of December 31, 2022	$	1,353		$	—		$	1,353

Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]

	September 30, 2023			December 31, 2022
Expected term (in years)		3.32			4.07
Dividend yield (%)		—	%		—	%
Expected volatility		67.3	%		50.4	%
Risk-free interest rate		4.8	%		4.1	%
Expected number of shares		1,775,962			1,775,962

	January 25,			December 31,
	2022			2022
Expected term (in years)		5.00			4.07
Dividend yield (%)		—			—
Expected volatility		30	%		50.4	%
Risk-free interest rate		1.6	%		4.1	%
Expected number of shares		1,842,759			1,775,962

Note 15 - Fair Value Measurements and Financial Instruments - Schedule of Assets and Liabilities at Fair Value (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Jan. 25, 2022	Jan. 22, 2022	Jan. 18, 2022	Dec. 31, 2021
Total Warrant Liabilities	$ 1,945	$ 8,335				$ 143,237
Earnout liabilities	223	1,353				0
Fair Value, Inputs, Level 1 [Member]
Total Warrant Liabilities	704	1,833
Earnout liabilities	0	0
Fair Value, Inputs, Level 1 [Member] \| Borrowings [Member]
Liabilities, fair value						0
Fair Value, Inputs, Level 1 [Member] \| Columbia Warrant [Member]
Liabilities, fair value						0
Fair Value, Inputs, Level 1 [Member] \| Notes Payable to Banks [Member]
Notes payable, fair value						0
Fair Value, Inputs, Level 1 [Member] \| Promissory Note [Member]
Notes payable, fair value						0
Fair Value, Inputs, Level 2 [Member]
Total Warrant Liabilities	0	0
Earnout liabilities	0	0
Fair Value, Inputs, Level 2 [Member] \| Borrowings [Member]
Liabilities, fair value						0
Fair Value, Inputs, Level 2 [Member] \| Columbia Warrant [Member]
Liabilities, fair value						0
Fair Value, Inputs, Level 2 [Member] \| Notes Payable to Banks [Member]
Notes payable, fair value						180,356
Fair Value, Inputs, Level 2 [Member] \| Promissory Note [Member]
Notes payable, fair value						40,925
Fair Value, Inputs, Level 3 [Member]
Total Warrant Liabilities	1,241	6,502
Earnout liabilities	223	1,353
Fair Value, Inputs, Level 3 [Member] \| Borrowings [Member]
Liabilities, fair value						7,522
Fair Value, Inputs, Level 3 [Member] \| Columbia Warrant [Member]
Liabilities, fair value						143,237
Fair Value, Inputs, Level 3 [Member] \| Notes Payable to Banks [Member]
Notes payable, fair value						0
Fair Value, Inputs, Level 3 [Member] \| Promissory Note [Member]
Notes payable, fair value						0
The 8.63 Warrants [Member]
Total Warrant Liabilities	704	1,833	$ 4,900			0
The 8.63 Warrants [Member] \| Fair Value, Inputs, Level 1 [Member]
Total Warrant Liabilities	704	1,833
The 8.63 Warrants [Member] \| Fair Value, Inputs, Level 2 [Member]
Total Warrant Liabilities	0	0
The 8.63 Warrants [Member] \| Fair Value, Inputs, Level 3 [Member]
Total Warrant Liabilities	0	0
Pipe Warrant [Member]
Total Warrant Liabilities	59	311		$ 1,300		0
Pipe Warrant [Member] \| Fair Value, Inputs, Level 1 [Member]
Total Warrant Liabilities	0	0
Pipe Warrant [Member] \| Fair Value, Inputs, Level 2 [Member]
Total Warrant Liabilities	0	0
Pipe Warrant [Member] \| Fair Value, Inputs, Level 3 [Member]
Total Warrant Liabilities	59	311
Liberty Warrants and Liberty Advisory Fee Warrant [Member]
Total Warrant Liabilities	1,182	6,191			$ 30,900	$ 0
Liberty Warrants and Liberty Advisory Fee Warrant [Member] \| Fair Value, Inputs, Level 1 [Member]
Total Warrant Liabilities	0	0
Liberty Warrants and Liberty Advisory Fee Warrant [Member] \| Fair Value, Inputs, Level 2 [Member]
Total Warrant Liabilities	0	0
Liberty Warrants and Liberty Advisory Fee Warrant [Member] \| Fair Value, Inputs, Level 3 [Member]
Total Warrant Liabilities	$ 1,182	$ 6,191

Note 11 - Stockholders' Equity 1 (Details Textual) - USD ($) $ / shares in Units, $ in Thousands		9 Months Ended		12 Months Ended
	Apr. 06, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Feb. 14, 2022	Jan. 18, 2022	Jan. 17, 2022
Common Stock, Par or Stated Value Per Share (in dollars per share)		$ 0.0001		$ 0.0001	$ 0.0001
Common Stock, Shares, Outstanding (in shares)								88,824,647	17,215,336
Stock Repurchase Program, Authorized Amount							$ 5,000
Payments for Repurchase of Common Stock		$ (0)	$ 8,603	$ 8,603	$ (0)	$ (0)
Hanover Holdings S A [Member]
Payments for Repurchase of Common Stock	$ 5,853
Common Class A [Member]
Common Stock, Par or Stated Value Per Share (in dollars per share)		$ 0.0001		$ 0.0001
Common Stock, Shares, Issued (in shares)		76,292,604		75,612,795
Common Stock, Shares, Outstanding (in shares)		76,292,604		75,612,795
Treasury Stock, Shares, Acquired (in shares)		0	516,123	516,123
Payments for Repurchase of Common Stock			$ 2,700	$ 2,700
Common Class A [Member] \| Hanover Holdings S A [Member]
Treasury Stock, Shares, Acquired (in shares)	51,700
Common Class B [Member]
Common Stock, Par or Stated Value Per Share (in dollars per share)		$ 0.0001		$ 0.0001
Common Stock, Shares, Issued (in shares)		13,582,642		13,582,642
Common Stock, Shares, Outstanding (in shares)		13,582,642		13,582,642
Common Stock, Voting Interest		100.00%		100.00%
Common Class B [Member] \| Chief Executive Officer [Member]
Common Stock, Shares, Outstanding (in shares)		13,582,642		13,582,642
Common Stock, Voting Interest		20.80%
Series A Preferred Stock [Member] \| Hanover Holdings S A [Member]
Treasury Stock, Shares, Acquired (in shares)	134,735
Series B-1 Preferred Stock [Member] \| Hanover Holdings S A [Member]
Treasury Stock, Shares, Acquired (in shares)	15,082

Note 6 - Warrant Liabilities - Schedule of Warrant Liabilities (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
As of December 31, 2021	$ 8,335	$ 143,237
Warrants issued	0	37,037
Fair Value Adjustment of Warrants	(6,390)	(47,000)
Write-off of deferred costs		203
Settlements		(337)
Reclassification to equity		(124,805)
As of December 31, 2022	1,945	8,335
Liberty Warrants and Liberty Advisory Fee Warrant [Member]
As of December 31, 2021	6,191	0
Warrants issued	0	30,853
Fair Value Adjustment of Warrants	(5,009)	(24,662)
Write-off of deferred costs		0
Settlements		0
Reclassification to equity		0
As of December 31, 2022	1,182	6,191
Pipe Warrant [Member]
As of December 31, 2021	311	0
Warrants issued	0	1,312
Fair Value Adjustment of Warrants	(252)	(1,001)
Write-off of deferred costs		0
Settlements		0
Reclassification to equity		0
As of December 31, 2022	59	311
Columbia Warrant [Member]
As of December 31, 2021	0	143,237
Warrants issued		0
Fair Value Adjustment of Warrants		(18,635)
Write-off of deferred costs		203
Settlements		0
Reclassification to equity		(124,805)
As of December 31, 2022		0
The 8.63 Warrants [Member]
As of December 31, 2021	1,833	0
Warrants issued	0	4,872
Fair Value Adjustment of Warrants	(1,129)	(2,702)
Write-off of deferred costs		0
Settlements		(337)
Reclassification to equity		0
As of December 31, 2022	$ 704	$ 1,833

Note 2 - Summary of Significant Accounting Policies (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Accounts Receivable, Allowance for Credit Loss [Table Text Block]

	Nine Months Ended September 30,
	2023		2022
Allowance for credit losses as of beginning of period	$	3,237	$	1,794
Provision		80		1,736
Allowance for credit losses as of end of period	$	3,317	$	3,530

	December 31,
	2022			2021
Allowance for doubtful accounts as of beginning of period	$	1,794		$	—
Provision		1,736			1,794
Write-offs		—			—
Foreign exchange and other		(293	)		—
Allowance for doubtful accounts as of end of period	$	3,237		$	1,794

Schedule of Cash and Cash Equivalents [Table Text Block]

	September 30, 2023		December 31, 2022
Cash and cash equivalents	$	30,971	$	76,528
Restricted cash		—		126
Restricted cash included in Other non-current assets		1,151		1,138
Total cash, cash equivalents and restricted cash	$	32,122	$	77,792

	December 31,
	2022		2021
Cash and cash equivalents	$	76,528	$	8,533
Restricted cash		126		—
Restricted cash included in Other non-current assets		1,138		—
Total cash, cash equivalents and restricted cash	$	77,792	$	8,533

Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]

	Year Ended December 31,
	2022		2021		2020
Cash paid during the period for:
Income tax, net of refunds	$	758	$	96	$	59
Interest	$	3,520	$	49,283	$	27,286

Note 2 - Summary of Significant Accounting Policies (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Equity Method Investment, Other than Temporary Impairment					$ 0
Payments to Acquire Equity Method Investments			$ (0)	$ 3,604	3,653	$ 0	$ 0
Gain (Loss), Foreign Currency Transaction, after Tax	$ 1,800	$ 1,100	$ 3,700	$ 1,600	$ 1,576	$ 1,022	$ 594

Note 12 - Stock-based Compensation 1

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Share-Based Payment Arrangement [Text Block]

12. Stock-based Compensation

Our employees, including senior executives, receive incentives in the form of stock options and RSUs, whereby employees render services as consideration for equity instruments (equity-settled transactions).

On the Closing Date, we established the Equity Incentive Plan, under which RSUs were issued. The Equity Incentive Plan provides for grant of options, stock appreciation rights, restricted stock awards, RSUs, shares granted as a bonus or in lieu of another award, dividend equivalents, or other stock-based awards or performance awards at the discretion of a board-elected committee. We also maintain our 2015 Share Plan as amended (the “2015 Plan”) under which stock-based awards were issued or modified. The options were typically granted for a four-year vesting term and have a maximum term of 10 years. As of December 31, 2022, no further awards have or shall be granted under the 2015 Share Plan. There were no options granted during the nine months ended September 30, 2023 or 2022. the direct allocation as well as the sale of shares and the granting of options for the purchase of shares, at the discretion of the Company’s board of directors, to certain employees, advisors and/or independent directors.

A summary of stock option activity for the nine months ended September 30, 2023 was as follows:

	Number of Options			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (years)		Intrinsic Value (in thousands)
Balance as of December 31, 2022		6,067,313		$	1.83		2.07
Forfeited		(425,178	)		3.98
Exercised		(186,307	)		1.13
Expired		(177,430	)		2.27
Outstanding at September 30, 2023		5,278,398		$	1.61		1.78	$	1,041
Exercisable at September 30, 2023		4,594,898		$	1.40		1.71	$	1,000

As further detailed in Note 4 (Reverse Recapitalization), all options to purchase the predecessor ordinary shares were assumed by Satellogic Inc., the new listed company, and became options to purchase Class A ordinary shares of Satellogic Inc., as determined in accordance with the Merger Agreement. There were no other material cancellations or modifications to the granted awards for the nine months ended September 30, 2023 and 2022. Exercises are net of 42,898 options that are reflected as forfeitures, which were forfeited for payment of payroll taxes.

A summary of RSU activity for the nine months ended September 30, 2023 is as follows:

	Number of RSUs			Intrinsic value (in thousands)
Outstanding unvested RSUs at December 31, 2022		1,459,280
Granted during the year		3,369,167
Forfeited during the year		(559,809	)
Vested during the year		(494,287	)
Outstanding unvested RSUs at September 30, 2023		3,774,351		$	4,416

The weighted-average grant-date price of RSUs at September 30, 2023 was $2.43. The number of shares vested is net of and total forfeitures includes 116,783 RSUs forfeited for payment of withholding taxes.

As of September 30, 2023, unrecognized stock-based compensation cost related to outstanding options and RSUs that are expected to vest was $0.9 million and $5.9 million, respectively, which is expected to be recognized over a weighted-average period of 0.87 years and 0.78 years, respectively.

Stock-based Compensation Expense

Total employee and non-employee stock-based compensation expense for the nine months ended September 30, 2023 and 2022 was classified in the Condensed Consolidated Statements of Operations and Comprehensive Loss as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
General and administrative expenses	$	884	$	554	$	2,714	$	2,240
Research and development expenses		312		781		933		1,753
Other operating expenses		218		804		607		2,631
Total	$	1,414	$	2,139	$	4,254	$	6,624

12. Stock-based Compensation

On the Closing Date, we established the Equity Incentive Plan, under which RSUs were issued during the year ended December 31, 2022. The Equity Incentive Plan provides for the grant options, stock appreciation rights, restricted stock awards, RSUs, shares granted as a bonus or in lieu of another award, dividend equivalents, or other stock-based awards or performance awards at the discretion of a board-elected committee. We also maintain our 2015 Share Plan as amended (the “2015 Plan”) under which stock-based option awards were issued or modified. The options were typically granted with a four-year vesting term and a maximum contractual term of 10 years. As of December 31, 2022, no further awards have or shall be granted under the 2015 Share Plan. There were no options granted during the year ended December 31, 2022.

A summary of stock option activity for the year ended December 31, 2022 is as follows:

	Number of Options			Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (years)		Intrinsic Value (in thousands)
Balance as of December 31, 2021		6,864,563		$	2.05		2.36
Granted		—			—
Forfeited		(574,299	)		4.56
Exercised		(102,825	)		1.12
Expired		(120,126	)		2.60
Outstanding at December 31, 2022		6,067,313		$	1.83		2.07	$	10,818
Exercisable at December 31, 2022		4,449,152		$	1.31		1.92	$	8,832

The total intrinsic value of options exercised during the years ended December 31, 2022, 2021 and 2020 was $75 thousand, $23.9 million and $9.7 million , respectively. The number of options exercised is net of 17,376 options forfeited for payment of withholding taxes.

The following table lists the inputs used under the Black-Scholes model for stock-option awards during the years ended December 31, 2022, 2021, and 2020, respectively:

	Year Ended December 31,
	2022			2021			2020
Weighted-average fair value of options at the measurement date (grant date)	$	—			$23.36			$6.31
Dividend yield (%)		—			—			—
Expected volatility (%)		—	%	61	-	72	59	-	61
Risk-free interest rate (%)		—	%	0.5	-	1.4	0.4	-	0.5
Weighted average share price	$	—			$6.79			$2.75

As further detailed in Note 4 (Reverse Recapitalization), all options to purchase the predecessor common stock were assumed by Satellogic Inc., the new listed company, and became options to purchase Class A ordinary shares of Satellogic Inc., as determined in accordance with the Merger Agreement. There were no other material cancellations or modifications to the granted awards for the years ended December 31, 2022, 2021, and 2020.

A summary of RSU activity for the year ended December 31, 2022 is as follows:

	Number of RSUs			Intrinsic Value (in thousands)
Outstanding unvested RSUs at December 31, 2021		—
Granted during the year		1,640,496
Forfeited during the year		(60,823	)
Vested during the year		(120,393	)
Expired during the year		—
Outstanding unvested RSUs at December 31, 2022		1,459,280		$	1,940

The weighted-average exercise price of RSUs at December 31, 2022 was $4.38. The number of shares vested is net of 56,649 options forfeited for payment of withholding taxes.

As of December 31, 2022, unrecognized stock-based compensation cost related to outstanding options and RSUs that are expected to vest was $3.2 million and $5.4 million, respectively, which is expected to be recognized over a weighted-average period of 1.42 years and 1.44 years, respectively.

Stock-based Compensation Expense

Total employee and non-employee stock-based compensation expense for the years ended December 31, 2022, 2021, and 2020 was classified in the Consolidated Statements of Operations and Comprehensive Loss as follows:

	Year Ended December 31,
	2022		2021		2020
General and administrative expenses	$	2,406	$	5,274	$	1,235
Research and development		3,631		1,968		382
Other operating expenses		2,331		3,639		115
Total	$	8,368	$	10,881	$	1,732

Note 14 - Net Loss Per Share 1 (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	Three Months Ended September						Nine Months Ended September
	2023			2022			2023			2022
Net loss attributable to common stockholders	$	(17,619	)	$	(14,823	)	$	(47,470	)	$	(22,944	)
Basic weighted-average common shares outstanding		89,739,310			89,002,430			89,476,065			81,221,550
Basic net loss per share for the period attributable to common stockholders	$	(0.20	)	$	(0.17	)	$	(0.53	)	$	(0.28	)

Effect of dilutive securities:
Net loss attributable to common stockholders	$	(17,619	)	$	(14,823	)	$	(47,470	)	$	(22,944	)
Adjustment to numerator - Change in fair value of Columbia Warrant liability		—			(18,635	)	$	—		$	(18,635	)
Dilutive numerator	$	(17,619	)	$	(33,458	)	$	(47,470	)	$	(41,579	)
Columbia Warrant		—			1,410,657			—			1,410,657
Diluted weighted-average common shares		89,739,310			90,413,087			89,476,065			82,632,207
Diluted net loss per share for the period attributable to common stockholders	$	(0.20	)	$	(0.37	)	$	(0.53	)	$	(0.50	)

	Year Ended December 31,
	2022			2021			2020
Net loss attributable to common stockholders	$	(36,641	)	$	(96,305	)	$	(21,529	)
Basic weighted-average common shares outstanding (1)		83,188,276			16,655,634			16,029,826
Basic loss per share for the period attributable to common stockholders	$	(0.44	)	$	(5.78	)	$	(1.34	)
Effect of dilutive securities:
Adjustment to numerator - Change in fair value of Columbia Warrant liability	$	(18,635	)	$	—		$	—
Dilutive numerator	$	(55,276	)	$	(96,305	)	$	(21,529	)
Columbia Warrant		609,873			—			—
Diluted weighted-average common shares outstanding		83,798,149			16,655,634			16,029,826
Diluted loss per share for the period attributable to common stockholders	$	(0.66	)	$	(5.78	)	$	(1.34	)

Note 12 - Stock-based Compensation - Schedule of Stock-based Compensation Expense 1 (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Payment Arrangement, Expense	$ 1,414	$ 2,139	$ 4,254	$ 6,624	$ 8,368	$ 10,881	$ 1,732
General and Administrative Expense [Member]
Share-Based Payment Arrangement, Expense	884	554	2,714	2,240	2,406	5,274	1,235
Research and Development Expense [Member]
Share-Based Payment Arrangement, Expense	312	781	933	1,753	3,631	1,968	382
Other Operating Income (Expense) [Member]
Share-Based Payment Arrangement, Expense	$ 218	$ 804	$ 607	$ 2,631	$ 2,331	$ 3,639	$ 115

Note 2 - Summary of Significant Accounting Policies - Schedule of Cash and Cash Equivalents (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash and cash equivalents	$ 30,971	$ 76,528		$ 8,533
Restricted cash	0	126		0
Restricted cash included in Other non-current assets	1,151	1,138		0
Total cash, cash equivalents and restricted cash	$ 32,122	$ 77,792	$ 97,307	$ 8,533	$ 17,267	$ 24,557

Note 2 - Summary of Significant Accounting Policies - Schedule of Cash Flow, Supplemental Disclosures (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income tax, net of refunds	$ 758	$ 96	$ 59
Interest	$ 3,520	$ 49,283	$ 27,286

Note 5 - Revenue from Contracts with Customers 1 (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Disaggregation of Revenue [Table Text Block]

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Revenue by timing
Over time	$	413	$	—	$	1,236	$	1,524
Point-in time		783		2,158		3,144		3,022
Total revenue	$	1,196	$	2,158	$	4,380	$	4,546

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Revenue by geography ^{(1) (2)}
Asia Pacific	$	82	$	232	$	351	$	1,946
Europe		513		43		1,506		80
North America		588		1,817		2,467		2,435
South America		13		66		56		85
Total revenue	$	1,196	$	2,158	$	4,380	$	4,546

	Year Ended December 31,
	2022		2021
Revenue by geography ⁽¹⁾
Asia Pacific	$	1,531	$	3,988
North America		3,438		201
Other		1,043		58
Total revenue	$	6,012	$	4,247

Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]

	September 30,		December 31,
	2023		2022
Non-current	$	1,000	$	1,000
Current		3,286		1,941
Total	$	4,286	$	2,941

	December 31,
	2022		2021
Non-current	$	1,000	$	1,000
Current		1,941		935
Total	$	2,941	$	1,935

Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]

		Within 1 Year				Years 2				Years 3				Thereafter
Remaining performance obligations		$	6,852			$	5,648			$	5,005			$	1,000

		Within 1 Year				Years 1-2				Years 2-3				Thereafter
Remaining performance obligations		$	6,422			$	11,296			$	3,860			$	—

Note 12 - Stock-based Compensation - Stock Options Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Balance, options (in shares)	6,067,313	6,864,563	6,864,563
Balance, options, exercise price (in dollars per share)	$ 1.83	$ 2.05	$ 2.05
Balance, options, contractual term (Year)	1 year 9 months 10 days		2 years 25 days	2 years 4 months 9 days
Granted, options (in shares)	0	0	0
Granted, options, exercise (in dollars per share)			$ 0
Forfeited, options (in shares)	(425,178)		(574,299)
Forfeited, options, exercise price (in dollars per share)	$ 3.98		$ 4.56
Exercised, options (in shares)	(186,307)		(102,825)
Exercised, options, exercise price (in dollars per share)	$ 1.13		$ 1.12
Expired, options (in shares)	(177,430)		(120,126)
Expired, options, exercise price (in dollars per share)	$ 2.27		$ 2.6
Outstanding, options (in shares)	5,278,398		6,067,313	6,864,563
Outstanding, options, exercise price (in dollars per share)	$ 1.61		$ 1.83	$ 2.05
Outstanding, options, intrinsic value	$ 1,041		$ 10,818
Exercisable, options (in shares)	4,594,898		4,449,152
Exercisable, options, exercise price (in dollars per share)	$ 1.4		$ 1.31
Exercisable, options, contractual term (Year)	1 year 8 months 15 days		1 year 11 months 1 day
Exercisable, options, intrinsic value	$ 1,000		$ 8,832

Note 17 - Debt

12 Months Ended

Dec. 31, 2022

Debt Disclosure [Text Block]

17. Debt

There was no debt as of December 31, 2022. Debt as of December 31, 2021 is as follows:

	December 31, 2021
2018 Convertible Notes	$	19,862
2019 Convertible Notes		27,498
2020 Convertible Notes		15,294
Cantor Loan		7,522
Columbia Loan		38,297
Total debt		108,473
Less deferred financing costs		—
Total debt less deferred financing fees		108,473
Less: Current portion		—
Total non-current debt, net of deferred financing fees	$	108,473

Convertible Notes

In April 2021, we and our 2018 and 2019 convertible note holders agreed to extend the maturity date of the 2018 and 2019 convertible notes from April and September 2021, respectively, to April 2022, and recognized a loss on extinguishment of debt of $37,216 on the Consolidated Statements of Operations and Comprehensive Loss for the year ended December 31, 2021.

On January 25, 2022, the convertible notes were converted into 17,980,954 Class A ordinary shares. See Note 4 (Reverse Recapitalization).

Cantor Loan

In December 2021, we entered into the Cantor Loan. As we elected to account for the Cantor Loan using the fair value option at inception, changes in fair value recognized through subsequent remeasurements were recorded in the Consolidated Statements of Operations and Comprehensive Loss at each reporting period.

Pursuant to the Promissory Note Waiver Letter, the Company repaid the Cantor Loan, including all principal and interest, by the issuance of 788,021 Class A ordinary shares. Such repayment occurred on the Closing Date.

The Promissory Note Waiver Letter included a provision where in the event the VWAP is less than $10.00 per Class A ordinary share, CF&Co. will be entitled to receive a certain number of additional Class A ordinary shares (the “Cantor Loan Additional Shares”), up to a maximum of 197,005 Cantor Loan Additional Shares (if the Adjustment Period VWAP, as defined in the Promissory Note Waiver Letter, is less than or equal to $8.00 per share).

We extinguished the remaining Cantor Loan liability through the issuance of 26,050 Cantor Loan Additional Shares on May 9, 2022 pursuant to the terms of the Promissory Note Waiver Letter.

Columbia Loan

On March 8, 2021, we signed an Exchange Agreement in conjunction with a Loan and Security Agreement and warrant with Columbia, a holder of Series A, Series B and Series B-1 preferred shares and convertible notes. The Exchange Agreement requires Columbia to sell back to us all its outstanding shares and Notes debt, in exchange for a loan and security interest in the principal amount of $40.1 million (the “Columbia Loan”), which represented the outstanding balance of the notes including unpaid accrued interest, in exchange for the Columbia Warrant. In connection with the Merger and as provided in the Exchange Agreement, we reacquired treasury stock having a fair value of $170.9 million, the Columbia Loan was settled and the fair value of the Columbia Warrant of $124.8 million was reclassified to additional paid-in capital. There is no balance outstanding remaining at December 31, 2022 related to the Columbia Loan or Columbia Warrant liability.

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 470
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//470/tableOfContent

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I

Note 5 - Revenue from Contracts with Customers (Details Textual) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Revenue from Contract with Customer, Excluding Assessed Tax	$ 1,196	$ 2,158	$ 4,380	$ 4,546	$ 6,012	$ 4,247	$ 0
Contract with Customer, Liability, Revenue Recognized			1,500	$ 900	$ 900	$ 500
Revenue Benchmark [Member] \| Customer Concentration Risk [Member]
Number of Major Customers		1		1	2	1
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Two Customers [Member]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 900		$ 4,400	$ 3,800	$ 4,800
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Two Customers [Member] \| Minimum [Member]
Concentration Risk, Percentage	10.00%		10.00%	10.00%	10.00%
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| One Customer [Member]
Revenue from Contract with Customer, Excluding Assessed Tax		$ 1,700				$ 3,900
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| One Customer [Member] \| Minimum [Member]
Concentration Risk, Percentage		10.00%				10.00%
Transferred over Time [Member]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 413	$ 0	$ 1,236	$ 1,524	$ 1,600	$ 3,800
Transferred at Point in Time [Member]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 783	$ 2,158	$ 3,144	$ 3,022	$ 4,400	$ 400

Consolidated Statements of Redeemable Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Cumulative Effect, Period of Adoption, Adjustment [Member] Redeemable Series X Preferred Stockholders [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] Additional Paid-in Capital [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member] Retained Earnings [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]	Hanover Holdings S A [Member] Redeemable Series X Preferred Stockholders [Member]	Hanover Holdings S A [Member] Preferred Stock [Member]	Hanover Holdings S A [Member] Common Stock [Member]	Hanover Holdings S A [Member] Additional Paid-in Capital [Member]	Hanover Holdings S A [Member] Treasury Stock, Common [Member]	Hanover Holdings S A [Member] AOCI Attributable to Parent [Member]	Hanover Holdings S A [Member] Retained Earnings [Member]	Hanover Holdings S A [Member]	Convertible Debt [Member] Redeemable Series X Preferred Stockholders [Member]	Convertible Debt [Member] Common Stock [Member]	Convertible Debt [Member] Additional Paid-in Capital [Member]	Convertible Debt [Member] Treasury Stock, Common [Member]	Convertible Debt [Member] AOCI Attributable to Parent [Member]	Convertible Debt [Member] Retained Earnings [Member]	Convertible Debt [Member]	Canter Loan [Member] Redeemable Series X Preferred Stockholders [Member]	Canter Loan [Member] Common Stock [Member]	Canter Loan [Member] Additional Paid-in Capital [Member]	Canter Loan [Member] Treasury Stock, Common [Member]	Canter Loan [Member] AOCI Attributable to Parent [Member]	Canter Loan [Member] Retained Earnings [Member]	Canter Loan [Member]	Forward Purchase Contract Warrant [Member] Redeemable Series X Preferred Stockholders [Member]	Forward Purchase Contract Warrant [Member] Common Stock [Member]	Forward Purchase Contract Warrant [Member] Additional Paid-in Capital [Member]	Forward Purchase Contract Warrant [Member] Treasury Stock, Common [Member]	Forward Purchase Contract Warrant [Member] AOCI Attributable to Parent [Member]	Forward Purchase Contract Warrant [Member] Retained Earnings [Member]	Forward Purchase Contract Warrant [Member]	Pipe Warrant [Member] Redeemable Series X Preferred Stockholders [Member]	Pipe Warrant [Member] Common Stock [Member]	Pipe Warrant [Member] Additional Paid-in Capital [Member]	Pipe Warrant [Member] Treasury Stock, Common [Member]	Pipe Warrant [Member] AOCI Attributable to Parent [Member]	Pipe Warrant [Member] Retained Earnings [Member]	Pipe Warrant [Member]	Liberty Subscription Agreement [Member] Redeemable Series X Preferred Stockholders [Member]	Liberty Subscription Agreement [Member] Common Stock [Member]	Liberty Subscription Agreement [Member] Additional Paid-in Capital [Member]	Liberty Subscription Agreement [Member] Treasury Stock, Common [Member]	Liberty Subscription Agreement [Member] AOCI Attributable to Parent [Member]	Liberty Subscription Agreement [Member] Retained Earnings [Member]	Liberty Subscription Agreement [Member]	Public Warrants [Member] Redeemable Series X Preferred Stockholders [Member]	Public Warrants [Member] Preferred Stock [Member]	Public Warrants [Member] Common Stock [Member]	Public Warrants [Member] Additional Paid-in Capital [Member]	Public Warrants [Member] Treasury Stock, Common [Member]	Public Warrants [Member] AOCI Attributable to Parent [Member]	Public Warrants [Member] Retained Earnings [Member]	Public Warrants [Member]	Redeemable Series X Preferred Stockholders [Member]	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock, Common [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2019																																																								0	8,740,398	15,961,703
Balance at Dec. 31, 2019	$ 0	$ (123)	$ (1,261)	$ (1,384)																																																				$ 0			$ 61,635	$ 0	$ 0	$ (67,084)	$ (5,449)
Issuance of stock (in shares)																																																								0	0	318,657
Issuance of stock																																																								$ 0			802	0	0	0	802
Net loss																																																								0			0	0	0	(21,529)	(21,529)
Stock-based compensation																																																								$ 0			1,727	0	0	5	1,732
Balance (in shares) at Dec. 31, 2020																																																								0	8,740,398	16,280,360
Balance at Dec. 31, 2020																																																								$ 0			64,041	0	0	(89,869)	(25,828)
Net loss																																																								0			0	0	0	(96,305)	(96,305)
Stock-based compensation																																																								$ 0			10,881	0	0	0	10,881
Issuance of Redeemable Series X preferred stock (in shares)																																																								2,033,230	0	0
Issuance of Redeemable Series X preferred stock																																																								$ 20,332			0	0	0	0	0
Dividends on Redeemable Series X preferred stock																																																								974			0	0	0	0	0
Extinguishment of Convertible Notes																																																								0			39,009	0	0	0	39,009
Exercise of stock options																																																								$ 0			791	0	0	0	791
Exercise of stock options (in shares)																																																									0	1,102,494
Preferred stockholder transaction (Note 11) (in shares)																																																								0	(4,128,413)	0
Preferred stockholder transaction (Note 11)																																																								$ 0			(18,251)	(170,949)	0	0	(189,200)
Comprehensive loss																																																								0			0	0	(86)	0	(86)
Repurchase of shares																																																								0			(18,251)	(170,949)	0	0	(189,200)
Other comprehensive loss																																																								$ 0			0	0	(86)	0	(86)
Balance (in shares) at Dec. 31, 2021																																																								2,033,230	4,611,985	17,382,854
Balance at Dec. 31, 2021																																																								$ 21,306			96,471	(170,949)	(86)	(186,174)	(260,738)
Issuance of stock (in shares)																					26,050
Issuance of stock																						$ 167				$ 167
Net loss																																																											0	0	0	(22,944)	(22,944)
Stock-based compensation																																																											6,624				6,624
Exercise of stock options																																																											37				37
Exercise of stock options (in shares)																																																									0	21,927
Preferred stockholder transaction (Note 11) (in shares)						149,817	51,700																																																			(516,123)
Preferred stockholder transaction (Note 11)																																																												(8,603)			(8,603)
Comprehensive loss																																																											0	0	(695)	0	(695)
Hannover Holdings Transaction (Note 11)								$ 0	$ 0	$ 0	$ 0	$ 0
Merger transaction and Reverse Recapitalization																																																											(166,634)	170,949	0	0	4,315
Merger transaction and Reverse Recapitalization (in shares)																																																									(4,462,168)	22,630,545
Issuance of Class A ordinary shares															$ 64,051				$ 64,051			7,880				7,880			$ 10,000				$ 10,000			$ 47,430				$ 47,430			$ 121,182				$ 121,182				$ 5,628				$ 5,628
Issuance of Class A ordinary shares (in shares)														17,980,954							788,021							1,250,000							6,108,332							20,619,835								613,111
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization (in shares)																																																										2,140,340
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization																																																											21,403				21,403
Reclassification of Columbia Warrant to equity																																																											124,805				124,805
Repayment of Columbia Loan																																																											(3,418)				(3,418)
Reclassification of Forfeiture Earnout Liability to equity																																																											1,005				1,005
Repurchase of shares																																																												(8,603)			(8,603)
Other comprehensive loss																																																											0	0	(695)	0	(695)
Balance (in shares) at Sep. 30, 2022																																																									0	88,994,146
Balance at Sep. 30, 2022																																																											336,631	(8,603)	(781)	(209,118)	118,129
Balance (in shares) at Dec. 31, 2021																																																								2,033,230	4,611,985	17,382,854
Balance at Dec. 31, 2021																																																								$ 21,306			96,471	(170,949)	(86)	(186,174)	(260,738)
Issuance of stock (in shares)																					26,050
Issuance of stock																				$ 0		167	$ 0	$ 0	$ 0	167
Net loss																																																								0			0	0	0	(36,641)	(36,641)
Stock-based compensation																																																								0			8,368	0	0	0	8,368
Dividends on Redeemable Series X preferred stock																																																								97				0	0	0	0
Exercise of stock options																																																								$ 0			144	0	0	0	$ 144
Exercise of stock options (in shares)																																																								0	0	223,218					102,825
Preferred stockholder transaction (Note 11) (in shares)						(149,817)	(51,700)																																																			(516,123)
Preferred stockholder transaction (Note 11)																																																								$ 0				(2,750)	0	0	$ (2,750)
Comprehensive loss																																																								0			0	0	(226)	0	(226)
Hannover Holdings Transaction (Note 11)					$ 0			0	(5,853)	0	0	(5,853)
Merger transaction and Reverse Recapitalization																																																								$ 0			(165,804)	170,949	0	0	5,145
Merger transaction and Reverse Recapitalization (in shares)																																																									(4,462,168)	22,630,545
Issuance of Class A ordinary shares													$ 0		$ 64,051	$ 0	$ 0	$ 0	$ 64,051	$ 0		$ 7,880	$ 0	$ 0	$ 0	$ 7,880	$ 0		$ 10,000	$ 0	$ 0	$ 0	$ 10,000	$ 0		$ 47,028	$ 0	$ 0	$ 0	$ 47,028	$ 0		$ 120,506	$ 0	$ 0	$ 0	$ 120,506	$ 0			$ 5,628	$ 0	$ 0	$ 0	$ 5,628
Issuance of Class A ordinary shares (in shares)														17,980,954							788,021							1,250,000							6,108,332							20,619,835						0	0	613,111
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization (in shares)																																																								(2,033,230)		2,140,340
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization																																																								$ (21,403)			21,403	0	0	0	21,403
Reclassification of Columbia Warrant to equity																																																								0			124,805	0	0	0	124,805
Repayment of Columbia Loan																																																								0			(3,418)	0	0	0	(3,418)
Reclassification of Forfeiture Earnout Liability to equity																																																								0			1,005	0	0	0	1,005
Repurchase of shares																																																								0				(2,750)	0	0	(2,750)
Other comprehensive loss																																																								0			0	0	(226)	0	(226)
Withholding of stock units to satisfy tax withholding obligations upon the vesting of restricted stock units and exercise of stock options																																																								$ 0			(306)	0	0	0	(306)
Balance (in shares) at Dec. 31, 2022																																																								0	0	89,195,437
Balance at Dec. 31, 2022																																																								$ 0			337,928	(8,603)	(312)	(222,815)	106,198
Balance (in shares) at Jun. 30, 2022																																																									0	88,994,146
Balance at Jun. 30, 2022																																																											335,306	(8,603)	(408)	(194,295)	132,000
Net loss																																																											0	0	0	(14,823)	(14,823)
Stock-based compensation																																																											2,139	0	0	0	2,139
Exercise of stock options																																																											16	0	0	0	16
Preferred stockholder transaction (Note 11)																																																											0	(5,853)	0	0	(5,853)
Comprehensive loss																																																											0	0	(373)	0	(373)
Hannover Holdings Transaction (Note 11)								$ 0	$ 5,853	$ 0	$ 0	$ 5,853
Merger transaction and Reverse Recapitalization																																																											(830)	0	0	0	(830)
Repurchase of shares																																																											0	(5,853)	0	0	(5,853)
Other comprehensive loss																																																											0	0	(373)	0	(373)
Balance (in shares) at Sep. 30, 2022																																																									0	88,994,146
Balance at Sep. 30, 2022																																																											336,631	(8,603)	(781)	(209,118)	118,129
Balance (in shares) at Dec. 31, 2022																																																								0	0	89,195,437
Balance at Dec. 31, 2022																																																								$ 0			337,928	(8,603)	(312)	(222,815)	106,198
Net loss																																																											0	0	0	(47,470)	(47,470)
Stock-based compensation																																																											4,254	0	0	0	4,254
Exercise of stock options																																																											249	0	0	0	$ 249
Exercise of stock options (in shares)																																																									0	186,307					186,307
Comprehensive loss																																																											0	0	(218)	0	$ (218)
Other comprehensive loss																																																											0	0	(218)	0	(218)
Withholding of stock units to satisfy tax withholding obligations upon the vesting of restricted stock units and exercise of stock options																																																											(272)	0	0	0	(272)
Balance (in shares) at Sep. 30, 2023																																																									0	89,875,246
Balance at Sep. 30, 2023																																																											342,159	(8,603)	(530)	(270,285)	62,741
Balance (in shares) at Jun. 30, 2023																																																									0	89,661,530
Balance at Jun. 30, 2023																																																											340,750	(8,603)	(236)	(252,666)	79,245
Net loss																																																											0	0	0	(17,619)	(17,619)
Stock-based compensation																																																											1,413	0	0	0	1,413
Exercise of stock options																																																											49	0	0	0	49
Exercise of stock options (in shares)																																																									0	80,626
Comprehensive loss																																																											0	0	(294)	0	(294)
Other comprehensive loss																																																											0	0	(294)	0	(294)
Withholding of stock units to satisfy tax withholding obligations upon the vesting of restricted stock units and exercise of stock options																																																											(53)	0	0	0	(53)
Balance (in shares) at Sep. 30, 2023																																																									0	89,875,246
Balance at Sep. 30, 2023																																																											$ 342,159	$ (8,603)	$ (530)	$ (270,285)	$ 62,741

Note 15 - Fair Value Measurement and Financial Instruments 1

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Fair Value Disclosures [Text Block]

15. Fair Value Measurements and Financial Instruments

The following tables provide the fair value measurement hierarchy of the Company’s assets and liabilities:

As of September 30, 2023	Fair value measurement using
Financial instruments	Quoted prices in active markets (Level 1)		Significant observable inputs (Level 2)		Significant unobservable inputs (Level 3)
$8.63 Warrants liability	$	704	$	—	$	—
PIPE Warrant liability		—		—		59
Liberty Warrants and Liberty Advisory Fee Warrant liability		—		—		1,182
Total Warrant Liabilities	$	704	$	—	$	1,241
Sponsor Earnout Liability	$	—	$	—	$	223

As of December 31, 2022	Fair value measurement using
Financial instruments	Quoted prices in active markets (Level 1)		Significant observable inputs (Level 2)		Significant unobservable inputs (Level 3)
$8.63 Warrants liability	$	1,833	$	—	$	—
PIPE Warrant liability		—		—		311
Liberty Warrants and Liberty Advisory Fee Warrant liability		—		—		6,191
Total Warrant Liabilities	$	1,833	$	—	$	6,502
Sponsor Earnout Liability	$	—	$	—	$	1,353

The following methods and assumptions were used to estimate the fair values:

•

The carrying values of cash and cash equivalents, restricted cash, accounts receivable, prepaid expenses and other current assets, accounts payable, and accrued expenses and other liabilities are considered to approximate their fair values due to the short term nature of these items.

•

The fair values of the PIPE Warrant, the Liberty Warrants and Liberty Advisory Fee Warrant have been estimated using the Black-Scholes model. Significant unobservable inputs include:

◦

Time to expiry - 3.4 years

◦

Volatility - 67%

◦

Risk free rate of return: 4.8%

•

The fair values of the Sponsor Earnout has been estimated using the Monte Carlo model. Significant unobservable inputs include:

◦

Time to expiry - 3.3 years

◦

Volatility - 67%

◦

Risk free rate of return: 4.8%

•

The fair values of the $8.63 Warrants were determined using quoted prices in the active warrant market.

•

The carrying value of operating lease liabilities is calculated as the present value of lease payments, discounted at its incremental borrowing rate at the lease commencement date. We consider that the incremental borrowing rate remained unchanged, therefore the carrying amount of operating lease liabilities approximates their fair value.

•

Changes in the fair value of Level 3 liabilities during the three months ended September 30, 2023 and 2022 were as follows:

	Liberty Warrants and Liberty Advisory Fee Warrant			PIPE Warrant			Columbia Warrant		Sponsor Earnout			Forfeiture Earnout		Cantor Loan
At June 30, 2022	$	15,377		$	952		$	—	$	3,111		$	—	$	—
Issues		—			—			—		—			—		—
Remeasurement (gain)/loss		(4,026	)		(415	)		—		(537	)		—		—
Write-off of deferred costs		—			—			—		—			—		—
Settlements		—			—			—		—			—		—
At September 30, 2022	$	11,351		$	537		$	—	$	2,574		$	—	$	—

At June 30, 2023	$	2,339		$	109		$	—	$	504		$	—	$	—
Remeasurement (gain)/loss		(1,157	)		(50	)		—		(281	)		—		—
At September 30, 2023	$	1,182		$	59		$	—	$	223		$	—	$	—

•

Changes in the fair value of Level 3 liabilities during the nine months ended September 30, 2023 and 2022 were as follows:

	Liberty Warrants and Liberty Advisory Fee Warrant			PIPE Warrant			Columbia Warrant			Sponsor Earnout			Forfeiture Earnout			Cantor Loan
At January 1, 2022	$	—		$	—		$	143,237		$	—		$	—		$	7,522
Issues		30,853			1,312			—			8,022			6,135			—
Remeasurement (gain)/loss⁽¹⁾		(19,502	)		(775	)		(18,635	)		(5,448	)		(5,130	)		489
Write-off of deferred costs		—			—			203			—			—			—
Settlements ⁽²⁾		—			—			(124,805	)		—			(1,005	)		(8,011	)
At September 30, 2022	$	11,351		$	537		$	—		$	2,574		$	—		$	—

At January 1, 2023	$	6,191		$	311		$	—		$	1,353		$	—		$	—
Remeasurement (gain)/loss ⁽¹⁾		(5,009	)		(252	)		—			(1,130	)		—			—
At September 30, 2023	$	1,182		$	59		$	—		$	223		$	—		$	—

⁽¹⁾

Recognized in the Condensed Consolidated Statements of Operations and Comprehensive Loss for the nine months ended September 30, 2023 and 2022, respectively.

⁽²⁾

These liabilities were settled in connection with the Merger. See Note 4 (Recapitalization Transaction).

There were no transfers between Level 1 and Level 2 during the nine months ended September 30, 2023 or 2022.

15. Fair Value Measurements and Financial Instruments

The following tables provide the fair value measurement hierarchy of our assets and liabilities:

As of December 31, 2022	Fair value measurement using
Financial instruments	Quoted prices in active markets (Level 1)		Significant observable inputs (Level 2)		Significant unobservable inputs (Level 3)
$8.63 Warrants liability	$	1,833	$	—	$	—
PIPE Warrant liability		—		—		311
Liberty Warrants and Liberty Advisory Fee Warrant liability		—		—		6,191
Total Warrant Liabilities	$	1,833	$	—	$	6,502
Sponsor Earnout liability	$	—	$	—	$	1,353

As of December 31, 2021	Fair value measurement using
Financial instruments	Quoted prices in active markets (Level 1)		Significant observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Liabilities measured at fair value
Cantor Loan	$	—	$	—	$	7,522
Columbia Warrant liability		—		—		143,237
Liabilities for which fair values are disclosed
Notes	$	—	$	180,356	$	—
Promissory notes		—		40,925		—

The following methods and assumptions were used to estimate the fair values:

•

The fair values of the PIPE Warrant, the Liberty Warrants and Liberty Advisory Fee Warrant, and the Columbia Warrant have been estimated using the Black-Scholes model.

•

The fair value of the Sponsor Earnout has been estimated using the Monte Carlo model.

•

The fair values of the $8.63 Warrants were determined using the quoted prices in the active warrant market.

•

The fair value of the Cantor Loan was determined by using the “with” method. At each measurement date, we valued the Cantor Loan with the make-whole premium. The difference between the aggregate fair value of the Cantor Loan and the unpaid principal balance was $22 thousand at December 31, 2021.

•

The fair value of the Notes debt is determined by using the “with” and “without” method. As of each measurement date, we first valued the Notes with the conversion options in certain scenarios (the “with” scenario) and subsequently valued the Notes without the conversion options (the “without” scenario). The difference between the fair values of the Notes in the “with” and “without” was de minimis at each measurement date.

Changes in the fair value of Level 3 liabilities during the years ended December 31, 2022 and 2021 were as follows:

	Liberty Warrants and Liberty Advisory Fee Warrant			PIPE Warrant			Columbia Warrant			Sponsor Earnout			Forfeiture Earnout			Cantor Loan
At January 1, 2021	$	—		$	—		$	—		$	—		$	—		$	—
Issues		—			—			161,432			—			—			7,513
Remeasurement (gain)/loss⁽¹⁾		—			—			(17,992	)		—			—			9
Amortization of deferred costs		—			—			(203	)		—			—			—
At December 31, 2021		—			—			143,237			—			—			7,522
Issues		30,853			1,312			—			8,022			6,135			—
Remeasurement (gain)/loss⁽¹⁾		(24,662	)		(1,001	)		(18,635	)		(6,669	)		(5,130	)		488
Write-off of deferred costs		—			—			203			—			—			—
Settlements ⁽²⁾		—			—			(124,805	)		—			(1,005	)		(8,010	)
At December 31, 2022	$	6,191		$	311		$	—		$	1,353		$	—		$	—

⁽¹⁾	Recognized in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2022 and 2021, respectively.

⁽²⁾	These liabilities were settled in connection with the Merger. See Note 4 (Recapitalization Transaction).

There were no transfers between Level 1 and Level 2 during the years ended December 31, 2022 or 2021.

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

Note 22 - Subsequent Events (Details Textual)	Mar. 08, 2023	Mar. 07, 2023
Subsequent Event [Member] \| Common Class B [Member]
Common Stock, Votes Per Share	1.472467906	1.463844005

Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands

3 Months Ended

9 Months Ended

12 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Sep. 30, 2023

Sep. 30, 2022

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Cost of sales, exclusive of depreciation shown separately below

$ 1,196

$ 2,158

$ 4,380

$ 4,546

$ 6,012

$ 4,247

$ 0

Costs and expenses

1,046

969

3,159

2,298

3,284

1,876

5,865

6,308

15,732

30,917

37,191

36,640

^[1],[2]

8,003

^[1],[2]

2,169

3,941

7,996

9,657

13,055

9,636

^[3]

5,924

^[3]

5,420

4,031

14,030

10,516

14,326

10,728

^[3]

3,031

^[3]

4,852

6,992

17,930

20,728

29,023

14,002

5,449

19,352

22,241

58,847

74,116

96,879

72,882

22,407

(18,156)

(20,083)

(54,467)

(69,570)

(90,867)

(68,635)

(22,407)

Other income (expense), net

389

381

1,471

(1,225)

(652)

(9,738)

^[2],[4]

1,940

6,270

7,520

50,866

58,311

17,983

^[4]

9,637

^[4]

(37,216)

^[4]

(9,240)

^[4]

2,277

1,592

4,199

2,111

1,140

1,069

^[2]

594

^[2]

4,606

8,243

13,190

51,752

58,799

(27,902)

1,026

Income tax (expense) benefit

(13,550)

(11,840)

(41,277)

(17,818)

(32,068)

(96,537)

(21,381)

(4,069)

(2,983)

(6,193)

(5,126)

(4,573)

232

(148)

(17,619)

(14,823)

(47,470)

(22,944)

(36,641)

(96,305)

(21,529)

Other comprehensive loss

(294)

(373)

(218)

(695)

(226)

(86)

Basic loss per share for the period attributable to common stockholders (in dollars per share)

$ (17,913)

$ (15,196)

$ (47,688)

$ (23,639)

$ (36,867)

$ (96,391)

$ (21,529)

$ (0.2)

$ (0.17)

$ (0.53)

$ (0.28)

$ (0.44)

$ (5.78)

^[5]

$ (1.34)

^[5]

Basic weighted-average common shares outstanding (in shares)

89,739,310

89,002,430

89,476,065

81,221,550

83,188,276

^[6]

16,655,634

^[5],[6]

16,029,826

^[5],[6]

Diluted loss per share for the period attributable to common stockholders (in dollars per share)

$ (0.2)

$ (0.37)

$ (0.53)

$ (0.5)

$ (0.66)

$ (5.78)

^[5]

$ (1.34)

^[5]

Diluted weighted-average common shares outstanding (in shares)

89,739,310

90,413,087

89,476,065

82,632,207

83,798,149

16,655,634

^[5]

16,029,826

^[5]

[1]	Certain awards granted by us have a service inception date preceding the grant date. Under IFRS, this resulted in the recognition of stock-based compensation expense prior to the grant date. Under U.S. GAAP, the stock-based compensation expense shall not be recognized until authorization at the grant date.
[2]	Under IFRS, all recognized leases are accounted for similarly to finance leases. Under U.S. GAAP, there is a dual classification on-balance sheet lease accounting model for lessees: finance and operating leases. Operating leases create a straight-line expense, and no interest expense is recognized on the lease liability.
[3]	Under IFRS, certain development expenditures may be capitalized. Under U.S. GAAP, all of our costs relating to R&D activities are expensed as incurred.
[4]	Under IFRS, the redeemable Series X preferred shares and convertible notes contained conversion features that resulted in a bifurcated derivative component with changes in fair value recognized as gain or (loss). Under U.S. GAAP, the conversion features did not result in a material bifurcated embedded derivative, resulting in the elimination of the change in fair value of financial instruments, reduction in interest expense and preferred dividends expense, and increase in the gain (loss) on extinguishment of debt. Under IFRS, it was determined that the redeemable Series X preferred shares should be classified as a liability since there is a contractual obligation to deliver cash or another financial asset and certain conversion events being beyond our control. Under U.S. GAAP, it was determined that the redeemable Series X preferred shares should be classified as mezzanine equity since the shares are redeemable based on events outside of our control. Under IFRS, it was determined that the Columbia Warrant should be classified as equity since settlement would only occur by exchanging a fixed amount of cash for a fixed number of our own equity instruments. Changes in fair value are not recognized. Under U.S. GAAP, it was determined that the Columbia Warrant should be classified as a liability since the number and type of shares received could be different pre- and post- Merger. The Columbia Warrant is recorded at fair value with changes recognized in the Consolidated Statement of Operations and Comprehensive Loss. Additionally, the resulting gain (loss) on extinguishment of the amended convertible notes differed under IFRS versus U.S. GAAP.
[5]	The change in net loss in the adoption of U.S. GAAP as described in items a-d above impacted net loss per share as follows:
[6]	After applying the 3.3028 Exchange Ratio as described in Note 4 (Reverse Recapitalization).

Note 7 - Earnout Liabilities - Schedule of Valuation Assumptions 1 (Details) - Sponsor Earnout [Member]	Sep. 30, 2023	Dec. 31, 2022	Jan. 25, 2022
Measurement Input, Expected Term [Member]
Earnout liability, measurement input	3.32	4.07	5
Measurement Input, Expected Dividend Rate [Member]
Earnout liability, measurement input	0	0	0
Measurement Input, Price Volatility [Member]
Earnout liability, measurement input	0.673	0.504	0.30
Measurement Input, Risk Free Interest Rate [Member]
Earnout liability, measurement input	0.048	0.041	0.016
Measurement Input, Expected Number of Shares [Member]
Earnout liability, measurement input	1,775,962	1,775,962	1,842,759

Note 5 - Revenue from Contracts with Customers - Schedule of Contract Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Contract liabilities	$ 1,000	$ 1,000	$ 1,000
Current	3,286	1,941	935
Total	$ 4,286	$ 2,941	$ 1,935

Note 4 - Reverse Recapitalization - Schedule of Reverse Recapitalization 1 (Details)	Jan. 18, 2022 shares
Shares outstanding (in shares)	17,215,336
Issuance of shares for transaction fees (in shares)	2,058,229
Shares outstanding (in shares)	88,824,647
Forward Purchase Securities Agreement [Member]
Shares issued (in shares)	1,250,000
Cantor Loan Repayment [Member]
Shares issued (in shares)	788,021
Series A Preferred Stockholders [Member]
Shares issued (in shares)	7,968,316
Series B Preferred Stockholders [Member]
Shares issued (in shares)	4,597,928
Series B-1 Preferred Stockholders [Member]
Shares issued (in shares)	2,171,399
The 2018 Convertible Noteholders [Member]
Shares issued (in shares)	5,581,416
The 2019 Convertible Noteholders [Member]
Shares issued (in shares)	7,846,333
The 2020 Convertible Noteholders [Member]
Shares issued (in shares)	4,553,205
Redeemable Series X Preferred Stockholders [Member]
Shares issued (in shares)	2,140,340
Liberty Investors [Member]
Shares issued (in shares)	20,000,000
PIPE Investors [Member]
Shares issued (in shares)	5,816,770
CF V Sponsor [Member]
Shares issued (in shares)	6,837,354

Note 5 - Revenue from Contract with Customer - Schedule of Remaining Performance Obligations 1 2 (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Remaining performance obligations		$ 6,422
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Remaining performance obligations	$ 6,852
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Remaining performance obligations	5,648	11,296
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Remaining performance obligations	5,005	3,860
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Remaining performance obligations	$ 1,000	$ 0

Note 10 - Income Tax - Schedule of Components of Income Tax Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Loss before income tax	$ (13,550)	$ (11,840)	$ (41,277)	$ (17,818)	$ (32,068)	$ (96,537)	$ (21,381)
Provision for income tax	$ 4,069	$ 2,983	$ 6,193	$ 5,126	$ 4,573	$ (232)	$ 148
Effective tax rate	(30.00%)	(25.20%)	(15.00%)	(28.80%)

Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(11))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-31

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 25
-Paragraph 1
-SubTopic 20
-Topic 940
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481913/940-20-25-1

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

Note 1 - Nature of the Business and Basis of Presentation 1

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Business Description and Basis of Presentation [Text Block]

1. Nature of the Business and Basis of Presentation

Nature of the Business

On January 25, 2022 (the “Closing Date”), Satellogic Inc. (“Satellogic” or the “Company”), a business company incorporated in the British Virgin Islands (“BVI”), as a company limited by shares, consummated the transactions contemplated by the Agreement and Plan of Merger dated as of July 5, 2021 (the “Merger Agreement”), by and among the Company, CF Acquisition Corp. V, a Delaware corporation (“CF V” and now known as “Satellogic V Inc.”), Ganymede Merger Sub 1 Inc., a BVI business company incorporated in the BVI as a company limited by shares and a direct wholly owned subsidiary of the Company, Ganymede Merger Sub 2 Inc., a Delaware corporation wholly owned subsidiary of the Company, and Nettar Group Inc. (d/b/a Satellogic), a limited liability company incorporated under the laws of the BVI (“Nettar”).

Nettar was, prior to the transaction, the holding company of the Satellogic group and was incorporated on October 7, 2014 under the laws of the BVI as a company limited by shares. The registered office of Satellogic is located at Kingston Chambers BOX 173 C/O Maples Corporate Services BVI LTD Road Town, Tortola D8 VG1110.

References to “Nettar” contained herein refer to Nettar Group Inc. prior to the mergers, and references to “the Company,” “we,” “our,” “us” or “Satellogic” refer to Satellogic Inc. prior to the mergers and to the combined company following the mergers.

Through our subsidiaries, we invest in the software, hardware, and optics of the aerospace industry focusing on satellite and image analytics technologies. Our strategy is to build a planetary scale analytics platform based on a proprietary satellite constellation with the capability to generate insights from images and information, with focus on multi-temporal analysis and high frequency of revisits. We also intend to leverage our ability to quickly build and launch high quality, sub-meter satellites at a low cost by selling satellites to certain key customers.

Basis of Presentation

The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The Company conducts business through one operating segment.

The accompanying Condensed Consolidated Financial Statements include our accounts and those of our wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The Condensed Consolidated Financial Statements are presented in United States dollars (hereinafter “U.S. dollars” or “$”).

The accompanying Condensed Consolidated Financial Statements are unaudited and reflect all adjustments of a normal, recurring nature that are, in the opinion of management, necessary for a fair presentation of the interim period financial statements. The results of operations for these interim periods are not necessarily indicative of the results of operations to be expected for any future period or the full fiscal year. Certain prior year amounts have been reclassified to conform to the current year presentation.

Emerging Growth Company

We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (“the Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). The JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging grown company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. We have elected not to opt out of such extended transition period, which means that when a standard is issued or revised that has different application dates for public or private companies, we can adopt the new or revised standard at the time required for private companies to adopt such standard. The foregoing may make comparison of our financial statements with those of another public company difficult or impossible if such other public company is (i) not an emerging growth company or (ii) is an emerging growth company that has opted out of using the extended transition period, due to the potential differences in accounting standards used.

Going Concern and Liquidity

The accompanying unaudited condensed consolidated financial statements have been prepared assuming we will continue as a going concern. The going concern basis of presentation assumes that we will continue in operation one year after the date these unaudited condensed consolidated financial statements are issued, and we will be able to realize its assets and discharge its liabilities and commitments in the normal course of business.

Pursuant to the requirements of ASC Topic 205-40, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, management must evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date these unaudited condensed consolidated interim financial statements are issued. This evaluation does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented or are not within control of the Company as of the date the unaudited condensed consolidated interim financial statements are issued. When substantial doubt exists, management evaluates whether the mitigating effect of its plans sufficiently alleviates substantial doubt about the Company’s ability to continue as a going concern. The mitigating effect of management’s plans, however, is only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date that the unaudited condensed consolidated interim financial statements are issued, and (2) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the unaudited condensed consolidated interim financial statements are issued.

We have evaluated whether there are any conditions and events, considered in the aggregate, that raise substantial doubt about our ability to continue as a going concern over the next twelve months through September 2024. Since inception, we have incurred significant operating losses and have an accumulated deficit of $270.3 million, with net cash used in operating activities of $36.1 million for the nine months ended September 30, 2023. As of September 30, 2023, our existing sources of liquidity included cash and cash equivalents of $31.0 million. We believe that this current level of cash and cash equivalents is not sufficient to fund operations and capital expenditures to reach larger scale revenue generation from our product offerings. We may encounter liquidity issues in the second or third quarter of 2024 if we are unable to raise additional funds or generate increased cash from operations in the near term.

In order for us to proceed and reach larger scale revenue generation, we will need to raise additional funds through the issuance of additional equity, debt or both. Until such time that we can generate revenue sufficient to achieve profitability, we expect to finance our operations through equity or debt financings, which may not be available to us on the timing needed or on terms that we deem to be favorable. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interest of our stockholders may be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of common stockholders. Debt financing and equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making acquisitions or capital expenditures or declaring dividends. If we are unable to obtain sufficient financial resources, our business, financial condition and results of operations will be materially and adversely affected. There can be no assurance that we will be able to obtain the needed financing on acceptable terms or at all. In an effort to alleviate these conditions, we continue to seek and evaluate opportunities to raise additional capital through the issuance of equity or debt securities.

As a result of these uncertainties, and notwithstanding our plans and efforts to date, there is substantial doubt about our ability to continue as a going concern for one year from the date of when these condensed consolidated interim financial statements are issued. If we are unable to raise additional capital as and when needed, or upon acceptable terms, such failure would have a significant negative impact on our financial condition. As such, these conditions raise substantial doubt about the Company’s ability to continue as a going concern.

1. Nature of the Business and Basis of Presentation

Nature of the Business

On January 25, 2022 (the “Closing Date”), Satellogic Inc. (“Satellogic” or the “Company”), a BVI business company incorporated in the BVI as a company limited by shares, consummated the transactions contemplated by the Agreement and Plan of Merger dated as of July 5, 2021 (the “Merger Agreement”), by and among the Company, CF Acquisition Corp. V, a Delaware corporation (“CF V” and now known as “Satellogic V Inc.”), Ganymede Merger Sub 1 Inc., a BVI business company incorporated in the BVI as a company limited by shares and a direct wholly owned subsidiary of the Company, Ganymede Merger Sub 2 Inc., a Delaware corporation and a direct wholly owned subsidiary of the Company, and Nettar Group Inc. (d/b/a Satellogic), a limited liability company incorporated under the laws of the BVI (“Nettar”).

Nettar was, prior to the transaction, the holding company of the Satellogic group and was incorporated on October 7, 2014, under the laws of the BVI as a company limited by shares. The registered office of Satellogic is located at Kingston Chambers BOX 173 C/O Maples Corporate Services BVI LTD Road Town, Tortola D8 VG1110.

Basis of Presentation

The accompanying Consolidated Financial Statements as of December 31, 2022 and 2021 and for the years ended December 31, 2022, 2021 and 2020 (“the Consolidated Financial Statements”) have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The Company conducts business through one operating segment.

The accompanying Consolidated Financial Statements include our accounts and those of our wholly owned subsidiaries. All intercompany accounts and transactions, including the intercompany portion of transactions with equity method investees, have been eliminated in consolidation. The Consolidated Financial Statements are presented in United States dollars (hereinafter “U.S. dollars” or “$”).

Historically the consolidated financial statements were prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board. For the Consolidated Financial Statements, we have prepared our consolidated financial statements in accordance with U.S. GAAP. The change from reporting in IFRS to U.S. GAAP was treated as a change in accounting standard, whereby we retrospectively applied the change to all prior reporting periods contained in these Consolidated Financial Statements. Where the initial adoption of U.S. GAAP resulted in a material change in an asset or liability, the adjustment was reported to the opening balance of accumulated deficit and additional paid-in capital as of January 1, 2020. Refer to Note 19 (Adoption of U.S. GAAP) for additional information.

Certain prior year amounts have been reclassified to conform to the current year presentation.

Emerging Growth Company

We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (“the Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). The JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. We have elected not to opt out of such extended transition period, which means that when a standard is issued or revised that has different application dates for public or private companies, we can adopt the new or revised standard at the time required for private companies to adopt such standard. The foregoing may make comparison of our financial statements with those of another public company difficult or impossible if such other public company is (i) not an emerging growth company or (ii) is an emerging growth company that has opted out of using the extended transition period, due to the potential differences in accounting standards used.

Liquidity

Since our formation, we have devoted substantial effort and capital resources to the development of our satellite constellation and image technologies. As of December 31, 2022, we had an accumulated deficit of $222.8 million. For the year ended December 31, 2022, we had net cash used in operating activities of $68.5 million. As of December 31, 2022, we had cash and cash equivalents of $76.5 million.

We anticipate losses and negative operating cash flows to continue, primarily as a result of our satellite constellation expansion as we obtain adequate sources of funding through revenue growth. We believe we will have sufficient funding for at least the next 12 months from the date these Consolidated Financial Statements are issued.

Failure to generate revenue growth with sufficient positive cash flows from operations or to raise additional funding in the longer term may require us to alter, or scale back, our capital expenditures and could have a material adverse effect on our ability to achieve its intended business objectives.

Note 14 - Net Loss Per Share - Schedule of Net Loss Per Share 1 (Details) - USD ($)
$ / shares in Units, $ in Thousands

3 Months Ended

9 Months Ended

12 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Sep. 30, 2023

Sep. 30, 2022

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Basic weighted-average common shares outstanding (in shares)

$ (17,619)

$ (14,823)

$ (47,470)

$ (22,944)

$ (36,641)

$ (96,305)

$ (21,529)

89,739,310

89,002,430

89,476,065

81,221,550

83,188,276

^[1]

16,655,634

^[1],[2]

16,029,826

^[1],[2]

Basic loss per share for the period attributable to common stockholders (in dollars per share)

$ (0.2)

$ (0.17)

$ (0.53)

$ (0.28)

$ (0.44)

$ (5.78)

^[2]

$ (1.34)

^[2]

Adjustment to numerator - Change in fair value of Columbia Warrant liability

$ 0

$ (18,635)

$ 0

$ (18,635)

$ 0

Columbia Warrant (in shares)

$ (17,619)

$ (33,458)

$ (47,470)

$ (41,579)

$ (55,276)

$ (96,305)

$ (21,529)

1,410,657

609,873

Diluted weighted-average common shares outstanding (in shares)

89,739,310

90,413,087

89,476,065

82,632,207

83,798,149

16,655,634

^[2]

16,029,826

^[2]

Diluted loss per share for the period attributable to common stockholders (in dollars per share)

$ (0.2)

$ (0.37)

$ (0.53)

$ (0.5)

$ (0.66)

$ (5.78)

^[2]

$ (1.34)

^[2]

[1]	After applying the 3.3028 Exchange Ratio as described in Note 4 (Reverse Recapitalization).
[2]	The change in net loss in the adoption of U.S. GAAP as described in items a-d above impacted net loss per share as follows:

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482635/260-10-55-15

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 65
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480175/815-40-65-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-7

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-4

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 52
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482635/260-10-55-52

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-7

Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-11

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-4

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 5
-Subparagraph (SAB Topic 6.B)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-10

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-31

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 11
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-11

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 60B
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B

Note 15 - Fair Value Measurement and Financial Instruments (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Jan. 25, 2022	Jan. 24, 2022
Canter Loan [Member]
Fair Value, Option, Aggregate Differences, Long-Term Debt Instruments		$ 22
The 8.63 Warrants [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 8.63	$ 8.63	$ 8.63	$ 11.5

Note 9 - Additional Financial Statement Information - Schedule of Accrued Expenses and Other Liabilities 1 (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Provisions	$ 66	$ 71	$ 2,934
Payroll and benefits payable	2,111	3,289	2,545
Other taxes payable	5,373	3,128	2,045
Other	430	451	2,200
Total	7,980	6,939	25,987
Accrued expenses and other liabilities	7,481	6,417	23,435
Other non-current liabilities	$ 499	$ 522	$ 2,552

Note 5 - Revenue from Contracts with Customers - Revenue by Geography (Details) - USD ($)
$ in Thousands

3 Months Ended

9 Months Ended

12 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Sep. 30, 2023

Sep. 30, 2022

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

$ 1,196

$ 2,158

$ 4,380

$ 4,546

$ 6,012

$ 4,247

$ 0

Asia Pacific [Member]

^[2]

^[1]

232

^[1]

351

^[1]

1,946

^[1]

1,531

3,988

North America [Member]

^[2]

$ 588

^[1]

$ 1,817

^[1]

$ 2,467

^[1]

$ 2,435

^[1]

3,438

201

Other Countries [Member]

^[2]

$ 1,043

$ 58

[1]	Certain comparative figures have been reclassified to conform to the current year presentation.
[2]	Revenue by geography is based on the geographical location of the customer.

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 924
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-30

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-42

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-40

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-22

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-32

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-41

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-4

Note 15 - Fair Value Measurements and Financial Instruments - Reconciliation of Level 3 Measurements 1 (Details) - USD ($)
$ in Thousands

3 Months Ended

9 Months Ended

12 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Sep. 30, 2023

Sep. 30, 2022

Dec. 31, 2022

Dec. 31, 2021

Borrowings [Member]

$ 0

$ 7,522

$ 0

7,513

^[1]

489

^[1]

488

^[2]

(8,011)

^[3]

(8,010)

^[3]

7,522

Sponsor Earnout [Member]

504

3,111

1,353

8,022

(281)

(537)

(1,130)

^[1]

(5,448)

^[1]

(6,669)

^[2]

^[3]

Forfeiture Earnout [Member]

223

2,574

223

2,574

1,353

6,135

^[1]

(5,130)

^[1]

(5,130)

^[2]

(1,005)

^[3]

(1,005)

^[3]

Liberty Warrants and Liberty Advisory Fee Warrant [Member]

2,339

15,377

6,191

30,853

(1,157)

(4,026)

(5,009)

^[1]

(19,502)

^[1]

(24,662)

^[2]

^[3]

1,182

11,351

1,182

11,351

6,191

Pipe Warrant [Member]

109

952

311

1,312

(50)

(415)

(252)

^[1]

(775)

^[1]

(1,001)

^[2]

^[3]

Columbia Warrant [Member]

537

311

143,237

161,432

^[1]

(18,635)

^[1]

(18,635)

^[2]

(17,992)

^[2]

203

(124,805)

^[3]

(124,805)

^[3]

$ 0

$ 143,237

[1]	Recognized in the Condensed Consolidated Statements of Operations and Comprehensive Loss for the nine months ended September 30, 2023 and 2022, respectively.
[2]	Recognized in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2022 and 2021, respectively.
[3]	These liabilities were settled in connection with the Merger. See Note 4 (Recapitalization Transaction).

Note 2 - Summary of Significant Accounting Policies 1 (Details Textual) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Revenue from Contract with Customer, Excluding Assessed Tax	$ 1,196	$ 2,158	$ 4,380	$ 4,546	$ 6,012	$ 4,247	$ 0
Gain (Loss), Foreign Currency Transaction, after Tax	1,800	1,100	3,700	1,600	1,576	1,022	594
Operating Lease, Expense	$ 600	$ 500	$ 1,900	$ 1,400	$ 314	$ 54	$ 51
Accounts Receivable [Member] \| Customer Concentration Risk [Member]
Number of Major Customers	2		2		1
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| Two Customers [Member]
Concentration Risk, Percentage			84.00%
Accounts Receivable [Member] \| Customer Concentration Risk [Member] \| One Customer [Member]
Concentration Risk, Percentage					72.00%
Revenue Benchmark [Member] \| Customer Concentration Risk [Member]
Number of Major Customers		1		1	2	1
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Two Customers [Member]
Revenue from Contract with Customer, Excluding Assessed Tax	$ 900		$ 4,400	$ 3,800	$ 4,800
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Two Customers [Member] \| Minimum [Member]
Concentration Risk, Percentage	10.00%		10.00%	10.00%	10.00%
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| One Customer [Member]
Revenue from Contract with Customer, Excluding Assessed Tax		$ 1,700				$ 3,900
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| One Customer [Member] \| Minimum [Member]
Concentration Risk, Percentage		10.00%				10.00%

Note 11 - Stockholder's Equity - Schedule of Preferred Stock (Details)	Dec. 31, 2021 shares
Preferred stock, authorized (in shares)	8,740,398
Preferred stock, issued (in shares)	4,611,985
Series A Preferred Stock [Member]
Preferred stock, authorized (in shares)	4,723,330
Preferred stock, issued (in shares)	2,547,330
Series B Preferred Stock [Member]
Preferred stock, authorized (in shares)	3,117,915
Preferred stock, issued (in shares)	1,392,131
Series B-1 Preferred Stock [Member]
Preferred stock, authorized (in shares)	899,153
Preferred stock, issued (in shares)	672,524

Note 4 - Reverse Recapitalization (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Schedule Of Reverse Recapitalization [Table Text Block]

Company stockholders	Shares
Class A stockholders immediately prior to merger		17,215,336
Series A preferred stockholders		7,968,316
Series B preferred stockholders		4,597,928
Series B-1 preferred stockholders		2,171,399
2018 convertible noteholders		5,581,416
2019 convertible noteholders		7,846,333
2020 convertible noteholders		4,553,205
Redeemable Series X preferred stockholders		2,140,340
Liberty investors		20,000,000
PIPE investors		5,816,770
Shares issued for Cantor loan repayment		788,021
Shares issued to Sponsor under Forward Purchase Securities Agreement		1,250,000
Issuance of shares for transaction fees		2,058,229
CF V shares		6,837,354
		88,824,647

Company stockholders	Shares
Class A stockholders immediately prior to merger		17,215,336
Series A preferred stockholders		7,968,316
Series B preferred stockholders		4,597,928
Series B-1 preferred stockholders		2,171,399
2018 convertible noteholders		5,581,416
2019 convertible noteholders		7,846,333
2020 convertible noteholders		4,553,205
Redeemable Series X preferred stockholders		2,140,340
Liberty investors		20,000,000
PIPE investors		5,816,770
Shares issued for Cantor loan repayment		788,021
Shares issued to Sponsor under Forward Purchase Securities Agreement		1,250,000
Issuance of shares for transaction fees		2,058,229
CF V shares		6,837,354
		88,824,647

Note 7 - Earnout Liabilities - Schedule of Valuation Assumptions (Details) - Sponsor Earnout [Member]	Sep. 30, 2023	Dec. 31, 2022	Jan. 25, 2022
Measurement Input, Expected Term [Member]
Earnout liability, measurement input	3.32	4.07	5
Measurement Input, Expected Dividend Rate [Member]
Earnout liability, measurement input	0	0	0
Measurement Input, Price Volatility [Member]
Earnout liability, measurement input	0.673	0.504	0.30
Measurement Input, Risk Free Interest Rate [Member]
Earnout liability, measurement input	0.048	0.041	0.016
Measurement Input, Expected Number of Shares [Member]
Earnout liability, measurement input	1,775,962	1,775,962	1,842,759

Note 12 - Stock-based Compensation - Stock Options Activity 1 (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Balance, options (in shares)	6,067,313	6,864,563
Balance, options, exercise price (in dollars per share)	$ 1.83	$ 2.05
Balance, options, contractual term (Year)	1 year 9 months 10 days	2 years 25 days	2 years 4 months 9 days
Forfeited, options (in shares)	(425,178)	(574,299)
Forfeited, options, exercise price (in dollars per share)	$ 3.98	$ 4.56
Exercised, options (in shares)	(186,307)	(102,825)
Exercised, options, exercise price (in dollars per share)	$ 1.13	$ 1.12
Expired, options (in shares)	(177,430)	(120,126)
Expired, options, exercise price (in dollars per share)	$ 2.27	$ 2.6
Outstanding, options (in shares)	5,278,398	6,067,313	6,864,563
Outstanding, options, exercise price (in dollars per share)	$ 1.61	$ 1.83	$ 2.05
Outstanding, options, intrinsic value	$ 1,041	$ 10,818
Exercisable, options (in shares)	4,594,898	4,449,152
Exercisable, options, exercise price (in dollars per share)	$ 1.4	$ 1.31
Exercisable, options, contractual term (Year)	1 year 8 months 15 days	1 year 11 months 1 day
Exercisable, options, intrinsic value	$ 1,000	$ 8,832

Note 8 - Property and Equipment (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Property, Plant and Equipment [Table Text Block]

	Estimated Useful Life (in years)			September 30, 2023			December 31, 2022
Satellites and other equipment	3	-	5	$	68,369		$	54,370
Satellites under construction	Not applicable				16,032			22,194
Leasehold improvements	5	-	10		7,601			6,433
Other property and equipment	3	-	10		4,227			4,146
Total property and equipment					96,229			87,143
Less: Accumulated depreciation					(53,501	)		(39,162	)
Property and equipment, net				$	42,728		$	47,981

	September 30, 2023		December 31, 2022
Uruguay	$	37,991	$	43,134
Argentina		930		1,346
Spain		828		729
Netherlands		11,820		9,471
Other countries		490		1,472
Total ^{(1) (2) (3)}	$	52,059	$	56,152

				December 31,
	Estimated Useful Life (in years)			2022			2021
Satellites in orbit		3		$	54,370		$	43,716
Satellites under construction	Not applicable				22,194			10,558
Leasehold improvements	5	-	10		6,433			769
Other property and equipment	3	-	10		4,146			2,138
Total property and equipment					87,143			57,181
Less: Accumulated depreciation					(39,162	)		(24,651	)
Property and equipment, net				$	47,981		$	32,530

	December 31,
	2022		2021
Uruguay	$	43,134	$	33,208
Argentina		1,346		1,250
Spain		729		791
Netherlands		9,471		—
Other countries		1,472		236
Total ⁽¹⁾ ⁽²⁾ ⁽³⁾	$	56,152	$	35,485

Note 2 - Summary of Significant Accounting Policies - Schedule of Cash and Cash Equivalents 1 (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash and cash equivalents	$ 30,971	$ 76,528		$ 8,533
Restricted cash	0	126		0
Restricted cash included in Other non-current assets	1,151	1,138		0
Total cash, cash equivalents and restricted cash	$ 32,122	$ 77,792	$ 97,307	$ 8,533	$ 17,267	$ 24,557

Note 16 - Related Parties (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Convertible notes from related parties
Interest expense on amounts owed to related parties	$	—	$	—	$	—	$	44

	December 31,
	2022		2021		2020
Convertible notes debt from related parties
Amounts owed to related parties	$	—	$	13,028	$	—
Interest expense	$	554	$	620	$	591

Note 9 - Additional Financial Statement Information 1 (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]

	September 30,		December 31,
	2023		2022
Prepaid expenses and other current assets
Prepaid expenses	$	2,604	$	1,767
Advances to suppliers		228		588
Other current assets		413		843
Total	$	3,245	$	3,198

	December 31,
	2022		2021
Prepaid expenses and other current assets
Prepaid expenses	$	1,767	$	1,153
Advances to suppliers		588		829
Other current assets		843		713
Total	$	3,198	$	2,695

Schedule of Accrued Liabilities [Table Text Block]

	September 30,		December 31,
	2023		2022
Accrued expenses and other liabilities
Provisions		66		71
Payroll and benefits payable		2,111		3,289
Other taxes payable		5,373		3,128
Other		430		451
Total	$	7,980	$	6,939

Total current	$	7,481	$	6,417
Total non-current	$	499	$	522

	December 31,
	2022		2021
Accrued expenses and other liabilities
Accrued professional fees related to Merger⁽¹⁾	$	—	$	16,263
Provisions		71		2,934
Payroll and benefits payable		3,289		2,545
Other taxes payable		3,128		2,045
Other		451		2,200
Total	$	6,939	$	25,987

Total current	$	6,417	$	23,435
Total non-current	$	522	$	2,552

Schedule of Finance Costs, Net and Other Financial Income (Expense) [Table Text Block]

	Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022
Finance income (expense), net
Interest expense	$	—		$	(9	)	$	(3	)	$	(1,597	)
Redeemable Series X preferred stock dividends		—			—			—			(97	)
Other finance costs		(38	)		(29	)		(103	)		(99	)
Interest income		427			419			1,577			568
Total	$	389		$	381		$	1,471		$	(1,225	)

	Year Ended December 31,
	2022			2021			2020
Finance costs, net
Interest expense	$	(1,596	)	$	(8,729	)	$	(43	)
Redeemable Series X preferred stock dividends		(97	)		(974	)		—
Other finance costs		(123	)		(71	)		—
Interest income		1,164			36			78
Total	$	(652	)	$	(9,738	)	$	35

Note 15 - Fair Value Measurements and Financial Instruments - Schedule of Assets and Liabilities at Fair Value 1 (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Jan. 25, 2022	Jan. 22, 2022	Jan. 18, 2022	Dec. 31, 2021
Total Warrant Liabilities	$ 1,945	$ 8,335				$ 143,237
Earnout liabilities	223	1,353				0
Fair Value, Inputs, Level 1 [Member]
Total Warrant Liabilities	704	1,833
Earnout liabilities	0	0
Fair Value, Inputs, Level 2 [Member]
Total Warrant Liabilities	0	0
Earnout liabilities	0	0
Fair Value, Inputs, Level 3 [Member]
Total Warrant Liabilities	1,241	6,502
Earnout liabilities	223	1,353
The 8.63 Warrants [Member]
Total Warrant Liabilities	704	1,833	$ 4,900			0
The 8.63 Warrants [Member] \| Fair Value, Inputs, Level 1 [Member]
Total Warrant Liabilities	704	1,833
The 8.63 Warrants [Member] \| Fair Value, Inputs, Level 2 [Member]
Total Warrant Liabilities	0	0
The 8.63 Warrants [Member] \| Fair Value, Inputs, Level 3 [Member]
Total Warrant Liabilities	0	0
Pipe Warrant [Member]
Total Warrant Liabilities	59	311		$ 1,300		0
Pipe Warrant [Member] \| Fair Value, Inputs, Level 1 [Member]
Total Warrant Liabilities	0	0
Pipe Warrant [Member] \| Fair Value, Inputs, Level 2 [Member]
Total Warrant Liabilities	0	0
Pipe Warrant [Member] \| Fair Value, Inputs, Level 3 [Member]
Total Warrant Liabilities	59	311
Liberty Warrants and Liberty Advisory Fee Warrant [Member]
Total Warrant Liabilities	1,182	6,191			$ 30,900	$ 0
Liberty Warrants and Liberty Advisory Fee Warrant [Member] \| Fair Value, Inputs, Level 1 [Member]
Total Warrant Liabilities	0	0
Liberty Warrants and Liberty Advisory Fee Warrant [Member] \| Fair Value, Inputs, Level 2 [Member]
Total Warrant Liabilities	0	0
Liberty Warrants and Liberty Advisory Fee Warrant [Member] \| Fair Value, Inputs, Level 3 [Member]
Total Warrant Liabilities	$ 1,182	$ 6,191

Note 14 - Net Loss Per Share 1

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Earnings Per Share [Text Block]

14. Net Loss Per Share

The weighted-average number of shares of common stock outstanding prior to the Merger have been retroactively adjusted by the Exchange Ratio of 3.3028 (“Exchange Ratio”) to give effect to the reverse recapitalization treatment of the Merger. Shares of common stock issued as a result of redeemable Series X preferred stock and the conversion of shares of preferred stock outstanding pre-Merger in connection with the Closing have been included in the basic net loss per share calculation on a prospective basis.

Diluted loss per share considers the impact of potentially dilutive securities. We identified financial instruments that qualify as potential common shares: (i) the share-based options awards described in Note 12 (Stock-based Compensation), (ii) the warrants described in Note 6 (Warrant Liabilities), and (iii) the earnout liabilities described in Note 7 (Earnout Liabilities). With the exception of the Columbia Warrant in 2022, each of these potential common shares are antidilutive for both periods since their conversion to common shares would decrease loss per share from continuing operations.

The Columbia Warrant was dilutive due to the change in fair value of financial instruments during the nine months ended September 30, 2022.

Basic and diluted net loss per share attributable to common stockholders is calculated as follows:

	Three Months Ended September						Nine Months Ended September
	2023			2022			2023			2022
Net loss attributable to common stockholders	$	(17,619	)	$	(14,823	)	$	(47,470	)	$	(22,944	)
Basic weighted-average common shares outstanding		89,739,310			89,002,430			89,476,065			81,221,550
Basic net loss per share for the period attributable to common stockholders	$	(0.20	)	$	(0.17	)	$	(0.53	)	$	(0.28	)

Effect of dilutive securities:
Net loss attributable to common stockholders	$	(17,619	)	$	(14,823	)	$	(47,470	)	$	(22,944	)
Adjustment to numerator - Change in fair value of Columbia Warrant liability		—			(18,635	)	$	—		$	(18,635	)
Dilutive numerator	$	(17,619	)	$	(33,458	)	$	(47,470	)	$	(41,579	)
Columbia Warrant		—			1,410,657			—			1,410,657
Diluted weighted-average common shares		89,739,310			90,413,087			89,476,065			82,632,207
Diluted net loss per share for the period attributable to common stockholders	$	(0.20	)	$	(0.37	)	$	(0.53	)	$	(0.50	)

¹ After applying the 3.3028 Exchange Ratio as described in Note 4 (Reverse Recapitalization).

14. Net Loss Per Share

Diluted loss per share considers the impact of potentially dilutive securities. We identified financial instruments that qualify as potential common shares: (i) the share-based options awards described in Note 12 (Stock-based Compensation), (ii) the warrants described in Note 6 (Warrant Liabilities), and (iii) the earnout liabilities described in Note 7 (Earnout Liabilities). With the exception of the Columbia Warrant, each of these potential common shares are antidilutive since their conversion to common shares would decrease loss per share from continuing operations.

The Columbia Warrant was dilutive due to the change in fair value of financial instruments during the years ended December 31, 2022 and 2021.

Basic and diluted net loss per share attributable to common stockholders is calculated as follows:

	Year Ended December 31,
	2022			2021			2020
Net loss attributable to common stockholders	$	(36,641	)	$	(96,305	)	$	(21,529	)
Basic weighted-average common shares outstanding (1)		83,188,276			16,655,634			16,029,826
Basic loss per share for the period attributable to common stockholders	$	(0.44	)	$	(5.78	)	$	(1.34	)
Effect of dilutive securities:
Adjustment to numerator - Change in fair value of Columbia Warrant liability	$	(18,635	)	$	—		$	—
Dilutive numerator	$	(55,276	)	$	(96,305	)	$	(21,529	)
Columbia Warrant		609,873			—			—
Diluted weighted-average common shares outstanding		83,798,149			16,655,634			16,029,826
Diluted loss per share for the period attributable to common stockholders	$	(0.66	)	$	(5.78	)	$	(1.34	)

¹ After applying the 3.3028 Exchange Ratio as described in Note 4 (Reverse Recapitalization).

Additionally, the following securities were not included in the computation of diluted shares outstanding because the effect would have been anti-dilutive:

	Year Ended December 31,
	2022		2021		2020
Warrants		49,184,868		15,931,360		—
Sponsor earnout shares		1,775,962		—		—
Stock options		6,067,313		6,864,563		4,694,314
Restricted stock units		1,459,280		—		—
Redeemable convertible preferred stock		—		6,645,215		8,740,398
Total		58,487,423		29,441,138		13,434,712

Note 10 - Income Tax - Schedule of Unrecognized Tax Benefits (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)
Balance	$ 0
Increases (decreases) in tax positions related to the current period	0
Increases (decreases) in tax positions related to prior periods	3,889
Increases (decreases) related to prior year tax positions as a result of lapse of statute	0
Balance	$ 3,889

Note 16 - Related Parties - Schedule of Related Party Transactions (Details) - Related Party [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Amounts owed to related parties					$ 0	$ 13,028	$ 0
Interest Expense [Member]
Related Party Transaction, Amounts of Transaction	$ 0	$ 0	$ 0	$ 44	$ 554	$ 620	$ 591

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Accounts receivable, allowance	$ 3,317	$ 3,237
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, authorized	Unlimited	Unlimited
Treasury stock, shares (in shares)	516,123	516,123
Common Class A [Member]
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, issued (in shares)	76,292,604	75,612,795
Common stock, outstanding (in shares)	76,292,604	75,612,795
Common Class B [Member]
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, issued (in shares)	13,582,642	13,582,642
Common stock, outstanding (in shares)	13,582,642	13,582,642

Note 5 - Revenue from Contracts with Customers 1 (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Revenue from Contract with Customer, Excluding Assessed Tax	$ 1,196	$ 2,158	$ 4,380	$ 4,546	$ 6,012	$ 4,247	$ 0
Contract with Customer, Liability, Revenue Recognized			$ 1,500	$ 900	$ 900	$ 500

Note 5 - Revenue from Contract with Customer - Schedule of Remaining Performance Obligations 1 (Details) (Parentheticals)	Sep. 30, 2023	Dec. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Remaining performance obligations, period (Year)		1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Remaining performance obligations, period (Year)	3 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Remaining performance obligations, period (Year)	1 year	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Remaining performance obligations, period (Year)	1 year	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Remaining performance obligations, period (Year)	1 year	1 year

Note 8 - Property and Equipment 1 (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Property, Plant and Equipment [Table Text Block]

	Estimated Useful Life (in years)			September 30, 2023			December 31, 2022
Satellites and other equipment	3	-	5	$	68,369		$	54,370
Satellites under construction	Not applicable				16,032			22,194
Leasehold improvements	5	-	10		7,601			6,433
Other property and equipment	3	-	10		4,227			4,146
Total property and equipment					96,229			87,143
Less: Accumulated depreciation					(53,501	)		(39,162	)
Property and equipment, net				$	42,728		$	47,981

	September 30, 2023		December 31, 2022
Uruguay	$	37,991	$	43,134
Argentina		930		1,346
Spain		828		729
Netherlands		11,820		9,471
Other countries		490		1,472
Total ^{(1) (2) (3)}	$	52,059	$	56,152

				December 31,
	Estimated Useful Life (in years)			2022			2021
Satellites in orbit		3		$	54,370		$	43,716
Satellites under construction	Not applicable				22,194			10,558
Leasehold improvements	5	-	10		6,433			769
Other property and equipment	3	-	10		4,146			2,138
Total property and equipment					87,143			57,181
Less: Accumulated depreciation					(39,162	)		(24,651	)
Property and equipment, net				$	47,981		$	32,530

	December 31,
	2022		2021
Uruguay	$	43,134	$	33,208
Argentina		1,346		1,250
Spain		729		791
Netherlands		9,471		—
Other countries		1,472		236
Total ⁽¹⁾ ⁽²⁾ ⁽³⁾	$	56,152	$	35,485

Note 16 - Related Parties 1

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

16. Related Parties

We had convertible notes with certain related parties that were settled in connection with the Merger. See Note 4 (Reverse Recapitalization).

The following table provides the associated finance costs as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Convertible notes from related parties
Interest expense on amounts owed to related parties	$	—	$	—	$	—	$	44

There are no sales or purchases transactions with entities which have significant influence over us or our key management personnel.

See description of transactions with CF&Co and Liberty Investment as part of the Merger Transaction described in Note 4 (Reverse Recapitalization).

We made purchases totaling $1.4 million from our equity method investee, OS, in the nine months ended September 30, 2023 and there was $0.7 million owed to OS and included in accounts payable at September 30, 2023.

16. Related Parties

We had convertible notes with certain related parties at December 31, 2021. The convertible notes were settled in connection with the Merger. See Note 4 (Recapitalization Transaction). The following table provides the balances owed and associated finance costs as follows:

	December 31,
	2022		2021		2020
Convertible notes debt from related parties
Amounts owed to related parties	$	—	$	13,028	$	—
Interest expense	$	554	$	620	$	591

There are no sales or purchases transactions with entities with significant influence over us or our key management personnel.

See description of transactions with CF&Co and Liberty Investment as part of the Merger transaction described in Note 4 (Reverse Recapitalization).

We made purchases totaling $456 from our equity method investee, OS, during the period beginning on the investment date to December 31, 2022. See Note 21 (Equity Method Investment).

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-6

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 235
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481062/946-235-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(g)(3))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(e))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//850/tableOfContent

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-6

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 850
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483326/850-10-50-1

Note 1 - Nature of the Business and Basis of Presentation

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Business Description and Basis of Presentation [Text Block]

1. Nature of the Business and Basis of Presentation

Nature of the Business

Basis of Presentation

Emerging Growth Company

Going Concern and Liquidity

1. Nature of the Business and Basis of Presentation

Nature of the Business

Basis of Presentation

Certain prior year amounts have been reclassified to conform to the current year presentation.

Emerging Growth Company

We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (“the Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). The JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. We have elected not to opt out of such extended transition period, which means that when a standard is issued or revised that has different application dates for public or private companies, we can adopt the new or revised standard at the time required for private companies to adopt such standard. The foregoing may make comparison of our financial statements with those of another public company difficult or impossible if such other public company is (i) not an emerging growth company or (ii) is an emerging growth company that has opted out of using the extended transition period, due to the potential differences in accounting standards used.

Liquidity

Note 19 - Adoption of U.S. GAAP

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Accounting Standards Update and Change in Accounting Principle [Text Block]

3. Accounting Standards Updates (“ASU”)

Accounting Standard Recently Adopted

3. Accounting Standards Updates (“ASU”)

Accounting Standards Recently Adopted

Accounting Standards Not Yet Adopted

Revision of Prior Period, Adjustment [Member]

Accounting Standards Update and Change in Accounting Principle [Text Block]

19. Adoption of U.S. GAAP

Reconciliation of the Consolidated Statement of Operations and Comprehensive Loss for the year ended December 31, 2021:

	Year Ended December 31, 2021
	IFRS			Adjustments/ Reclassifications			Note	U.S. GAAP
Revenue	$	4,247		$	—			$	4,247
Costs and expenses
Cost of sales		1,876			—				1,876
General administrative expenses		36,649			(9	)	a, c		36,640
Research and development		9,640			(4	)	b		9,636
Depreciation expense		10,825			(97	)	b		10,728
Other operating expenses, net		14,002			—				14,002
Total costs and expenses		72,992			(110	)			72,882
Operating loss		(68,745	)		110				(68,635	)
Other income (expense), net
Finance costs, net		(11,769	)		2,031		c, d		(9,738	)
Change in fair value of financial instruments		(42,102	)		60,085		d		17,983
Gain (loss) on extinguishment of debt		3,576			(40,792	)	d		(37,216	)
Other income (expense), net		1,067			2		c		1,069
Total other income (expense), net		(49,228	)		21,326				(27,902	)
Loss before income tax		(117,973	)		21,436				(96,537	)
Income tax		232			—				232
Net loss available to common stockholders	$	(117,741	)	$	21,436			$	(96,305	)
Other comprehensive loss
Foreign currency translation loss, net of tax		(86	)		—				(86	)
Comprehensive loss	$	(117,827	)	$	21,436			$	(96,391	)

Basic loss for the period attributable to common stockholders	$	(7.07	)	$	1.29		e	$	(5.78	)
Basic weighted-average common shares outstanding		16,655,634			—		e		16,655,634
Diluted loss for the period attributable to common stockholders	$	(7.07	)	$	1.29		e	$	(5.78	)
Diluted weighted-average common shares outstanding		16,655,634			—		e		16,655,634

Reconciliation of the Consolidated Statement of Operations and Comprehensive Loss for the year ended December 31, 2020:

	Year Ended December 31, 2020
	IFRS			Adjustments/ Reclassifications			Note	U.S. GAAP
Revenue	$	—		$	—			$	—
Costs and expenses
Cost of sales		—			—				—
General administrative expenses		8,127			(124	)	a, c		8,003
Research and development		5,878			46		a, b		5,924
Depreciation expense		3,182			(151	)	b		3,031
Other operating expenses, net		5,476			(27	)	a, b		5,449
Total costs and expenses		22,663			(256	)			22,407
Operating loss		(22,663	)		256				(22,407	)
Other income (expense), net
Finance costs, net		(22	)		57		c, d		35
Change in fair value of financial instruments		(84,224	)		93,861		d		9,637
Gain (loss) on extinguishment of debt		(7,466	)		(1,774	)	d		(9,240	)
Other income (expense), net		597			(3	)	c		594
Total other income (expense), net		(91,115	)		92,141				1,026
Loss before income tax		(113,778	)		92,397				(21,381	)
Income tax		(148	)		—				(148	)
Net loss available to common stockholders	$	(113,926	)	$	92,397			$	(21,529	)
Other comprehensive loss
Foreign currency translation loss, net of tax		—			—				—
Comprehensive loss	$	(113,926	)	$	92,397			$	(21,529	)

Basic loss for the period attributable to common stockholders	$	(7.11	)	$	5.76		e	$	(1.34	)
Basic weighted-average common shares outstanding		16,029,826			—		e		16,029,826
Diluted loss for the period attributable to common stockholders	$	(7.11	)	$	5.76		e	$	(1.34	)
Diluted weighted-average common shares outstanding		16,029,826			—		e		16,029,826

Reconciliation of the Consolidated Balance Sheet as of December 31, 2021:

	IFRS			Adjustments / Reclassifications			Note	U.S. GAAP
ASSETS
Current assets
Cash and cash equivalents	$	8,533		$	—			$	8,533
Accounts receivable		1,196			—				1,196
Prepaid expenses and other current assets		2,695			—				2,695
Total current assets		12,424			—				12,424
Property and equipment, net		33,586			(1,056	)	b		32,530
Operating lease right-of-use assets		2,663			292		c		2,955
Deferred income tax assets		1,640			—				1,640
Other non-current assets		369			—				369
Total assets	$	50,682		$	(764	)		$	49,918
LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities
Accounts payable	$	6,650		$	—			$	6,650
Debt		246,189			(137,716	)	d		108,473
Warrant liabilities		—			143,237		d		143,237
Operating lease liabilities		891			94		c		985
Contract liabilities		935			—				935
Accrued expenses and other liabilities		23,435			—				23,435
Total current liabilities		278,100			5,615				283,715
Operating lease liabilities		1,908			175		c		2,083
Contract liabilities		1,000			—				1,000
Other non-current liabilities		2,552			—				2,552
Total liabilities		283,560			5,790				289,350
Redeemable preferred stock		—			21,306		d		21,306
Stockholders’ equity (deficit)
Treasury stock		(170,949	)		—				(170,949	)
Additional paid-in capital		235,909			(139,438	)	a, d		96,471
Accumulated other comprehensive loss		(86	)		—				(86	)
Accumulated deficit		(297,752	)		111,578				(186,174	)
Total stockholders’ equity (deficit)		(232,878	)		(27,860	)			(260,738	)
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)	$	50,682		$	(764	)		$	49,918

a.	Stock-based compensation

Certain awards granted by us have a service inception date preceding the grant date. Under IFRS, this resulted in the recognition of stock-based compensation expense prior to the grant date. Under U.S. GAAP, the stock-based compensation expense shall not be recognized until authorization at the grant date.

The impact of this change before considering the tax effect is as follows:

	Year Ended December 31,
(Consolidated Statement of Operations and Comprehensive Loss)	2021			2020
General and administrative expenses	$	(80	)	$	(136	)
Research and development		—			(89	)
Other operating expenses		—			(27	)
Increase (decrease) to loss before income tax	$	(80	)	$	(252	)

(Consolidated Balance Sheet)	December 31, 2021
Additional paid-in-capital	$	542
Adjustment to accumulated deficit		(542	)
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)	$	—

b.	Research and development

Under IFRS, certain development expenditures may be capitalized. Under U.S. GAAP, all of our costs relating to R&D activities are expensed as incurred.

The impact of this change before considering the tax effect is as follows:

	Year Ended December 31,
(Consolidated Statement of Operations and Comprehensive Loss)	2021			2020
Research and development	$	(4	)	$	135
Depreciation expense		(97	)		(151	)
Other operating expenses		—			—
Increase (decrease) to loss before income tax	$	(101	)	$	(16	)

(Consolidated Balance Sheet)	December 31, 2021
Property and equipment, net	$	(1,056	)
Total assets	$	(1,056	)
Adjustment to accumulated deficit	$	(1,056	)
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)	$	(1,056	)

Leases

Under IFRS, all recognized leases are accounted for similarly to finance leases. Under U.S. GAAP, there is a dual classification on-balance sheet lease accounting model for lessees: finance and operating leases. Operating leases create a straight-line expense, and no interest expense is recognized on the lease liability.

The impact of this change before considering the tax effect is as follows:

	Year Ended December 31,
(Consolidated Statement of Operations and Comprehensive Loss)	2021			2020
General and administrative expenses	$	71		$	12
Less: Finance costs, net		(49	)		(57	)
Less: Other income, net		(2	)		3
Increase (decrease) to loss before income tax	$	20		$	(42	)

(Consolidated Balance Sheet)	December 31, 2021
Operating lease right-of-use assets	$	292
Total assets	$	292
Operating lease liabilities	$	94
Non-current operating lease liabilities		175
Adjustment to accumulated deficit		23
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)	$	292

d.	Financial instruments

Under IFRS, it was determined that the redeemable Series X preferred shares should be classified as a liability since there is a contractual obligation to deliver cash or another financial asset and certain conversion events being beyond our control. Under U.S. GAAP, it was determined that the redeemable Series X preferred shares should be classified as mezzanine equity since the shares are redeemable based on events outside of our control.

Under IFRS, it was determined that the Columbia Warrant should be classified as equity since settlement would only occur by exchanging a fixed amount of cash for a fixed number of our own equity instruments. Changes in fair value are not recognized. Under U.S. GAAP, it was determined that the Columbia Warrant should be classified as a liability since the number and type of shares received could be different pre- and post- Merger. The Columbia Warrant is recorded at fair value with changes recognized in the Consolidated Statement of Operations and Comprehensive Loss.

Additionally, the resulting gain (loss) on extinguishment of the amended convertible notes differed under IFRS versus U.S. GAAP.

The impact of this change before considering the tax effect is as follows:

	Year Ended December 31,
(Consolidated Statements of Operations and Comprehensive Loss)	2021			2020
Less: Finance costs, net	$	(1,982	)	$	—
Less: Change in fair value of financial instruments		(60,085	)		(93,861	)
Less: Gain (Loss) on extinguishment of debt		40,792			1,774
Increase (decrease) to loss before income tax	$	(21,275	)	$	(92,087	)

(Consolidated Balance Sheet)	December 31, 2021
Debt	$	(137,716	)
Redeemable Series X preferred stock		21,306
Warrant liability		143,237
Additional paid-in capital		(139,980	)
Adjustment to accumulated deficit		113,153
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)	$	—

e.	Net loss per share

The change in net loss in the adoption of U.S. GAAP as described in items a-d above impacted net loss per share as follows:

	Year Ended December 31,
	2021			2020
Net loss attributable to common stockholders	$	(96,305	)	$	(21,529	)
Basic weighted-average common shares outstanding ⁽¹⁾		16,655,634			16,029,826
Basic loss per share for the period attributable to common stockholders	$	(5.78	)	$	(1.34	)

Dilutive numerator	$	(96,305	)	$	(21,529	)
Diluted weighted-average common shares outstanding		16,655,634			16,029,826
Diluted loss per share for the period attributable to common stockholders	$	(5.78	)	$	(1.34	)

⁽¹⁾ After applying the 3.3028 Exchange Ratio as described in Note 4 (Reverse Recapitalization).

Note 6 - Warrant Liabilities (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2021	Sep. 30, 2023	Dec. 31, 2022	May 06, 2022	Jan. 25, 2022	Jan. 24, 2022	Jan. 22, 2022	Jan. 18, 2022	Dec. 31, 2021	Mar. 08, 2021
Warrant Liability, Fair Value Disclosure		$ 1,945	$ 8,335						$ 143,237
Warrants and Rights Outstanding, Term (Year)				36 months
Fair Value Adjustment of Warrants		(6,390)	(47,000)
Warrant Liability, Reclassified to Equity			(124,805)
Liberty Warrants and Liberty Advisory Fee Warrant [Member]
Warrant Liability, Fair Value Disclosure		1,182	6,191					$ 30,900	0
Fair Value Adjustment of Warrants		(5,009)	(24,662)
Warrant Liability, Reclassified to Equity			0
Pipe Warrant [Member]
Warrant Liability, Fair Value Disclosure		59	311				$ 1,300		0
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)					2,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)					$ 20
Fair Value Adjustment of Warrants		(252)	(1,001)
Warrant Liability, Reclassified to Equity			0
Columbia Warrant [Member]
Warrant Liability, Fair Value Disclosure			0						143,237	$ 161,200
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 2.51635975
Proceeds from Issuance of Warrants	$ 40,100
Warrants and Rights Outstanding, Term (Year)	25 years
Fair Value Adjustment of Warrants			(18,635)
Warrant Liability, Reclassified to Equity			(124,805)
Columbia Warrant [Member] \| Common Stock [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)	15,931,360
The 8.63 Warrants [Member]
Warrant Liability, Fair Value Disclosure		$ 704	$ 1,833		$ 4,900				$ 0
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)		$ 8.63	$ 8.63		$ 8.63	$ 11.5
Warrants and Rights Outstanding, Term (Year)					5 years
Fair Value Adjustment of Warrants		$ (1,129)	$ (2,702)
Warrant Liability, Reclassified to Equity			$ 0
Class of Warrant or Right, Redemption Price of Warrants or Rights (in dollars per share)					$ 13.5	$ 18
The 8.63 Warrants [Member] \| Common Class A [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)					8,333,333
The 8.63 Warrants [Member] \| CF V Sponsor [Member]
Warrants and Rights Outstanding, Term (Year)					5 years
Stock Issued During Period, Shares, Warrants Exercised (in shares)			613,111
SPAC Public Warrants [Member \| CF V Sponsor [Member] \| Common Class A [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)					8,333,333
SPAC Private Placement Warrants [Member] \| CF V Sponsor [Member]
Class of Warrant or Right, Outstanding (in shares)					200,000
Forward Purchase Contract Warrant [Member] \| CF V Sponsor [Member] \| Common Class A [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)					333,333

Note 10 - Income Tax - Schedule of Reconciliation (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Loss before income tax	$ (13,550)	$ (11,840)	$ (41,277)	$ (17,818)	$ (32,068)	$ (96,537)	$ (21,381)
Provision for (benefit from) income tax at weighted-average statutory rates					0	0	0
U.S. state and local income tax, net of federal benefit					(3)	5	(4)
U.S. foreign-derived intangible income deduction					(141)	(200)	0
Argentina Tax Inflation Adjustment					239	(381)	(198)
Change in valuation allowances					4,283	3,648	1,198
Uncertain tax positions					2,293	0	0
Change in carryforward attributes					(1,740)	0	0
Effect of rates different than statutory					(423)	(3,300)	(828)
Tax credits					(112)	0	0
Other					177	(4)	(20)
Total provision for (benefit from) income tax	$ 4,069	$ 2,983	$ 6,193	$ 5,126	$ 4,573	$ (232)	$ 148

Note 9 - Additional Financial Statement Information 1

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Additional Financial Information Disclosure [Text Block]

9. Additional Financial Statement Information

Prepaid Expenses and Other Current Assets

	September 30,		December 31,
	2023		2022
Prepaid expenses and other current assets
Prepaid expenses	$	2,604	$	1,767
Advances to suppliers		228		588
Other current assets		413		843
Total	$	3,245	$	3,198

Accrued Expenses and Other Liabilities

	September 30,		December 31,
	2023		2022
Accrued expenses and other liabilities
Provisions		66		71
Payroll and benefits payable		2,111		3,289
Other taxes payable		5,373		3,128
Other		430		451
Total	$	7,980	$	6,939

Total current	$	7,481	$	6,417
Total non-current	$	499	$	522

Finance Costs, net

	Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022
Finance income (expense), net
Interest expense	$	—		$	(9	)	$	(3	)	$	(1,597	)
Redeemable Series X preferred stock dividends		—			—			—			(97	)
Other finance costs		(38	)		(29	)		(103	)		(99	)
Interest income		427			419			1,577			568
Total	$	389		$	381		$	1,471		$	(1,225	)

9. Additional Financial Statement Information

Prepaid Expenses and Other Current Assets

	December 31,
	2022		2021
Prepaid expenses and other current assets
Prepaid expenses	$	1,767	$	1,153
Advances to suppliers		588		829
Other current assets		843		713
Total	$	3,198	$	2,695

Accrued Expenses and Other Liabilities

	December 31,
	2022		2021
Accrued expenses and other liabilities
Accrued professional fees related to Merger⁽¹⁾	$	—	$	16,263
Provisions		71		2,934
Payroll and benefits payable		3,289		2,545
Other taxes payable		3,128		2,045
Other		451		2,200
Total	$	6,939	$	25,987

Total current	$	6,417	$	23,435
Total non-current	$	522	$	2,552

⁽¹⁾	Refer to Note 4 (Reverse Recapitalization) for further details on the Merger.

Finance Costs, Net

	Year Ended December 31,
	2022			2021			2020
Finance costs, net
Interest expense	$	(1,596	)	$	(8,729	)	$	(43	)
Redeemable Series X preferred stock dividends		(97	)		(974	)		—
Other finance costs		(123	)		(71	)		—
Interest income		1,164			36			78
Total	$	(652	)	$	(9,738	)	$	35

Note 13 - Redeemable Preferred Stock (Details Textual) - USD ($) $ / shares in Units, $ in Millions	Jan. 25, 2022	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Temporary Equity, Par or Stated Value Per Share (in dollars per share)			$ 0.0001	$ 0.0001
Conversion of Stock, Shares Issued (in shares)	2,140,340
Series X Preferred Stock [Member]
Temporary Equity, Par or Stated Value Per Share (in dollars per share)	$ 0.0001
Temporary Equity, Dividend Rate, Percentage	7.00%
Conversion of Stock, Shares Converted (in shares)	2,033,230
Conversion of Stock, Amount Converted	$ 21.4
Preferred Stock, Convertible, Conversion Price (in dollars per share)	$ 10
Temporary Equity, Shares Issued (in shares)		0	0
Temporary Equity, Shares Outstanding (in shares)		0	0

Note 7 - Earnout Liabilities

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Earnout Liability [Text Block]

7. Earnout Liabilities

	Sponsor Earnout
As of December 31, 2022	$	1,353
Change in fair value of financial instruments		(1,130	)
As of September 30, 2023	$	223

Sponsor Earnout

	September 30, 2023			December 31, 2022
Expected term (in years)		3.32			4.07
Dividend yield (%)		—	%		—	%
Expected volatility		67.3	%		50.4	%
Risk-free interest rate		4.8	%		4.1	%
Expected number of shares		1,775,962			1,775,962

Forfeiture Earnout

7. Earnout Liabilities

	Sponsor Earnout			Forfeiture Earnout			Total Earnout Liabilities
As of December 31, 2021	$	—		$	—		$	—
Additions	$	8,022		$	6,135		$	14,157
Change in fair value of financial instruments		(6,669	)		(5,130	)		(11,799	)
Reclassification to equity		—			(1,005	)		(1,005	)
As of December 31, 2022	$	1,353		$	—		$	1,353

Sponsor Earnout

Pursuant to that certain Sponsor Support Agreement, dated as of July 5, 2021, by and among us, the Sponsor and Nettar, the Sponsor has agreed that during the period between the Closing and the five-year anniversary of the Closing, the Sponsor shall not sell, transfer or otherwise dispose of Class A ordinary shares equal to 1,869,000 less 30% of Forfeiture Escrow Shares retired and canceled (“Sponsor Earnout”). The Sponsor Earnout is subject to potential forfeiture to us for no consideration until the occurrence of each tranche’s respective earnout triggering event. The earnout triggering events related to achieving a closing price at or above $12.50, $15.00 and $20.00 per share, respectively, for any 10 trading days over a 20 trading day period were not satisfied during the year ended December 31, 2022. As a result, the 1,775,962 Class A ordinary shares were not vested and are subject to transfer restrictions and contingent forfeiture provisions.

	January 25,			December 31,
	2022			2022
Expected term (in years)		5.00			4.07
Dividend yield (%)		—			—
Expected volatility		30	%		50.4	%
Risk-free interest rate		1.6	%		4.1	%
Expected number of shares		1,842,759			1,775,962

Forfeiture Earnout

SATELLOGIC INC.

Notes to Consolidated Financial Statements

(in thousands of U.S. dollars, except share and per share information, unless otherwise stated)

Note 20 - Commitments and Contingencies

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Commitments and Contingencies Disclosure [Text Block]

17. Commitments and Contingencies

Contingencies

We may be named from time to time as a party to lawsuits arising in the ordinary course of business related to our sales, marketing, and the provision of our services and equipment. Litigation and contingency accruals are based on our assessment, including advice of legal counsel, regarding the expected outcome of litigation or other dispute resolution proceedings. If we determine that an unfavorable outcome is probable and can be reasonably assessed, we establish the necessary accruals. As of September 30, 2023 and December 31, 2022, we are not aware of any contingent liabilities that should be reflected in the Condensed Consolidated Financial Statements.

20. Commitments and Contingencies

Contingencies

We may be named from time to time as a party to lawsuits arising in the ordinary course of business related to its sales, marketing, and the provision of its services and equipment. Litigation and contingency accruals are based on our assessment, including advice of legal counsel, regarding the expected outcome of litigation or other dispute resolution proceedings. If we determine that an unfavorable outcome is probable and can be reasonably assessed, we establish the necessary accruals. As of December 31, 2022 and December 31, 2021, we are not aware of any contingent liabilities that should be reflected in the Consolidated Financial Statements.

Note 5 - Revenue from Contracts with Customers - Disaggregation of Revenue 1 (Details) - USD ($)
$ in Thousands

3 Months Ended

9 Months Ended

12 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Sep. 30, 2023

Sep. 30, 2022

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

$ 1,196

$ 2,158

$ 4,380

$ 4,546

$ 6,012

$ 4,247

$ 0

Asia Pacific [Member]

^[2]

^[1]

232

^[1]

351

^[1]

1,946

^[1]

1,531

3,988

Europe [Member]

^[1],[2]

513

1,506

North America [Member]

^[2]

588

^[1]

1,817

^[1]

2,467

^[1]

2,435

^[1]

3,438

201

South America [Member]

Transferred over Time [Member]

^[1],[2]

Transferred at Point in Time [Member]

413

1,236

1,524

1,600

3,800

$ 783

$ 2,158

$ 3,144

$ 3,022

$ 4,400

$ 400

[1]	Certain comparative figures have been reclassified to conform to the current year presentation.
[2]	Revenue by geography is based on the geographical location of the customer.

Note 16 - Related Parties

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

16. Related Parties

We had convertible notes with certain related parties that were settled in connection with the Merger. See Note 4 (Reverse Recapitalization).

The following table provides the associated finance costs as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Convertible notes from related parties
Interest expense on amounts owed to related parties	$	—	$	—	$	—	$	44

There are no sales or purchases transactions with entities which have significant influence over us or our key management personnel.

See description of transactions with CF&Co and Liberty Investment as part of the Merger Transaction described in Note 4 (Reverse Recapitalization).

16. Related Parties

	December 31,
	2022		2021		2020
Convertible notes debt from related parties
Amounts owed to related parties	$	—	$	13,028	$	—
Interest expense	$	554	$	620	$	591

There are no sales or purchases transactions with entities with significant influence over us or our key management personnel.

See description of transactions with CF&Co and Liberty Investment as part of the Merger transaction described in Note 4 (Reverse Recapitalization).

We made purchases totaling $456 from our equity method investee, OS, during the period beginning on the investment date to December 31, 2022. See Note 21 (Equity Method Investment).

Note 9 - Additional Financial Statement Information - Schedule of Prepaid and Other Current Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Prepaid expenses	$ 2,604	$ 1,767	$ 1,153
Advances to suppliers	228	588	829
Other current assets	413	843	713
Total	$ 3,245	$ 3,198	$ 2,695

Note 12 - Stock-based Compensation 1 (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Share-Based Payment Arrangement, Option, Activity [Table Text Block]

	Number of Options			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (years)		Intrinsic Value (in thousands)
Balance as of December 31, 2022		6,067,313		$	1.83		2.07
Forfeited		(425,178	)		3.98
Exercised		(186,307	)		1.13
Expired		(177,430	)		2.27
Outstanding at September 30, 2023		5,278,398		$	1.61		1.78	$	1,041
Exercisable at September 30, 2023		4,594,898		$	1.40		1.71	$	1,000

	Number of Options			Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (years)		Intrinsic Value (in thousands)
Balance as of December 31, 2021		6,864,563		$	2.05		2.36
Granted		—			—
Forfeited		(574,299	)		4.56
Exercised		(102,825	)		1.12
Expired		(120,126	)		2.60
Outstanding at December 31, 2022		6,067,313		$	1.83		2.07	$	10,818
Exercisable at December 31, 2022		4,449,152		$	1.31		1.92	$	8,832

Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]

	Number of RSUs			Intrinsic value (in thousands)
Outstanding unvested RSUs at December 31, 2022		1,459,280
Granted during the year		3,369,167
Forfeited during the year		(559,809	)
Vested during the year		(494,287	)
Outstanding unvested RSUs at September 30, 2023		3,774,351		$	4,416

	Number of RSUs			Intrinsic Value (in thousands)
Outstanding unvested RSUs at December 31, 2021		—
Granted during the year		1,640,496
Forfeited during the year		(60,823	)
Vested during the year		(120,393	)
Expired during the year		—
Outstanding unvested RSUs at December 31, 2022		1,459,280		$	1,940

Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
General and administrative expenses	$	884	$	554	$	2,714	$	2,240
Research and development expenses		312		781		933		1,753
Other operating expenses		218		804		607		2,631
Total	$	1,414	$	2,139	$	4,254	$	6,624

	Year Ended December 31,
	2022		2021		2020
General and administrative expenses	$	2,406	$	5,274	$	1,235
Research and development		3,631		1,968		382
Other operating expenses		2,331		3,639		115
Total	$	8,368	$	10,881	$	1,732

Note 22 - Subsequent Events

12 Months Ended

Dec. 31, 2022

Subsequent Events [Text Block]

22. Subsequent Events

On March 8, 2023, we filed an amendment to our Memorandum and Articles of Association. The amendment updated the voting multiplier for our Class B shares from 1.463844005 to 1.472467906. The Amended and Restated Memorandum and Articles of Association (the “Satellogic BVI Articles”) are included as Exhibit 1.1 to this Report.

Note 12 - Stock-based Compensation - Schedule of Stock Options Valuation Assumptions (Details) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Weighted-average fair value of options at the measurement date (grant date) (in dollars per share)	$ 0	$ 23.36	$ 6.31
Dividend yield (%)	0.00%	0.00%	0.00%
Expected volatility (%)	0.00%
Risk-free interest rate (%)	0.00%
Weighted average share price (in dollars per share)	$ 0	$ 6.79	$ 2.75
Minimum [Member]
Expected volatility (%)		61.00%	59.00%
Risk-free interest rate (%)		0.50%	0.40%
Maximum [Member]
Expected volatility (%)		72.00%	61.00%
Risk-free interest rate (%)		1.40%	0.50%

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 76,528	$ 8,533
Restricted cash	126	0
Accounts receivable, net of allowance of $3,317 and $3,237, respectively	1,388	1,196
Prepaid expenses and other current assets	3,198	2,695
Total current assets	81,240	12,424
Property and equipment, net	47,981	32,530
Operating lease right-of-use assets	8,171	2,955
Deferred income tax assets	0	1,640
Other non-current assets	6,463	369
Total assets	143,855	49,918
Current liabilities
Accounts payable	9,850	6,650
Debt	0	108,473
Warrant liabilities	8,335	143,237
Earnout liabilities	1,353	0
Operating lease liabilities	2,176	985
Contract liabilities	1,941	935
Accrued expenses and other liabilities	6,417	23,435
Total current liabilities	30,072	283,715
Operating lease liabilities	6,063	2,083
Contract liabilities	1,000	1,000
Other non-current liabilities	522	2,552
Total liabilities	37,657	289,350
Commitments and contingencies (Note 17)
Redeemable preferred stock	0	21,306
Stockholders' equity
Preferred stock, $0.0001 par value	0	0
Common stock, $0.0001 par value, unlimited shares authorized; 76,292,604 Class A shares issued and outstanding; and 13,582,642 Class B shares issued and outstanding as of September 30, 2023 and 75,612,795 Class A shares issued and outstanding and 13,582,642 Class B shares issued and outstanding as of December 31, 2022	0	0
Treasury stock, at cost	(8,603)	(170,949)
Additional paid-in capital	337,928	96,471
Accumulated other comprehensive loss	(312)	(86)
Accumulated deficit	(222,815)	(186,174)
Total stockholders’ equity	106,198	(260,738)
Total liabilities, redeemable preferred stock and stockholders’ equity	$ 143,855	$ 49,918

Note 14 - Net Loss Per Share

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Earnings Per Share [Text Block]

14. Net Loss Per Share

The Columbia Warrant was dilutive due to the change in fair value of financial instruments during the nine months ended September 30, 2022.

Basic and diluted net loss per share attributable to common stockholders is calculated as follows:

	Three Months Ended September						Nine Months Ended September
	2023			2022			2023			2022
Net loss attributable to common stockholders	$	(17,619	)	$	(14,823	)	$	(47,470	)	$	(22,944	)
Basic weighted-average common shares outstanding		89,739,310			89,002,430			89,476,065			81,221,550
Basic net loss per share for the period attributable to common stockholders	$	(0.20	)	$	(0.17	)	$	(0.53	)	$	(0.28	)

Effect of dilutive securities:
Net loss attributable to common stockholders	$	(17,619	)	$	(14,823	)	$	(47,470	)	$	(22,944	)
Adjustment to numerator - Change in fair value of Columbia Warrant liability		—			(18,635	)	$	—		$	(18,635	)
Dilutive numerator	$	(17,619	)	$	(33,458	)	$	(47,470	)	$	(41,579	)
Columbia Warrant		—			1,410,657			—			1,410,657
Diluted weighted-average common shares		89,739,310			90,413,087			89,476,065			82,632,207
Diluted net loss per share for the period attributable to common stockholders	$	(0.20	)	$	(0.37	)	$	(0.53	)	$	(0.50	)

¹ After applying the 3.3028 Exchange Ratio as described in Note 4 (Reverse Recapitalization).

14. Net Loss Per Share

Diluted loss per share considers the impact of potentially dilutive securities. We identified financial instruments that qualify as potential common shares: (i) the share-based options awards described in Note 12 (Stock-based Compensation), (ii) the warrants described in Note 6 (Warrant Liabilities), and (iii) the earnout liabilities described in Note 7 (Earnout Liabilities). With the exception of the Columbia Warrant, each of these potential common shares are antidilutive since their conversion to common shares would decrease loss per share from continuing operations.

The Columbia Warrant was dilutive due to the change in fair value of financial instruments during the years ended December 31, 2022 and 2021.

Basic and diluted net loss per share attributable to common stockholders is calculated as follows:

	Year Ended December 31,
	2022			2021			2020
Net loss attributable to common stockholders	$	(36,641	)	$	(96,305	)	$	(21,529	)
Basic weighted-average common shares outstanding (1)		83,188,276			16,655,634			16,029,826
Basic loss per share for the period attributable to common stockholders	$	(0.44	)	$	(5.78	)	$	(1.34	)
Effect of dilutive securities:
Adjustment to numerator - Change in fair value of Columbia Warrant liability	$	(18,635	)	$	—		$	—
Dilutive numerator	$	(55,276	)	$	(96,305	)	$	(21,529	)
Columbia Warrant		609,873			—			—
Diluted weighted-average common shares outstanding		83,798,149			16,655,634			16,029,826
Diluted loss per share for the period attributable to common stockholders	$	(0.66	)	$	(5.78	)	$	(1.34	)

¹ After applying the 3.3028 Exchange Ratio as described in Note 4 (Reverse Recapitalization).

Additionally, the following securities were not included in the computation of diluted shares outstanding because the effect would have been anti-dilutive:

	Year Ended December 31,
	2022		2021		2020
Warrants		49,184,868		15,931,360		—
Sponsor earnout shares		1,775,962		—		—
Stock options		6,067,313		6,864,563		4,694,314
Restricted stock units		1,459,280		—		—
Redeemable convertible preferred stock		—		6,645,215		8,740,398
Total		58,487,423		29,441,138		13,434,712

Note 9 - Additional Financial Statement Information - Schedule of Finance Costs, Net and Other Financial Income 1 (Details) - USD ($)
$ in Thousands

3 Months Ended

9 Months Ended

12 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Sep. 30, 2023

Sep. 30, 2022

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Interest expense

$ (0)

$ 9

$ 3

$ 1,597

$ 1,596

$ 8,729

$ 43

Redeemable Series X preferred stock dividends

(97)

(974)

Other finance costs

(38)

(29)

(103)

(99)

(123)

(71)

Interest income

427

419

1,577

568

1,164

Total

$ 389

$ 381

$ 1,471

$ (1,225)

$ (652)

$ (9,738)

^[1],[2]

$ 35

^[1],[2]

[1]

[2]

Note 18 - Leases (Tables)

12 Months Ended

Dec. 31, 2022

Schedule of Change in Right-of-Use Assets [Table Text Block]

	December 31,
	2022			2021
Balance as of beginning of period	$	2,955		$	1,403
Lease expense		(1,701	)		(494	)
Foreign exchange differences		115			(48	)
Additions		7,171			2,119
Disposals		(322	)		—
Transfers		(47	)		(25	)
Balance as of end of period	$	8,171		$	2,955

Schedule of Change in Lease Liabilities [Table Text Block]

	December 31,
	2022			2021
Balance as of beginning of period	$	3,068		$	1,415
Additions to operating lease liabilities		7,171			2,119
Lease expense		314			54
Foreign exchange differences		(293	)		(48	)
Disposals		(329	)		—
Payments		(1,692	)		(472	)
Balance as of end of period	$	8,239		$	3,068

Total current	$	2,176		$	985
Total non-current		6,063			2,083

Lease, Cost [Table Text Block]

	Year Ended December 31,
	2022		2021		2020
Right-of-use assets	$	1,701	$	494	$	247
Operating lease liabilities		314		54		51
Total lease expense	$	2,015	$	548	$	298

Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]

	Operating leases
Years Ended
2023	$	2,484
2024		2,235
2025		824
2026		603
2027 and thereafter		3,166
Total remaining lease payments		9,312
Less imputed interest		(1,073	)
Present value of lease liability	$	8,239

Total current	$	2,176
Total non-current	$	6,063

Note 19 - Adoption of U.S. GAAP (Details Textual)	9 Months Ended	12 Months Ended
Note 19 - Adoption of U.S. GAAP (Details Textual)	Sep. 30, 2023	Dec. 31, 2022
Recapitalization Exchange Ratio	3.3028	3.3028

Note 12 - Stock-based Compensation 1 (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)	0	0	0
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)			4 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)			10 years
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in shares)	42,898		17,376
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 870		$ 3,200
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)			1 year 5 months 1 day
Restricted Stock Units (RSUs) [Member]
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in shares)	116,783		56,649
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value (in dollars per share)	$ 2.43		$ 4.38
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 5,900		$ 5,400
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)	9 months 10 days		1 year 5 months 8 days

Note 10 - Income Tax - Schedule of Unrecognized Tax Benefits 1 (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2023 USD ($)
Balance	$ 3,889
Increases (decreases) in tax positions related to prior periods	(1,974)
Balance	$ 1,915

Note 2 - Summary of Significant Accounting Policies 1

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Significant Accounting Policies [Text Block]

2. Summary of Significant Accounting Policies

Use of Estimates

Revenue Recognition

The nature of our contracts does not currently give rise to variable consideration related to returns or refunds as those are not offered.

We exclude amounts collected on behalf of third parties, such as sales taxes, when determining transaction price.

Contract liabilities consist of payments received from customers, or such consideration that is contractually due, in advance of providing the product or performing services.

Fair Value Measurement

Certain assets and liabilities are carried at fair value in accordance with U.S. GAAP.

•

Level 1: Quoted prices in active markets for identical assets or liabilities.

•

Level 2: Valuation techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable.

•

Level 3: Valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable.

For fair value disclosures, classes of assets and liabilities are based on the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy.

Credit risk management

The credit risk in respect of cash balances held with banks and deposits with banks are managed via diversification of bank deposits and are only with major reputable financial institutions.

Impairment of Assets

Equity Method Investments

Stock-Based Compensation

The fair values for stock options are calculated using the Black-Scholes option pricing model using the following inputs:

Expected term - The simplified method is used to calculate the expected term.

Expected volatility - We determine the expected stock price volatility based on the historical volatilities of guideline companies from comparable industries.

Risk-free interest rate - We base our interest rate on a treasury instrument for which the term is commensurate with the maximum expected life of the stock options.

The fair values for restricted stock units ("RSUs") with service-based vesting conditions are calculated based upon our closing stock price on the date of the grant.

Foreign Currencies

Leases

For the periods presented, the Company does not have any financing type leases.

Accounts Receivable and Allowance for Credit Losses

	Nine Months Ended September 30,
	2023		2022
Allowance for credit losses as of beginning of period	$	3,237	$	1,794
Provision		80		1,736
Allowance for credit losses as of end of period	$	3,317	$	3,530

Cash, Cash Equivalents and Restricted Cash

Restricted cash, including amounts in Other non-current assets, represents amounts pledged as guarantees for sales and lease agreements as contractually required.

	September 30, 2023		December 31, 2022
Cash and cash equivalents	$	30,971	$	76,528
Restricted cash		—		126
Restricted cash included in Other non-current assets		1,151		1,138
Total cash, cash equivalents and restricted cash	$	32,122	$	77,792

2. Summary of Significant Accounting Policies

Use of Estimates

Revenue Recognition

The nature of our contracts does not currently give rise to variable consideration related to returns or refunds as those are not offered.

We evaluate contracts with a minimum purchase commitment to determine whether we expect to be entitled to a breakage amount. We consider the requirements on constraining estimates variable consideration. The following factors are evaluated when assessing the increased likelihood of a significant revenue reversal: (i) the amount of consideration is highly susceptible to factors outside our influence or control (e.g., volatility in a market, judgment of action of third parties, weather conditions), (ii) uncertainty about the amount of consideration is not expected to be resolved for a long period of time, (iii) our experience with similar types of contracts is limited, or that experience has limited predictive value, (iv) we have a practice of either offering a broad range of price concessions or changing the payment terms and conditions of similar contracts in similar circumstances, and (v) the contract has a large number and broad range of possible consideration amounts.

We exclude amounts collected on behalf of third parties, such as sales taxes, when determining transaction price.

Contract liabilities consist of payments received from customers, or such consideration that is contractually due, in advance of providing the product or performing services.

Fair Value Measurement

Certain assets and liabilities are carried at fair value in accordance with U.S. GAAP.

•

Level 1: Quoted prices in active markets for identical assets or liabilities.

•

Level 2: Valuation techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable.

•

Level 3: Valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable.

For fair value disclosures, classes of assets and liabilities are based on the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy.

Credit risk management

The credit risk in respect of cash balances held with banks and deposits with banks are managed via diversification of bank deposits and are only with major reputable financial institutions.

Impairment of Assets

We assess potential impairments to long-lived assets whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable. An impairment is considered to exist if the total estimated future cash flows on an undiscounted basis are less than the carrying amount of the assets or asset group. We performed an impairment test as of December 31, 2022, 2021 and 2020 due to our net loss for those years and concluded that the asset group is not impaired.

If estimates or underlying assumptions change in the future, we may be required to record impairment charges. If the fair value of an asset group is less than its carrying amount, then the carrying amount of the asset group would be reduced to its fair value. That reduction is an impairment loss that would be recognized in the Consolidated Statements of Operations and Comprehensive Loss.

Equity Method Investments

We account for equity investments in which we have significant influence, but not a controlling financial interest, using the equity method of accounting. Under the equity method of accounting, investments are initially recorded at cost, less impairment, and subsequently adjusted to recognize our share of earnings or losses as a component of Other income (expense), net in the Consolidated Statements of Operations and Comprehensive Loss. Our equity method investments are required to be reviewed for impairment when it is determined there may be an other-than-temporary loss in value. We have not recorded any impairment losses related to our equity method investments during the year ended December 31, 2022. We did not hold any equity investments in 2021 or 2020.

Stock-Based Compensation

The fair values for stock options are calculated using the Black-Scholes option pricing model using the following inputs:

Expected term - The simplified method is used to calculate the expected term.

Expected volatility - We determine the expected stock price volatility based on the historical volatilities of guideline companies from comparable industries.

Risk-free interest rate - We base our interest rate on a treasury instrument for which the term is commensurate with the maximum expected life of the stock options.

The fair values for restricted stock units ("RSUs") with service-based vesting conditions are calculated based upon our closing stock price on the date of the grant.

Foreign Currencies

Aggregate foreign currency gains and losses, such as those resulting from the settlement of receivables or payables, foreign currency contracts and short-term intercompany advances in a currency other than the relevant subsidiary’s functional currency, are recorded currently in the Consolidated Statements of Operations and Comprehensive Loss (included in other income, net) and resulted in gains of $1,576, $1,022, and $594 during the years ended December 31, 2022, 2021, and 2020, respectively.

Leases

We determine if a contract is a lease or contains a lease at inception. On the lease commencement date, we recognize a right-of-use (“ROU”) asset and lease liability related to operating type leases. The cost of ROU assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Operating lease liabilities are recorded based on the present value of the future lease fixed payments. In determining the present value of future lease payments, we use our incremental borrowing rate applicable to the economic environment and the duration of the lease based on the information available at the commencement date as the majority of leases do not provide an implicit rate. For real estate and equipment contracts, we generally account for the lease and non-lease components as a single lease component. In assessing the lease term, we include options to renew only when we are reasonably certain that such option(s) will be exercised; a determination which is at our sole discretion. Variable lease payments are recognized as expenses in the period incurred. For leases with an initial term of 12 months or less, we have elected to not record an ROU asset and lease liability. We record lease expense on a straight-line basis over the shorter of the lease term and the estimated useful lives of the assets, beginning on the commencement date.

For the periods presented, we do not have any financing type leases.

Accounts Receivable and Allowance for Doubtful Accounts

	December 31,
	2022			2021
Allowance for doubtful accounts as of beginning of period	$	1,794		$	—
Provision		1,736			1,794
Write-offs		—			—
Foreign exchange and other		(293	)		—
Allowance for doubtful accounts as of end of period	$	3,237		$	1,794

Cash, Cash Equivalents and Restricted Cash

Restricted cash, including amounts in Other non-current assets, represents amounts pledged as guarantees for sales and lease agreements as contractually required.

	December 31,
	2022		2021
Cash and cash equivalents	$	76,528	$	8,533
Restricted cash		126		—
Restricted cash included in Other non-current assets		1,138		—
Total cash, cash equivalents and restricted cash	$	77,792	$	8,533

Cash Flow Information

	Year Ended December 31,
	2022		2021		2020
Cash paid during the period for:
Income tax, net of refunds	$	758	$	96	$	59
Interest	$	3,520	$	49,283	$	27,286

Note 10 - Income Tax

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Income Tax Disclosure [Text Block]

10. Income Tax

The Company is incorporated in the BVI. The BVI does not impose corporate income taxes. Our operations are conducted through various subsidiaries in a number of countries throughout the world with significant operations in Uruguay, where we operate in a free trade zone. Consequently, income tax has been provided based on the laws and rates in effect in the countries in which operations are conducted or in which our subsidiaries are considered resident for corporate income tax purposes, including Argentina, China, Israel, the Netherlands, Spain, Uruguay, and the United States.

The components of income tax expense were as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022
Loss before income tax	$	(13,550	)	$	(11,840	)	$	(41,277	)	$	(17,818	)
Provision for income tax		4,069			2,983		$	6,193		$	5,126
Effective tax rate		(30.0	%)		(25.2	%)		(15.0	%)		(28.8	%)

Our effective tax rate for the nine months ended September 30, 2023 differs from the BVI statutory rate of 0%. We maintain the exception under ASC 740-270-30-36(b), Accounting for Income Taxes, for jurisdictions that do not have reliable estimates of income. We have used a year-to-date methodology to determine the effective tax rate for the nine months ended September 30, 2023 and 2022.

The Company recognizes uncertain income tax positions when it is not more-likely-than-not a tax position will be sustained upon examination. As of September 30, 2023, the Company has recognized uncertain tax positions related to positions taken in Argentina and Spain. If necessary, the Company accrues interest and penalties related to uncertain tax positions as a component of the income tax provision.

A reconciliation of the beginning and ending amounts of our gross unrecognized tax benefits is as follows:

	Nine Months Ended September 30,
	2023
Balance at January 1, 2023	$	3,889
Increases (decreases) in tax positions related to prior periods		(1,974	)
Balance at September 30, 2023	$	1,915

The Company believes that it is reasonably possible that a decrease of up to $0.2 million in unrecognized tax benefits related to foreign exposures may be necessary within the coming year.

10. Income Tax

We are incorporated in the BVI. See Item 10.E, “BVI Taxation,” for a description of considerations applicable to BVI taxation. Our operations are conducted through various subsidiaries in a number of countries throughout the world with significant operations in Uruguay, where we operate in a free trade zone. Consequently, income tax has been provided based on the laws and tax rates in effect in the countries in which operations are conducted or in which our subsidiaries are considered resident for corporate income tax purposes, including Argentina, China, Israel, the Netherlands, Spain, Uruguay, and the United States. Our provision for (benefit from) income tax for the years ended December 31, 2022, 2021 and 2020 is as follows:

	Year Ended December 31,
	2022		2021			2020
Current	$	2,972	$	1,387		$	186
Deferred		1,601		(1,619	)		(38	)
Total provision for (benefit from) income tax	$	4,573	$	(232	)	$	148

We maintain the exception under ASC 740-270-30-36(b), Accounting for Income Taxes, for jurisdictions that do not have reliable estimates of income.

As of December 31, 2022, we have gross unrecognized tax benefits of $3.9 million, exclusive of interest and penalties. If recognized, $2.0 million would reduce our effective tax rate. If applicable, we accrue interest and penalties related to uncertain tax positions as a component of the income tax provision.

A reconciliation of the beginning and ending amounts of our gross unrecognized tax benefits is as follows.

	Year Ended December 31,
	2022
Balance at January 1	$	—
Increases (decreases) in tax positions related to the current period		—
Increases (decreases) in tax positions related to prior periods		3,889
Increases (decreases) related to prior year tax positions as a result of lapse of statute		—
Balance at December 31	$	3,889

We did not have any unrecognized tax benefits in 2021 or 2020.

The BVI does not impose an income tax. Our provision for (benefit from) income tax differed from the 0% tax rate imposed in the BVI due to the following items for the years ended December 31, 2022, 2021 and 2020:

	Year Ended December 31,
	2022			2021			2020
Loss before income tax	$	(32,068	)	$	(96,537	)	$	(21,381	)

Provision for (benefit from) income tax at weighted-average statutory rates		—			—			—
U.S. state and local income tax, net of federal benefit		(3	)		5			(4	)
U.S. foreign-derived intangible income deduction		(141	)		(200	)		—
Argentina Tax Inflation Adjustment		239			(381	)		(198	)
Change in valuation allowances		4,283			3,648			1,198
Uncertain tax positions		2,293			—			—
Change in carryforward attributes		(1,740	)		—			—
Effect of rates different than statutory		(423	)		(3,300	)		(828	)
Tax credits		(112	)		—			—
Other		177			(4	)		(20	)
Total	$	4,573		$	(232	)	$	148

The change in the effective tax rate from December 31, 2021 to December 31, 2022 is primarily related to management’s decision to record a full valuation allowance on deferred tax assets on a worldwide basis due to the consolidated three-year cumulative loss position.

Deferred tax assets and liabilities as of December 31, 2022 and 2021 consisted of the following:

	December 31,
	2022			2021
Deferred income tax assets:
Stock-based compensation	$	3,023		$	2,053
Bad debt expense		415			407
Deferred financing costs		806			—
Other		193			419
Net operating loss carryforwards		1,365			6,245
Total deferred income tax assets		5,802			9,124
Valuation allowance		(5,802	)		(7,484	)
Total deferred income tax assets (liabilities), net	$	—		$	1,640

The assessment of the realizability of the deferred income tax assets is based on all available positive and negative evidence. Such evidence includes, but is not limited to, recent cumulative earnings or losses at the worldwide consolidated level, expectations of future taxable income by taxing jurisdiction, and the carry-forward periods available for the utilization of deferred income tax assets. The assessment of the recoverability of deferred income tax assets will not change until there is sufficient evidence to support their realizability.

Below is a summary of our estimated loss and tax credit carryforwards at December 31, 2022. Our tax attributes are subject to limitations on utilization due to historic ownership changes and may be subject to future limitations upon subsequent change of control, as defined by the Internal Revenue Code Sections 382 and 383.

Net Operating Loss	Expiration	Gross Amount Carried Forward		Net Amount Recognized as of December 31, 2022
Argentina	December 31, 2023 - December 31, 2027	$	7,864	$	—
Netherlands	Indefinite		2,856		—
China	December 31, 2026 - December 31, 2027		2,258		—
United States	Indefinite		280		—
Uruguay	December 31, 2026 - December 31, 2027		19		—

As of December 31, 2022 and 2021, we had $13.3 million and $20.9 million of net operating loss (“NOL”) carryforwards, respectively.

In the normal course of business, we are subject to examination by taxing authorities. Tax years vary by jurisdiction, ranging from 2017 to 2022 remaining open for examination.

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480990/946-20-50-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//740/tableOfContent

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482685/740-10-50-14

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482685/740-10-50-21

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482526/740-270-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482685/740-10-50-17

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482603/740-30-50-2

Note 10 - Income Tax 1 (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]

	Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022
Loss before income tax	$	(13,550	)	$	(11,840	)	$	(41,277	)	$	(17,818	)
Provision for income tax		4,069			2,983		$	6,193		$	5,126
Effective tax rate		(30.0	%)		(25.2	%)		(15.0	%)		(28.8	%)

	Year Ended December 31,
	2022		2021			2020
Current	$	2,972	$	1,387		$	186
Deferred		1,601		(1,619	)		(38	)
Total provision for (benefit from) income tax	$	4,573	$	(232	)	$	148

Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]

	Nine Months Ended September 30,
	2023
Balance at January 1, 2023	$	3,889
Increases (decreases) in tax positions related to prior periods		(1,974	)
Balance at September 30, 2023	$	1,915

	Year Ended December 31,
	2022
Balance at January 1	$	—
Increases (decreases) in tax positions related to the current period		—
Increases (decreases) in tax positions related to prior periods		3,889
Increases (decreases) related to prior year tax positions as a result of lapse of statute		—
Balance at December 31	$	3,889

Note 10 - Income Tax 1

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Income Tax Disclosure [Text Block]

10. Income Tax

The components of income tax expense were as follows:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022
Loss before income tax	$	(13,550	)	$	(11,840	)	$	(41,277	)	$	(17,818	)
Provision for income tax		4,069			2,983		$	6,193		$	5,126
Effective tax rate		(30.0	%)		(25.2	%)		(15.0	%)		(28.8	%)

A reconciliation of the beginning and ending amounts of our gross unrecognized tax benefits is as follows:

	Nine Months Ended September 30,
	2023
Balance at January 1, 2023	$	3,889
Increases (decreases) in tax positions related to prior periods		(1,974	)
Balance at September 30, 2023	$	1,915

The Company believes that it is reasonably possible that a decrease of up to $0.2 million in unrecognized tax benefits related to foreign exposures may be necessary within the coming year.

10. Income Tax

	Year Ended December 31,
	2022		2021			2020
Current	$	2,972	$	1,387		$	186
Deferred		1,601		(1,619	)		(38	)
Total provision for (benefit from) income tax	$	4,573	$	(232	)	$	148

We maintain the exception under ASC 740-270-30-36(b), Accounting for Income Taxes, for jurisdictions that do not have reliable estimates of income.

A reconciliation of the beginning and ending amounts of our gross unrecognized tax benefits is as follows.

	Year Ended December 31,
	2022
Balance at January 1	$	—
Increases (decreases) in tax positions related to the current period		—
Increases (decreases) in tax positions related to prior periods		3,889
Increases (decreases) related to prior year tax positions as a result of lapse of statute		—
Balance at December 31	$	3,889

We did not have any unrecognized tax benefits in 2021 or 2020.

	Year Ended December 31,
	2022			2021			2020
Loss before income tax	$	(32,068	)	$	(96,537	)	$	(21,381	)

Provision for (benefit from) income tax at weighted-average statutory rates		—			—			—
U.S. state and local income tax, net of federal benefit		(3	)		5			(4	)
U.S. foreign-derived intangible income deduction		(141	)		(200	)		—
Argentina Tax Inflation Adjustment		239			(381	)		(198	)
Change in valuation allowances		4,283			3,648			1,198
Uncertain tax positions		2,293			—			—
Change in carryforward attributes		(1,740	)		—			—
Effect of rates different than statutory		(423	)		(3,300	)		(828	)
Tax credits		(112	)		—			—
Other		177			(4	)		(20	)
Total	$	4,573		$	(232	)	$	148

Deferred tax assets and liabilities as of December 31, 2022 and 2021 consisted of the following:

	December 31,
	2022			2021
Deferred income tax assets:
Stock-based compensation	$	3,023		$	2,053
Bad debt expense		415			407
Deferred financing costs		806			—
Other		193			419
Net operating loss carryforwards		1,365			6,245
Total deferred income tax assets		5,802			9,124
Valuation allowance		(5,802	)		(7,484	)
Total deferred income tax assets (liabilities), net	$	—		$	1,640

Net Operating Loss	Expiration	Gross Amount Carried Forward		Net Amount Recognized as of December 31, 2022
Argentina	December 31, 2023 - December 31, 2027	$	7,864	$	—
Netherlands	Indefinite		2,856		—
China	December 31, 2026 - December 31, 2027		2,258		—
United States	Indefinite		280		—
Uruguay	December 31, 2026 - December 31, 2027		19		—

As of December 31, 2022 and 2021, we had $13.3 million and $20.9 million of net operating loss (“NOL”) carryforwards, respectively.

In the normal course of business, we are subject to examination by taxing authorities. Tax years vary by jurisdiction, ranging from 2017 to 2022 remaining open for examination.

Note 6 - Warrant Liabilities 1 (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2023	Dec. 31, 2022	May 06, 2022	Jan. 25, 2022	Jan. 24, 2022	Jan. 22, 2022	Jan. 18, 2022	Dec. 31, 2021
Warrant Liability, Fair Value Disclosure		$ 1,945	$ 8,335						$ 143,237
Warrants and Rights Outstanding, Term (Year)				36 months
Liberty Warrants and Liberty Advisory Fee Warrant [Member]
Warrant Liability, Fair Value Disclosure		1,182	6,191					$ 30,900	0
Pipe Warrant [Member]
Warrant Liability, Fair Value Disclosure		59	311				$ 1,300		0
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)					$ 20
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)					2,500,000
The 8.63 Warrants [Member]
Warrant Liability, Fair Value Disclosure		$ 704	$ 1,833		$ 4,900				$ 0
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)		$ 8.63	$ 8.63		$ 8.63	$ 11.5
Warrants and Rights Outstanding, Term (Year)					5 years
Class of Warrant or Right, Redemption Price of Warrants or Rights (in dollars per share)					$ 13.5	$ 18
The 8.63 Warrants [Member] \| Private Placement Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)					200,000
The 8.63 Warrants [Member] \| Common Class A [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)					8,333,333
Class of Warrant or Right, Unissued (in shares)					333,333
Public Warrants [Member] \| Common Class A [Member]
Stock Issued During Period, Shares, Warrants Exercised (in shares)	613,111

Note 16 - Related Parties 1 (Details Textual) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Accounts Payable, Trade, Current		$ 9,850	$ 6,650
OS [Member]
Related Party Transaction, Purchases from Related Party	$ 1,400
Accounts Payable, Trade, Current	$ 700

Note 15 - Fair Value Measurement and Financial Instruments

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Fair Value Disclosures [Text Block]

15. Fair Value Measurements and Financial Instruments

The following tables provide the fair value measurement hierarchy of the Company’s assets and liabilities:

As of September 30, 2023	Fair value measurement using
Financial instruments	Quoted prices in active markets (Level 1)		Significant observable inputs (Level 2)		Significant unobservable inputs (Level 3)
$8.63 Warrants liability	$	704	$	—	$	—
PIPE Warrant liability		—		—		59
Liberty Warrants and Liberty Advisory Fee Warrant liability		—		—		1,182
Total Warrant Liabilities	$	704	$	—	$	1,241
Sponsor Earnout Liability	$	—	$	—	$	223

As of December 31, 2022	Fair value measurement using
Financial instruments	Quoted prices in active markets (Level 1)		Significant observable inputs (Level 2)		Significant unobservable inputs (Level 3)
$8.63 Warrants liability	$	1,833	$	—	$	—
PIPE Warrant liability		—		—		311
Liberty Warrants and Liberty Advisory Fee Warrant liability		—		—		6,191
Total Warrant Liabilities	$	1,833	$	—	$	6,502
Sponsor Earnout Liability	$	—	$	—	$	1,353

The following methods and assumptions were used to estimate the fair values:

•

The fair values of the PIPE Warrant, the Liberty Warrants and Liberty Advisory Fee Warrant have been estimated using the Black-Scholes model. Significant unobservable inputs include:

◦

Time to expiry - 3.4 years

◦

Volatility - 67%

◦

Risk free rate of return: 4.8%

•

The fair values of the Sponsor Earnout has been estimated using the Monte Carlo model. Significant unobservable inputs include:

◦

Time to expiry - 3.3 years

◦

Volatility - 67%

◦

Risk free rate of return: 4.8%

•

The fair values of the $8.63 Warrants were determined using quoted prices in the active warrant market.

•

Changes in the fair value of Level 3 liabilities during the three months ended September 30, 2023 and 2022 were as follows:

	Liberty Warrants and Liberty Advisory Fee Warrant			PIPE Warrant			Columbia Warrant		Sponsor Earnout			Forfeiture Earnout		Cantor Loan
At June 30, 2022	$	15,377		$	952		$	—	$	3,111		$	—	$	—
Issues		—			—			—		—			—		—
Remeasurement (gain)/loss		(4,026	)		(415	)		—		(537	)		—		—
Write-off of deferred costs		—			—			—		—			—		—
Settlements		—			—			—		—			—		—
At September 30, 2022	$	11,351		$	537		$	—	$	2,574		$	—	$	—

At June 30, 2023	$	2,339		$	109		$	—	$	504		$	—	$	—
Remeasurement (gain)/loss		(1,157	)		(50	)		—		(281	)		—		—
At September 30, 2023	$	1,182		$	59		$	—	$	223		$	—	$	—

•

Changes in the fair value of Level 3 liabilities during the nine months ended September 30, 2023 and 2022 were as follows:

	Liberty Warrants and Liberty Advisory Fee Warrant			PIPE Warrant			Columbia Warrant			Sponsor Earnout			Forfeiture Earnout			Cantor Loan
At January 1, 2022	$	—		$	—		$	143,237		$	—		$	—		$	7,522
Issues		30,853			1,312			—			8,022			6,135			—
Remeasurement (gain)/loss⁽¹⁾		(19,502	)		(775	)		(18,635	)		(5,448	)		(5,130	)		489
Write-off of deferred costs		—			—			203			—			—			—
Settlements ⁽²⁾		—			—			(124,805	)		—			(1,005	)		(8,011	)
At September 30, 2022	$	11,351		$	537		$	—		$	2,574		$	—		$	—

At January 1, 2023	$	6,191		$	311		$	—		$	1,353		$	—		$	—
Remeasurement (gain)/loss ⁽¹⁾		(5,009	)		(252	)		—			(1,130	)		—			—
At September 30, 2023	$	1,182		$	59		$	—		$	223		$	—		$	—

⁽¹⁾

Recognized in the Condensed Consolidated Statements of Operations and Comprehensive Loss for the nine months ended September 30, 2023 and 2022, respectively.

⁽²⁾

These liabilities were settled in connection with the Merger. See Note 4 (Recapitalization Transaction).

There were no transfers between Level 1 and Level 2 during the nine months ended September 30, 2023 or 2022.

15. Fair Value Measurements and Financial Instruments

The following tables provide the fair value measurement hierarchy of our assets and liabilities:

As of December 31, 2022	Fair value measurement using
Financial instruments	Quoted prices in active markets (Level 1)		Significant observable inputs (Level 2)		Significant unobservable inputs (Level 3)
$8.63 Warrants liability	$	1,833	$	—	$	—
PIPE Warrant liability		—		—		311
Liberty Warrants and Liberty Advisory Fee Warrant liability		—		—		6,191
Total Warrant Liabilities	$	1,833	$	—	$	6,502
Sponsor Earnout liability	$	—	$	—	$	1,353

As of December 31, 2021	Fair value measurement using
Financial instruments	Quoted prices in active markets (Level 1)		Significant observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Liabilities measured at fair value
Cantor Loan	$	—	$	—	$	7,522
Columbia Warrant liability		—		—		143,237
Liabilities for which fair values are disclosed
Notes	$	—	$	180,356	$	—
Promissory notes		—		40,925		—

The following methods and assumptions were used to estimate the fair values:

•

The fair values of the PIPE Warrant, the Liberty Warrants and Liberty Advisory Fee Warrant, and the Columbia Warrant have been estimated using the Black-Scholes model.

•

The fair value of the Sponsor Earnout has been estimated using the Monte Carlo model.

•

The fair values of the $8.63 Warrants were determined using the quoted prices in the active warrant market.

•

Changes in the fair value of Level 3 liabilities during the years ended December 31, 2022 and 2021 were as follows:

	Liberty Warrants and Liberty Advisory Fee Warrant			PIPE Warrant			Columbia Warrant			Sponsor Earnout			Forfeiture Earnout			Cantor Loan
At January 1, 2021	$	—		$	—		$	—		$	—		$	—		$	—
Issues		—			—			161,432			—			—			7,513
Remeasurement (gain)/loss⁽¹⁾		—			—			(17,992	)		—			—			9
Amortization of deferred costs		—			—			(203	)		—			—			—
At December 31, 2021		—			—			143,237			—			—			7,522
Issues		30,853			1,312			—			8,022			6,135			—
Remeasurement (gain)/loss⁽¹⁾		(24,662	)		(1,001	)		(18,635	)		(6,669	)		(5,130	)		488
Write-off of deferred costs		—			—			203			—			—			—
Settlements ⁽²⁾		—			—			(124,805	)		—			(1,005	)		(8,010	)
At December 31, 2022	$	6,191		$	311		$	—		$	1,353		$	—		$	—

⁽¹⁾	Recognized in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2022 and 2021, respectively.

⁽²⁾	These liabilities were settled in connection with the Merger. See Note 4 (Recapitalization Transaction).

There were no transfers between Level 1 and Level 2 during the years ended December 31, 2022 or 2021.

Note 8 - Property and Equipment - Summary of Property and Equipment 1 (Details) - USD ($)
$ in Thousands

Sep. 30, 2023

Dec. 31, 2022

Dec. 31, 2021

Less: Accumulated depreciation

$ 96,229

$ 87,143

$ 57,181

(53,501)

(39,162)

(24,651)

Property, Plant And Equipment And Operating Lease, Right-of-Use Assets

42,728

47,981

32,530

^[1],[3]

52,059

^[2]

56,152

^[2],[4]

35,485

^[4]

URUGUAY

Property, Plant And Equipment And Operating Lease, Right-of-Use Assets

37,991

43,134

33,208

ARGENTINA

Property, Plant And Equipment And Operating Lease, Right-of-Use Assets

930

1,346

1,250

SPAIN

Property, Plant And Equipment And Operating Lease, Right-of-Use Assets

828

729

791

NETHERLANDS

Property, Plant And Equipment And Operating Lease, Right-of-Use Assets

11,820

9,471

Other Countries [Member]

Property, Plant And Equipment And Operating Lease, Right-of-Use Assets

490

1,472

236

Satellites and Other Equipment [Member]

Satellites Under Construction [Member]

68,369

54,370

Leasehold Improvements [Member]

16,032

22,194

10,558

Property, Plant and Equipment, Other Types [Member]

7,601

6,433

769

Minimum [Member] | Satellites and Other Equipment [Member]

$ 4,227

$ 4,146

$ 2,138

Minimum [Member] | Leasehold Improvements [Member]

3 years

Minimum [Member] | Property, Plant and Equipment, Other Types [Member]

5 years

Maximum [Member] | Satellites and Other Equipment [Member]

3 years

Maximum [Member] | Leasehold Improvements [Member]

5 years

Maximum [Member] | Property, Plant and Equipment, Other Types [Member]

10 years

10 years

[1]	Non-current assets include property and equipment, net and operating lease right-of-use assets.
[2]	Presentation in the table is based on the geographic location of the entity that holds the assets.
[3]	We do not have any non-current assets in the country of incorporation of the holding company.
[4]	The presentation in the table above is based on the geographic location of the entity that holds the assets.

Note 2 - Summary of Significant Accounting Policies 1 (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Accounts Receivable, Allowance for Credit Loss [Table Text Block]

	Nine Months Ended September 30,
	2023		2022
Allowance for credit losses as of beginning of period	$	3,237	$	1,794
Provision		80		1,736
Allowance for credit losses as of end of period	$	3,317	$	3,530

	December 31,
	2022			2021
Allowance for doubtful accounts as of beginning of period	$	1,794		$	—
Provision		1,736			1,794
Write-offs		—			—
Foreign exchange and other		(293	)		—
Allowance for doubtful accounts as of end of period	$	3,237		$	1,794

Schedule of Cash and Cash Equivalents [Table Text Block]

	September 30, 2023		December 31, 2022
Cash and cash equivalents	$	30,971	$	76,528
Restricted cash		—		126
Restricted cash included in Other non-current assets		1,151		1,138
Total cash, cash equivalents and restricted cash	$	32,122	$	77,792

	December 31,
	2022		2021
Cash and cash equivalents	$	76,528	$	8,533
Restricted cash		126		—
Restricted cash included in Other non-current assets		1,138		—
Total cash, cash equivalents and restricted cash	$	77,792	$	8,533

Note 4 - Reverse Recapitalization

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Reverse Recapitalization Disclosure [Text Block]

4. Reverse Recapitalization

On the Closing Date, the Company consummated the Merger contemplated by the Merger Agreement, including the following:

Private Placement (“PIPE”) Investment

Forward Purchase Agreement

Cantor Loan

Redeemable Series X Preferred Stock

Liberty Investment

Transaction Fees

Company Stockholders

In connection with the Merger Transaction:

•

all Convertible Notes of Nettar converted into Nettar Preferred Shares which were exchanged for shares of Satellogic’s Class A ordinary shares as determined in the Merger Agreement;

•

Company stockholders	Shares
Class A stockholders immediately prior to merger		17,215,336
Series A preferred stockholders		7,968,316
Series B preferred stockholders		4,597,928
Series B-1 preferred stockholders		2,171,399
2018 convertible noteholders		5,581,416
2019 convertible noteholders		7,846,333
2020 convertible noteholders		4,553,205
Redeemable Series X preferred stockholders		2,140,340
Liberty investors		20,000,000
PIPE investors		5,816,770
Shares issued for Cantor loan repayment		788,021
Shares issued to Sponsor under Forward Purchase Securities Agreement		1,250,000
Issuance of shares for transaction fees		2,058,229
CF V shares		6,837,354
		88,824,647

4. Reverse Recapitalization

On the Closing Date, the Company consummated the Merger contemplated by the Merger Agreement, including the following:

Private Placement (“PIPE”) Investment

Forward Purchase Agreement

Cantor Loan

Redeemable Series X Preferred Stock

Per the transaction, the 2,033,230 outstanding shares of redeemable Series X preferred stock and accrued dividends in the amount of $21.4 million were converted to 2,140,340 Class A ordinary shares.

Liberty Investment

On January 18, 2022, Satellogic and CF V entered into the Liberty Subscription Agreement with an investor (the “Liberty Investor”). Satellogic agreed to issue and sell to the Liberty Investor (i) 20,000,000 of Satellogic’s Class A ordinary shares (the “Liberty Shares”), (ii) a warrant to purchase up to 5,000,000 Satellogic’s Class A ordinary shares at an exercise price of $10.00 per share (the “$10.00 Liberty Warrant”), and (iii) a warrant to purchase up to 15,000,000 of Satellogic’s Class A ordinary shares at an exercise price of $15.00 per share (the “$15.00 Liberty Warrant”, and together with the $10.00 Liberty Warrant, the “Liberty Warrants”), in a private placement for an aggregate purchase price of $150.0 million. The transaction closed on February 10, 2022 (the “Liberty Closing” and the transaction collectively, the “Liberty Investment”).

Transaction Fees

Company Stockholders

In connection with the Merger transaction:

•

all Convertible Notes of Nettar converted into Nettar Preferred Shares which were exchanged for shares of Satellogic’s Class A ordinary shares as determined in the Merger Agreement;

•

all options to purchase common stock of Nettar were assumed by the Company and became options to purchase Satellogic’s Class A ordinary shares as determined in accordance with the Merger Agreement;

•

Company stockholders	Shares
Class A stockholders immediately prior to merger		17,215,336
Series A preferred stockholders		7,968,316
Series B preferred stockholders		4,597,928
Series B-1 preferred stockholders		2,171,399
2018 convertible noteholders		5,581,416
2019 convertible noteholders		7,846,333
2020 convertible noteholders		4,553,205
Redeemable Series X preferred stockholders		2,140,340
Liberty investors		20,000,000
PIPE investors		5,816,770
Shares issued for Cantor loan repayment		788,021
Shares issued to Sponsor under Forward Purchase Securities Agreement		1,250,000
Issuance of shares for transaction fees		2,058,229
CF V shares		6,837,354
		88,824,647

Note 7 - Earnout Liabilities 1 (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2022	Jan. 25, 2022	Dec. 31, 2021	Jul. 05, 2021
Earnout Liability		$ 223	$ 1,353		$ 0
Sponsor Earnout [Member]
Earnout Liability		$ 223	1,353		0
Sponsor Earnout [Member] \| Closing Price 1 [Member]
Contingent Consideration, Liability, Earnout Period, Stock Price Trigger (in dollars per share)						$ 12.5
Sponsor Earnout [Member] \| Closing Price 2 [Member]
Contingent Consideration, Liability, Earnout Period, Stock Price Trigger (in dollars per share)						15
Sponsor Earnout [Member] \| Closing Price 3 [Member]
Contingent Consideration, Liability, Earnout Period, Stock Price Trigger (in dollars per share)						$ 20
Sponsor Earnout [Member] \| Common Class A [Member]
Contingent Consideration, Liability, Shares (in shares)						1,869,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number (in shares)	1,775,962	1,775,962
Forfeiture Earnout [Member]
Earnout Liability		$ 1,000	$ 1,000	$ 6,100	$ 0
Forfeiture Earnout [Member] \| Closing Price 1 [Member]
Contingent Consideration, Liability, Earnout Period, Stock Price Trigger (in dollars per share)				$ 10
Forfeiture Earnout [Member] \| Closing Price 2 [Member]
Contingent Consideration, Liability, Earnout Period, Stock Price Trigger (in dollars per share)				$ 15
Forfeiture Earnout [Member] \| Common Class A [Member]
Contingent Consideration, Shares in Escrow (in shares)				310,127

Note 12 - Stock-based Compensation (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)	0	0	0
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value			$ 75	$ 23,900	$ 9,700
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)			4 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period (Year)			10 years
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in shares)	42,898		17,376
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 870		$ 3,200
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)			1 year 5 months 1 day
Restricted Stock Units (RSUs) [Member]
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation (in shares)	116,783		56,649
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value (in dollars per share)	$ 2.43		$ 4.38
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 5,900		$ 5,400
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)	9 months 10 days		1 year 5 months 8 days

Note 18 - Leases - Maturity of Operating Lease Liability (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
2023		$ 2,484
2024		2,235
2025		824
2026		603
2027 and thereafter		3,166
Total remaining lease payments		9,312
Less imputed interest		(1,073)
Present value of lease liability		8,239	$ 3,068	$ 1,415
Operating lease liabilities	$ 2,034	2,176	985
Total non-current	$ 7,641	$ 6,063	$ 2,083

Note 6 - Warrant Liabilities - Schedule of Warrant Liabilities 1 (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
As of December 31, 2021	$ 8,335	$ 143,237
Warrants issued	0	37,037
Fair Value Adjustment of Warrants	(6,390)	(47,000)
As of December 31, 2022	1,945	8,335
Liberty Warrants and Liberty Advisory Fee Warrant [Member]
As of December 31, 2021	6,191	0
Warrants issued	0	30,853
Fair Value Adjustment of Warrants	(5,009)	(24,662)
As of December 31, 2022	1,182	6,191
Pipe Warrant [Member]
As of December 31, 2021	311	0
Warrants issued	0	1,312
Fair Value Adjustment of Warrants	(252)	(1,001)
As of December 31, 2022	59	311
The 8.63 Warrants [Member]
As of December 31, 2021	1,833	0
Warrants issued	0	4,872
Fair Value Adjustment of Warrants	(1,129)	(2,702)
As of December 31, 2022	$ 704	$ 1,833

Note 18 - Leases - Changes in Operating Lease Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Balance as of beginning of period			$ 8,239	$ 3,068	$ 3,068	$ 1,415
Additions to operating lease liabilities					7,171	2,119
Operating Lease, Expense	$ 600	$ 500	1,900	$ 1,400	314	54	$ 51
Foreign exchange differences					(293)	(48)
Disposals					(329)	0
Payments					(1,692)	(472)
Balance as of end of period					8,239	3,068	$ 1,415
Operating lease liabilities	2,034		2,034		2,176	985
Total non-current	$ 7,641		$ 7,641		$ 6,063	$ 2,083

Note 9 - Additional Financial Statement Information

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Additional Financial Information Disclosure [Text Block]

9. Additional Financial Statement Information

Prepaid Expenses and Other Current Assets

	September 30,		December 31,
	2023		2022
Prepaid expenses and other current assets
Prepaid expenses	$	2,604	$	1,767
Advances to suppliers		228		588
Other current assets		413		843
Total	$	3,245	$	3,198

Accrued Expenses and Other Liabilities

	September 30,		December 31,
	2023		2022
Accrued expenses and other liabilities
Provisions		66		71
Payroll and benefits payable		2,111		3,289
Other taxes payable		5,373		3,128
Other		430		451
Total	$	7,980	$	6,939

Total current	$	7,481	$	6,417
Total non-current	$	499	$	522

Finance Costs, net

	Three Months Ended September 30,						Nine Months Ended September 30,
	2023			2022			2023			2022
Finance income (expense), net
Interest expense	$	—		$	(9	)	$	(3	)	$	(1,597	)
Redeemable Series X preferred stock dividends		—			—			—			(97	)
Other finance costs		(38	)		(29	)		(103	)		(99	)
Interest income		427			419			1,577			568
Total	$	389		$	381		$	1,471		$	(1,225	)

9. Additional Financial Statement Information

Prepaid Expenses and Other Current Assets

	December 31,
	2022		2021
Prepaid expenses and other current assets
Prepaid expenses	$	1,767	$	1,153
Advances to suppliers		588		829
Other current assets		843		713
Total	$	3,198	$	2,695

Accrued Expenses and Other Liabilities

	December 31,
	2022		2021
Accrued expenses and other liabilities
Accrued professional fees related to Merger⁽¹⁾	$	—	$	16,263
Provisions		71		2,934
Payroll and benefits payable		3,289		2,545
Other taxes payable		3,128		2,045
Other		451		2,200
Total	$	6,939	$	25,987

Total current	$	6,417	$	23,435
Total non-current	$	522	$	2,552

⁽¹⁾	Refer to Note 4 (Reverse Recapitalization) for further details on the Merger.

Finance Costs, Net

	Year Ended December 31,
	2022			2021			2020
Finance costs, net
Interest expense	$	(1,596	)	$	(8,729	)	$	(43	)
Redeemable Series X preferred stock dividends		(97	)		(974	)		—
Other finance costs		(123	)		(71	)		—
Interest income		1,164			36			78
Total	$	(652	)	$	(9,738	)	$	35

Note 11 - Stockholders' Equity (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Schedule of Stock by Class [Table Text Block]

	Authorized Shares (prior to Merger)		Issued and Outstanding Shares (as of December 31, 2021)
Series A preferred stock		4,723,330		2,547,330
Series B preferred stock		3,117,915		1,392,131
Series B-1 preferred stock		899,153		672,524
Total preferred stock		8,740,398		4,611,985

	Authorized Shares (prior to Merger)		Issued and Outstanding Shares (as of December 31, 2021)
Series A preferred stock		4,723,330		2,547,330
Series B preferred stock		3,117,915		1,392,131
Series B-1 preferred stock		899,153		672,524
Total preferred stock		8,740,398		4,611,985

Note 11 - Stockholders' Equity 1

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Equity [Text Block]

11. Stockholders’ Equity

Reverse Recapitalization

Preferred Stock

Prior to the Merger, the Company’s authorized and issued preferred stock consisted of the following:

	Authorized Shares (prior to Merger)		Issued and Outstanding Shares (as of December 31, 2021)
Series A preferred stock		4,723,330		2,547,330
Series B preferred stock		3,117,915		1,392,131
Series B-1 preferred stock		899,153		672,524
Total preferred stock		8,740,398		4,611,985

In connection with the Merger, all shares of preferred stock were converted to shares of Class A ordinary shares.

Preferred Stockholder Transaction

The Columbia Warrant was initially recognized as a liability. The fair value of the Columbia Warrant was reclassified to additional paid-in capital in connection with the Merger.

Common Stock

Treasury Stock

Hannover Holdings Transaction

11. Stockholders’ Equity (Deficit)

Reverse Recapitalization

Preferred Stock

Prior to the Merger, our authorized and issued preferred stock consisted of the following:

	Authorized Shares (prior to Merger)		Issued and Outstanding Shares (as of December 31, 2021)
Series A preferred stock		4,723,330		2,547,330
Series B preferred stock		3,117,915		1,392,131
Series B-1 preferred stock		899,153		672,524
Total preferred stock		8,740,398		4,611,985

In connection with the Merger, all shares of preferred stock were converted to shares of Class A ordinary shares.

Preferred Stockholder Transaction

Common Stock

Our registration statement was filed on May 2, 2022 and was declared effective on May 9, 2022.

We are authorized to issue unlimited Class A ordinary shares with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. As of December 31, 2022, there were 75,612,795 Class A ordinary shares issued and outstanding.

Treasury Stock

We repurchased 516,123 Class A ordinary shares for $2.7 million during the year ended December 31, 2022.

Hannover Holdings Transaction

The entire disclosure for equity.

Note 12 - Stock-based Compensation - RSU Activity (Details) - Restricted Stock Units (RSUs) [Member] - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Outstanding unvested RSUs (in shares)	1,459,280	0
Granted during the year (in shares)	3,369,167	1,640,496
Forfeited during the year (in shares)	(559,809)	(60,823)
Vested during the year (in shares)	(494,287)	(120,393)
Expired during the year (in shares)		0
Outstanding unvested RSUs (in shares)	3,774,351	1,459,280
Outstanding unvested RSUs at December 31, 2022	$ 4,416	$ 1,940

Condensed Consolidated Statements of Redeemable Preferred Stock and Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Series X Preferred Stock [Member]	Preferred Stock [Member] Hanover Holdings S A [Member]	Preferred Stock [Member] Public Warrants [Member]	Preferred Stock [Member]	Common Stock [Member] Hanover Holdings S A [Member]	Common Stock [Member] Convertible Debt [Member]	Common Stock [Member] Canter Loan [Member]	Common Stock [Member] Forward Purchase Contract Warrant [Member]	Common Stock [Member] Pipe Warrant [Member]	Common Stock [Member] Liberty Subscription Agreement [Member]	Common Stock [Member] Public Warrants [Member]	Common Stock [Member]	Additional Paid-in Capital [Member] Hanover Holdings S A [Member]	Additional Paid-in Capital [Member] Convertible Debt [Member]	Additional Paid-in Capital [Member] Canter Loan [Member]	Additional Paid-in Capital [Member] Forward Purchase Contract Warrant [Member]	Additional Paid-in Capital [Member] Pipe Warrant [Member]	Additional Paid-in Capital [Member] Liberty Subscription Agreement [Member]	Additional Paid-in Capital [Member] Public Warrants [Member]	Additional Paid-in Capital [Member]	Treasury Stock, Common [Member] Hanover Holdings S A [Member]	Treasury Stock, Common [Member] Convertible Debt [Member]	Treasury Stock, Common [Member] Canter Loan [Member]	Treasury Stock, Common [Member] Forward Purchase Contract Warrant [Member]	Treasury Stock, Common [Member] Pipe Warrant [Member]	Treasury Stock, Common [Member] Liberty Subscription Agreement [Member]	Treasury Stock, Common [Member] Public Warrants [Member]	Treasury Stock, Common [Member]	AOCI Attributable to Parent [Member] Hanover Holdings S A [Member]	AOCI Attributable to Parent [Member] Convertible Debt [Member]	AOCI Attributable to Parent [Member] Canter Loan [Member]	AOCI Attributable to Parent [Member] Forward Purchase Contract Warrant [Member]	AOCI Attributable to Parent [Member] Pipe Warrant [Member]	AOCI Attributable to Parent [Member] Liberty Subscription Agreement [Member]	AOCI Attributable to Parent [Member] Public Warrants [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member] Hanover Holdings S A [Member]	Retained Earnings [Member] Convertible Debt [Member]	Retained Earnings [Member] Canter Loan [Member]	Retained Earnings [Member] Forward Purchase Contract Warrant [Member]	Retained Earnings [Member] Pipe Warrant [Member]	Retained Earnings [Member] Liberty Subscription Agreement [Member]	Retained Earnings [Member] Public Warrants [Member]	Retained Earnings [Member]	Hanover Holdings S A [Member]	Convertible Debt [Member]	Canter Loan [Member]	Forward Purchase Contract Warrant [Member]	Pipe Warrant [Member]	Liberty Subscription Agreement [Member]	Public Warrants [Member]	Total
Balance (in shares) at Dec. 31, 2019				8,740,398								15,961,703
Balance at Dec. 31, 2019																				$ 61,635								$ 0								$ 0								$ (67,084)								$ (5,449)
Net loss																				0								0								0								(21,529)								(21,529)
Stock-based compensation																				1,727								0								0								5								1,732
Balance (in shares) at Dec. 31, 2020				8,740,398								16,280,360
Balance at Dec. 31, 2020																				64,041								0								0								(89,869)								(25,828)
Issuance of stock (in shares)				0								318,657
Issuance of stock																				802								0								0								0								802
Net loss																				0								0								0								(96,305)								(96,305)
Other comprehensive loss																				0								0								(86)								0								(86)
Exercise of stock options (in shares)				0								1,102,494
Exercise of stock options																				791								0								0								0								791
Stock-based compensation																				10,881								0								0								0								10,881
Balance (in shares) at Dec. 31, 2021	2,033,230			4,611,985								17,382,854
Balance at Dec. 31, 2021	$ 21,306																			96,471								(170,949)								(86)								(186,174)								(260,738)
Repurchase of shares																				(18,251)								(170,949)								0								0								(189,200)
Hannover Holdings Transaction (Note 11) (in shares)				4,128,413								(0)
Dividends on Redeemable Series X preferred stock																				0								0								0								0								0
Preferred stockholder transaction (Note 11) (in shares)				(4,128,413)								0
Net loss																				0								0								0								(22,944)								(22,944)
Other comprehensive loss																				0								0								(695)								0								(695)
Exercise of stock options (in shares)				0								21,927
Exercise of stock options																				37																																37
Stock-based compensation																				6,624																																6,624
Balance (in shares) at Sep. 30, 2022	0			0								88,994,146
Balance at Sep. 30, 2022	$ 0																			336,631								(8,603)								(781)								(209,118)								118,129
Hannover Holdings Transaction (Note 11)													$ 0								$ 0								$ 0								$ 0								$ 0
Merger transaction and Reverse Recapitalization																				(166,634)								170,949								0								0								4,315
Repurchase of shares																												(8,603)																								(8,603)
Hannover Holdings Transaction (Note 11) (in shares)		(149,817)			(51,700)							516,123
Merger transaction and Reverse Recapitalization (in shares)				(4,462,168)								22,630,545
Issuance of Class A ordinary shares (in shares)						17,980,954	788,021	1,250,000	6,108,332	20,619,835	613,111
Issuance of Class A ordinary shares														$ 64,051	$ 7,880	$ 10,000	$ 47,430	$ 121,182	$ 5,628																											$ 64,051	$ 7,880	$ 10,000	$ 47,430	$ 121,182	$ 5,628
Dividends on Redeemable Series X preferred stock	$ 97
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization (in shares)	(2,033,230)											2,140,340
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization	$ (21,403)																			21,403																																21,403
Reclassification of Columbia Warrant to equity																				124,805																																124,805
Repayment of Columbia Loan																				(3,418)																																(3,418)
Reclassification of Forfeiture Earnout Liability to equity																				1,005																																1,005
Preferred stockholder transaction (Note 11) (in shares)		149,817			51,700							(516,123)
Issuance of stock (in shares)							26,050
Issuance of stock															167																																167
Balance (in shares) at Dec. 31, 2021	2,033,230			4,611,985								17,382,854
Balance at Dec. 31, 2021	$ 21,306																			96,471								(170,949)								(86)								(186,174)								(260,738)
Net loss																				0								0								0								(36,641)								(36,641)
Other comprehensive loss																				0								0								(226)								0								$ (226)
Exercise of stock options (in shares)				0								223,218																																								102,825
Exercise of stock options																				144								0								0								0								$ 144
Withholding of stock units to satisfy tax withholding obligations upon the vesting of restricted stock units and exercise of stock options																				(306)								0								0								0								(306)
Stock-based compensation																				8,368								0								0								0								8,368
Balance (in shares) at Dec. 31, 2022				0								89,195,437
Balance at Dec. 31, 2022																				337,928								(8,603)								(312)								(222,815)								106,198
Hannover Holdings Transaction (Note 11)													0								(5,853)								0								0								(5,853)
Merger transaction and Reverse Recapitalization																				(165,804)								170,949								0								0								5,145
Repurchase of shares																												(2,750)								0								0								(2,750)
Hannover Holdings Transaction (Note 11) (in shares)		149,817			51,700							516,123
Merger transaction and Reverse Recapitalization (in shares)				(4,462,168)								22,630,545
Issuance of Class A ordinary shares (in shares)			0			17,980,954	788,021	1,250,000	6,108,332	20,619,835	613,111
Issuance of Class A ordinary shares														$ 64,051	7,880	$ 10,000	$ 47,028	$ 120,506	$ 5,628			$ 0	$ 0	$ 0	$ 0	$ 0	$ 0			$ 0	$ 0	$ 0	$ 0	$ 0	$ 0			$ 0	$ 0	$ 0	$ 0	$ 0	$ 0			$ 64,051	7,880	$ 10,000	$ 47,028	$ 120,506	$ 5,628
Dividends on Redeemable Series X preferred stock																												0								0								0								0
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization (in shares)												2,140,340
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization																				21,403								0								0								0								21,403
Reclassification of Columbia Warrant to equity																				124,805								0								0								0								124,805
Repayment of Columbia Loan																				(3,418)								0								0								0								(3,418)
Reclassification of Forfeiture Earnout Liability to equity																				1,005								0								0								0								1,005
Preferred stockholder transaction (Note 11) (in shares)		(149,817)			(51,700)							(516,123)
Issuance of stock (in shares)							26,050
Issuance of stock															$ 167								$ 0								$ 0								$ 0								$ 167
Balance (in shares) at Jun. 30, 2022				0								88,994,146
Balance at Jun. 30, 2022																				335,306								(8,603)								(408)								(194,295)								132,000
Net loss																				0								0								0								(14,823)								(14,823)
Other comprehensive loss																				0								0								(373)								0								(373)
Exercise of stock options																				16								0								0								0								16
Stock-based compensation																				2,139								0								0								0								2,139
Balance (in shares) at Sep. 30, 2022	0			0								88,994,146
Balance at Sep. 30, 2022	$ 0																			336,631								(8,603)								(781)								(209,118)								118,129
Hannover Holdings Transaction (Note 11)													$ 0								$ 5,853								$ 0								$ 0								$ 5,853
Merger transaction and Reverse Recapitalization																				(830)								0								0								0								(830)
Repurchase of shares																				0								(5,853)								0								0								(5,853)
Balance (in shares) at Dec. 31, 2022				0								89,195,437
Balance at Dec. 31, 2022																				337,928								(8,603)								(312)								(222,815)								106,198
Net loss																				0								0								0								(47,470)								(47,470)
Other comprehensive loss																				0								0								(218)								0								$ (218)
Exercise of stock options (in shares)				0								186,307																																								186,307
Exercise of stock options																				249								0								0								0								$ 249
Withholding of stock units to satisfy tax withholding obligations upon the vesting of restricted stock units and exercise of stock options																				(272)								0								0								0								(272)
Stock-based compensation (in shares)				0								493,502
Stock-based compensation																				4,254								0								0								0								4,254
Balance (in shares) at Sep. 30, 2023				0								89,875,246
Balance at Sep. 30, 2023																				342,159								(8,603)								(530)								(270,285)								62,741
Balance (in shares) at Jun. 30, 2023				0								89,661,530
Balance at Jun. 30, 2023																				340,750								(8,603)								(236)								(252,666)								79,245
Net loss																				0								0								0								(17,619)								(17,619)
Other comprehensive loss																				0								0								(294)								0								(294)
Exercise of stock options (in shares)				0								80,626
Exercise of stock options																				49								0								0								0								49
Withholding of stock units to satisfy tax withholding obligations upon the vesting of restricted stock units and exercise of stock options																				(53)								0								0								0								(53)
Stock-based compensation (in shares)				0								133,090
Stock-based compensation																				1,413								0								0								0								1,413
Balance (in shares) at Sep. 30, 2023				0								89,875,246
Balance at Sep. 30, 2023																				$ 342,159								$ (8,603)								$ (530)								$ (270,285)								$ 62,741

Note 2 - Summary of Significant Accounting Policies - Summary of Allowance for Credit Losses (Details) - USD ($) $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Allowance for doubtful accounts as of beginning of period	$ 3,237	$ 1,794	$ 1,794	$ 0
Bad debt expense	80	1,736	1,736	1,794	$ 0
Write-offs			0	0
Foreign exchange and other			(293)	0
Allowance for doubtful accounts as of end of period	$ 3,317	$ 3,530	$ 3,237	$ 1,794	$ 0

Note 10 - Income Tax (Details Textual) - USD ($) Pure in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Sep. 30, 2023
Unrecognized Tax Benefits	$ 3,889	$ 0	$ 0	$ 1,915
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	$ 2,000
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	0.00%	0.00%	0.00%
Operating Loss Carryforwards	$ 13,300	$ 20,900
Open Tax Year	2017 2018 2019 2020 2021 2022

Note 5 - Revenue from Contracts with Customers 1

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Revenue from Contract with Customer [Text Block]

5. Revenue from Contracts with Customers

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Revenue by timing
Over time	$	413	$	—	$	1,236	$	1,524
Point-in time		783		2,158		3,144		3,022
Total revenue	$	1,196	$	2,158	$	4,380	$	4,546

Information about the Company’s revenue by geography is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Revenue by geography ^{(1) (2)}
Asia Pacific	$	82	$	232	$	351	$	1,946
Europe		513		43		1,506		80
North America		588		1,817		2,467		2,435
South America		13		66		56		85
Total revenue	$	1,196	$	2,158	$	4,380	$	4,546

⁽¹⁾	Revenue by geography is based on the geographical location of the customer.
⁽²⁾	Certain comparative figures have been reclassified to conform to the current year presentation.

Contract liabilities and Remaining Performance Obligations

	September 30,		December 31,
	2023		2022
Non-current	$	1,000	$	1,000
Current		3,286		1,941
Total	$	4,286	$	2,941

		Within 1 Year				Years 2				Years 3				Thereafter
Remaining performance obligations		$	6,852			$	5,648			$	5,005			$	1,000

5. Revenue from Contracts with Customers

Information about our revenue by geography is as follows:

	Year Ended December 31,
	2022		2021
Revenue by geography ⁽¹⁾
Asia Pacific	$	1,531	$	3,988
North America		3,438		201
Other		1,043		58
Total revenue	$	6,012	$	4,247

⁽¹⁾	Revenue by geography is based on the geographical location of the customer.

Contract Liabilities and Remaining Performance Obligations

	December 31,
	2022		2021
Non-current	$	1,000	$	1,000
Current		1,941		935
Total	$	2,941	$	1,935

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. The following table represents the total transaction price for the remaining performance obligations as of December 31, 2022 related to non-cancellable contracts longer than 12 months in duration that is expected to be recognized over future periods.

		Within 1 Year				Years 1-2				Years 2-3				Thereafter
Remaining performance obligations		$	6,422			$	11,296			$	3,860			$	—

Note 18 - Leases - Summary of Lease Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Right-of-use assets					$ 1,701	$ 494	$ 247
Operating lease liabilities	$ 600	$ 500	$ 1,900	$ 1,400	314	54	51
Total lease expense			$ 2,112	$ 1,475	$ 2,015	$ 548	$ 298

Note 6 - Warrant Liabilities (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Schedule Of Warrant Liability [Table Text Block]

	Liberty Warrants and Liberty Advisory Fee Warrant			PIPE Warrant			*$8.63* Warrants			Total Warrants
As of December 31, 2022	$	6,191		$	311		$	1,833		$	8,335
Warrants issued	$	—		$	—		$	—		$	—
Change in fair value of financial instruments		(5,009	)		(252	)		(1,129	)		(6,390	)
As of September 30, 2023	$	1,182		$	59		$	704		$	1,945

	Liberty Warrants and Liberty Advisory Fee Warrant			PIPE Warrant			Columbia Warrant			$8.63 Warrants			Total Warrant Liabilities
As of December 31, 2021	$	—		$	—		$	143,237		$	—		$	143,237
Warrants issued	$	30,853		$	1,312		$	—		$	4,872		$	37,037
Change in fair value of financial instruments		(24,662	)		(1,001	)		(18,635	)		(2,702	)		(47,000	)
Write-off of deferred costs		—			—			203			—			203
Settlements		—			—			—			(337	)		(337	)
Reclassification to equity		—			—			(124,805	)		—			(124,805	)
As of December 31, 2022	$	6,191		$	311		$	—		$	1,833		$	8,335

Document And Entity Information	9 Months Ended
Document And Entity Information	Sep. 30, 2023
Document Information [Line Items]
Entity Central Index Key	0001874315
Entity Registrant Name	Satellogic Inc.
Amendment Flag	false
Document Type	F-4
Entity Incorporation, State or Country Code	D8
Entity Address, Address Line One	Ruta 8 Km 17,500, Edificio 300 Oficina 324 Zonamerica
Entity Address, City or Town	Montevideo
Entity Address, Postal Zip Code	91600
Entity Address, Country	UY
City Area Code	00-598
Local Phone Number	25182302
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Business Contact [Member]
Document Information [Line Items]
Entity Address, Address Line One	210 Delburg Street
Entity Address, City or Town	Davidson
Entity Address, Postal Zip Code	28036
City Area Code	704
Local Phone Number	894-4482
Contact Personnel Name	Rick Dunn
Entity Address, State or Province	NC

Note 7 - Earnout Liabilities - Schedule of Earnout Liabilities 1 (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Balance	$ 1,353	$ 0
Change in fair value of financial instruments		(11,799)
Balance	223	1,353
Sponsor Earnout [Member]
Balance	1,353	0
Change in fair value of financial instruments	(1,130)	(6,669)
Balance	$ 223	$ 1,353

Note 10 - Income Tax 1 (Details Textual) $ in Millions	9 Months Ended
Note 10 - Income Tax 1 (Details Textual) $ in Millions	Sep. 30, 2023 USD ($)
Unrecognized Tax Benefits, Decrease Resulting from Foreign Tax Exposure	$ 0.2

Note 19 - Adoption of U.S. GAAP (Tables)

12 Months Ended

Dec. 31, 2022

Accounting Standards Update and Change in Accounting Principle [Table Text Block]

	Year Ended December 31, 2021
	IFRS			Adjustments/ Reclassifications			Note	U.S. GAAP
Revenue	$	4,247		$	—			$	4,247
Costs and expenses
Cost of sales		1,876			—				1,876
General administrative expenses		36,649			(9	)	a, c		36,640
Research and development		9,640			(4	)	b		9,636
Depreciation expense		10,825			(97	)	b		10,728
Other operating expenses, net		14,002			—				14,002
Total costs and expenses		72,992			(110	)			72,882
Operating loss		(68,745	)		110				(68,635	)
Other income (expense), net
Finance costs, net		(11,769	)		2,031		c, d		(9,738	)
Change in fair value of financial instruments		(42,102	)		60,085		d		17,983
Gain (loss) on extinguishment of debt		3,576			(40,792	)	d		(37,216	)
Other income (expense), net		1,067			2		c		1,069
Total other income (expense), net		(49,228	)		21,326				(27,902	)
Loss before income tax		(117,973	)		21,436				(96,537	)
Income tax		232			—				232
Net loss available to common stockholders	$	(117,741	)	$	21,436			$	(96,305	)
Other comprehensive loss
Foreign currency translation loss, net of tax		(86	)		—				(86	)
Comprehensive loss	$	(117,827	)	$	21,436			$	(96,391	)

Basic loss for the period attributable to common stockholders	$	(7.07	)	$	1.29		e	$	(5.78	)
Basic weighted-average common shares outstanding		16,655,634			—		e		16,655,634
Diluted loss for the period attributable to common stockholders	$	(7.07	)	$	1.29		e	$	(5.78	)
Diluted weighted-average common shares outstanding		16,655,634			—		e		16,655,634

	Year Ended December 31, 2020
	IFRS			Adjustments/ Reclassifications			Note	U.S. GAAP
Revenue	$	—		$	—			$	—
Costs and expenses
Cost of sales		—			—				—
General administrative expenses		8,127			(124	)	a, c		8,003
Research and development		5,878			46		a, b		5,924
Depreciation expense		3,182			(151	)	b		3,031
Other operating expenses, net		5,476			(27	)	a, b		5,449
Total costs and expenses		22,663			(256	)			22,407
Operating loss		(22,663	)		256				(22,407	)
Other income (expense), net
Finance costs, net		(22	)		57		c, d		35
Change in fair value of financial instruments		(84,224	)		93,861		d		9,637
Gain (loss) on extinguishment of debt		(7,466	)		(1,774	)	d		(9,240	)
Other income (expense), net		597			(3	)	c		594
Total other income (expense), net		(91,115	)		92,141				1,026
Loss before income tax		(113,778	)		92,397				(21,381	)
Income tax		(148	)		—				(148	)
Net loss available to common stockholders	$	(113,926	)	$	92,397			$	(21,529	)
Other comprehensive loss
Foreign currency translation loss, net of tax		—			—				—
Comprehensive loss	$	(113,926	)	$	92,397			$	(21,529	)

Basic loss for the period attributable to common stockholders	$	(7.11	)	$	5.76		e	$	(1.34	)
Basic weighted-average common shares outstanding		16,029,826			—		e		16,029,826
Diluted loss for the period attributable to common stockholders	$	(7.11	)	$	5.76		e	$	(1.34	)
Diluted weighted-average common shares outstanding		16,029,826			—		e		16,029,826

	IFRS			Adjustments / Reclassifications			Note	U.S. GAAP
ASSETS
Current assets
Cash and cash equivalents	$	8,533		$	—			$	8,533
Accounts receivable		1,196			—				1,196
Prepaid expenses and other current assets		2,695			—				2,695
Total current assets		12,424			—				12,424
Property and equipment, net		33,586			(1,056	)	b		32,530
Operating lease right-of-use assets		2,663			292		c		2,955
Deferred income tax assets		1,640			—				1,640
Other non-current assets		369			—				369
Total assets	$	50,682		$	(764	)		$	49,918
LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities
Accounts payable	$	6,650		$	—			$	6,650
Debt		246,189			(137,716	)	d		108,473
Warrant liabilities		—			143,237		d		143,237
Operating lease liabilities		891			94		c		985
Contract liabilities		935			—				935
Accrued expenses and other liabilities		23,435			—				23,435
Total current liabilities		278,100			5,615				283,715
Operating lease liabilities		1,908			175		c		2,083
Contract liabilities		1,000			—				1,000
Other non-current liabilities		2,552			—				2,552
Total liabilities		283,560			5,790				289,350
Redeemable preferred stock		—			21,306		d		21,306
Stockholders’ equity (deficit)
Treasury stock		(170,949	)		—				(170,949	)
Additional paid-in capital		235,909			(139,438	)	a, d		96,471
Accumulated other comprehensive loss		(86	)		—				(86	)
Accumulated deficit		(297,752	)		111,578				(186,174	)
Total stockholders’ equity (deficit)		(232,878	)		(27,860	)			(260,738	)
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)	$	50,682		$	(764	)		$	49,918

	Year Ended December 31,
(Consolidated Statement of Operations and Comprehensive Loss)	2021			2020
General and administrative expenses	$	(80	)	$	(136	)
Research and development		—			(89	)
Other operating expenses		—			(27	)
Increase (decrease) to loss before income tax	$	(80	)	$	(252	)

(Consolidated Balance Sheet)	December 31, 2021
Additional paid-in-capital	$	542
Adjustment to accumulated deficit		(542	)
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)	$	—

	Year Ended December 31,
(Consolidated Statement of Operations and Comprehensive Loss)	2021			2020
Research and development	$	(4	)	$	135
Depreciation expense		(97	)		(151	)
Other operating expenses		—			—
Increase (decrease) to loss before income tax	$	(101	)	$	(16	)

(Consolidated Balance Sheet)	December 31, 2021
Property and equipment, net	$	(1,056	)
Total assets	$	(1,056	)
Adjustment to accumulated deficit	$	(1,056	)
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)	$	(1,056	)

	Year Ended December 31,
(Consolidated Statement of Operations and Comprehensive Loss)	2021			2020
General and administrative expenses	$	71		$	12
Less: Finance costs, net		(49	)		(57	)
Less: Other income, net		(2	)		3
Increase (decrease) to loss before income tax	$	20		$	(42	)

(Consolidated Balance Sheet)	December 31, 2021
Operating lease right-of-use assets	$	292
Total assets	$	292
Operating lease liabilities	$	94
Non-current operating lease liabilities		175
Adjustment to accumulated deficit		23
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)	$	292

	Year Ended December 31,
(Consolidated Statements of Operations and Comprehensive Loss)	2021			2020
Less: Finance costs, net	$	(1,982	)	$	—
Less: Change in fair value of financial instruments		(60,085	)		(93,861	)
Less: Gain (Loss) on extinguishment of debt		40,792			1,774
Increase (decrease) to loss before income tax	$	(21,275	)	$	(92,087	)

(Consolidated Balance Sheet)	December 31, 2021
Debt	$	(137,716	)
Redeemable Series X preferred stock		21,306
Warrant liability		143,237
Additional paid-in capital		(139,980	)
Adjustment to accumulated deficit		113,153
Total liabilities, redeemable preferred stock and stockholders’ equity (deficit)	$	—

	Year Ended December 31,
	2021			2020
Net loss attributable to common stockholders	$	(96,305	)	$	(21,529	)
Basic weighted-average common shares outstanding ⁽¹⁾		16,655,634			16,029,826
Basic loss per share for the period attributable to common stockholders	$	(5.78	)	$	(1.34	)

Dilutive numerator	$	(96,305	)	$	(21,529	)
Diluted weighted-average common shares outstanding		16,655,634			16,029,826
Diluted loss per share for the period attributable to common stockholders	$	(5.78	)	$	(1.34	)

Note 5 - Revenue from Contract with Customer - Schedule of Remaining Performance Obligations (Details) (Parentheticals)	Sep. 30, 2023	Dec. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Remaining performance obligations, period (Year)		1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Remaining performance obligations, period (Year)	3 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Remaining performance obligations, period (Year)	1 year	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Remaining performance obligations, period (Year)	1 year	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Remaining performance obligations, period (Year)	1 year	1 year

Note 13 - Redeemable Preferred Stock 1 (Details Textual) - USD ($) $ / shares in Units, $ in Millions	Jan. 25, 2022	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Temporary Equity, Par or Stated Value Per Share (in dollars per share)			$ 0.0001	$ 0.0001
Conversion of Stock, Shares Issued (in shares)	2,140,340
Series X Preferred Stock [Member]
Temporary Equity, Par or Stated Value Per Share (in dollars per share)	$ 0.0001
Temporary Equity, Dividend Rate, Percentage	7.00%
Conversion of Stock, Shares Converted (in shares)	2,033,230
Conversion of Stock, Amount Converted	$ 21.4
Preferred Stock, Convertible, Conversion Price (in dollars per share)	$ 10
Temporary Equity, Shares Issued (in shares)		0	0
Temporary Equity, Shares Outstanding (in shares)		0	0

Note 1 - Nature of the Business and Basis of Presentation 1 (Details Textual) $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Number of Operating Segments	1		1
Retained Earnings (Accumulated Deficit)	$ (270,285)		$ (222,815)	$ (186,174)
Net Cash Provided by (Used in) Operating Activities	(36,132)	$ (54,763)	(68,462)	(28,439)	$ (11,174)
Cash and Cash Equivalents, at Carrying Value	$ 30,971		$ 76,528	$ 8,533

Amount of accumulated undistributed earnings (deficit).

Note 18 - Leases

12 Months Ended

Dec. 31, 2022

Lessee, Operating Leases [Text Block]

18. Leases

We have operating leases for property and equipment. Lease terms range from two years to 10 years.

Changes in our operating lease ROU assets carrying amounts were as follows:

	December 31,
	2022			2021
Balance as of beginning of period	$	2,955		$	1,403
Lease expense		(1,701	)		(494	)
Foreign exchange differences		115			(48	)
Additions		7,171			2,119
Disposals		(322	)		—
Transfers		(47	)		(25	)
Balance as of end of period	$	8,171		$	2,955

Changes in our operating lease liabilities carrying amounts were as follows:

	December 31,
	2022			2021
Balance as of beginning of period	$	3,068		$	1,415
Additions to operating lease liabilities		7,171			2,119
Lease expense		314			54
Foreign exchange differences		(293	)		(48	)
Disposals		(329	)		—
Payments		(1,692	)		(472	)
Balance as of end of period	$	8,239		$	3,068

Total current	$	2,176		$	985
Total non-current		6,063			2,083

We recognized in the Consolidated Statements of Operations and Comprehensive Loss the following expenses related to our operating leases for the years ended December 31, 2022, 2021 and 2020:

	Year Ended December 31,
	2022		2021		2020
Right-of-use assets	$	1,701	$	494	$	247
Operating lease liabilities		314		54		51
Total lease expense	$	2,015	$	548	$	298

The amounts of future undiscounted cash flows related to the lease payments over the lease term and the reconciliation to the present value of the operating lease liabilities at December 31, 2022 is as follows:

	Operating leases
Years Ended
2023	$	2,484
2024		2,235
2025		824
2026		603
2027 and thereafter		3,166
Total remaining lease payments		9,312
Less imputed interest		(1,073	)
Present value of lease liability	$	8,239

Total current	$	2,176
Total non-current	$	6,063

The weighted-average remaining years for the operating leases are 5.66. The weighted-average discount rate for operating leases is 4.6%.

Note 15 - Fair Value Measurement and Financial Instruments 1 (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

As of September 30, 2023	Fair value measurement using
Financial instruments	Quoted prices in active markets (Level 1)		Significant observable inputs (Level 2)		Significant unobservable inputs (Level 3)
$8.63 Warrants liability	$	704	$	—	$	—
PIPE Warrant liability		—		—		59
Liberty Warrants and Liberty Advisory Fee Warrant liability		—		—		1,182
Total Warrant Liabilities	$	704	$	—	$	1,241
Sponsor Earnout Liability	$	—	$	—	$	223

As of December 31, 2022	Fair value measurement using
Financial instruments	Quoted prices in active markets (Level 1)		Significant observable inputs (Level 2)		Significant unobservable inputs (Level 3)
$8.63 Warrants liability	$	1,833	$	—	$	—
PIPE Warrant liability		—		—		311
Liberty Warrants and Liberty Advisory Fee Warrant liability		—		—		6,191
Total Warrant Liabilities	$	1,833	$	—	$	6,502
Sponsor Earnout Liability	$	—	$	—	$	1,353

As of December 31, 2022	Fair value measurement using
Financial instruments	Quoted prices in active markets (Level 1)		Significant observable inputs (Level 2)		Significant unobservable inputs (Level 3)
$8.63 Warrants liability	$	1,833	$	—	$	—
PIPE Warrant liability		—		—		311
Liberty Warrants and Liberty Advisory Fee Warrant liability		—		—		6,191
Total Warrant Liabilities	$	1,833	$	—	$	6,502
Sponsor Earnout liability	$	—	$	—	$	1,353

As of December 31, 2021	Fair value measurement using
Financial instruments	Quoted prices in active markets (Level 1)		Significant observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Liabilities measured at fair value
Cantor Loan	$	—	$	—	$	7,522
Columbia Warrant liability		—		—		143,237
Liabilities for which fair values are disclosed
Notes	$	—	$	180,356	$	—
Promissory notes		—		40,925		—

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

	Liberty Warrants and Liberty Advisory Fee Warrant			PIPE Warrant			Columbia Warrant		Sponsor Earnout			Forfeiture Earnout		Cantor Loan
At June 30, 2022	$	15,377		$	952		$	—	$	3,111		$	—	$	—
Issues		—			—			—		—			—		—
Remeasurement (gain)/loss		(4,026	)		(415	)		—		(537	)		—		—
Write-off of deferred costs		—			—			—		—			—		—
Settlements		—			—			—		—			—		—
At September 30, 2022	$	11,351		$	537		$	—	$	2,574		$	—	$	—

At June 30, 2023	$	2,339		$	109		$	—	$	504		$	—	$	—
Remeasurement (gain)/loss		(1,157	)		(50	)		—		(281	)		—		—
At September 30, 2023	$	1,182		$	59		$	—	$	223		$	—	$	—

	Liberty Warrants and Liberty Advisory Fee Warrant			PIPE Warrant			Columbia Warrant			Sponsor Earnout			Forfeiture Earnout			Cantor Loan
At January 1, 2022	$	—		$	—		$	143,237		$	—		$	—		$	7,522
Issues		30,853			1,312			—			8,022			6,135			—
Remeasurement (gain)/loss⁽¹⁾		(19,502	)		(775	)		(18,635	)		(5,448	)		(5,130	)		489
Write-off of deferred costs		—			—			203			—			—			—
Settlements ⁽²⁾		—			—			(124,805	)		—			(1,005	)		(8,011	)
At September 30, 2022	$	11,351		$	537		$	—		$	2,574		$	—		$	—

At January 1, 2023	$	6,191		$	311		$	—		$	1,353		$	—		$	—
Remeasurement (gain)/loss ⁽¹⁾		(5,009	)		(252	)		—			(1,130	)		—			—
At September 30, 2023	$	1,182		$	59		$	—		$	223		$	—		$	—

	Liberty Warrants and Liberty Advisory Fee Warrant			PIPE Warrant			Columbia Warrant			Sponsor Earnout			Forfeiture Earnout			Cantor Loan
At January 1, 2021	$	—		$	—		$	—		$	—		$	—		$	—
Issues		—			—			161,432			—			—			7,513
Remeasurement (gain)/loss⁽¹⁾		—			—			(17,992	)		—			—			9
Amortization of deferred costs		—			—			(203	)		—			—			—
At December 31, 2021		—			—			143,237			—			—			7,522
Issues		30,853			1,312			—			8,022			6,135			—
Remeasurement (gain)/loss⁽¹⁾		(24,662	)		(1,001	)		(18,635	)		(6,669	)		(5,130	)		488
Write-off of deferred costs		—			—			203			—			—			—
Settlements ⁽²⁾		—			—			(124,805	)		—			(1,005	)		(8,010	)
At December 31, 2022	$	6,191		$	311		$	—		$	1,353		$	—		$	—

Note 6 - Warrant Liabilities 1

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Warrant Liabilities Disclosure [Text Block]

6. Warrant Liabilities

	Liberty Warrants and Liberty Advisory Fee Warrant			PIPE Warrant			*$8.63* Warrants			Total Warrants
As of December 31, 2022	$	6,191		$	311		$	1,833		$	8,335
Warrants issued	$	—		$	—		$	—		$	—
Change in fair value of financial instruments		(5,009	)		(252	)		(1,129	)		(6,390	)
As of September 30, 2023	$	1,182		$	59		$	704		$	1,945

Liberty Warrants and Liberty Advisory Fee Warrant

PIPE Warrant

$8.63 Warrants

Public Warrants to purchase 613,111 shares of Class A ordinary shares were exercised during the nine months ended September 30, 2022.

6. Warrant Liabilities

	Liberty Warrants and Liberty Advisory Fee Warrant			PIPE Warrant			Columbia Warrant			$8.63 Warrants			Total Warrant Liabilities
As of December 31, 2021	$	—		$	—		$	143,237		$	—		$	143,237
Warrants issued	$	30,853		$	1,312		$	—		$	4,872		$	37,037
Change in fair value of financial instruments		(24,662	)		(1,001	)		(18,635	)		(2,702	)		(47,000	)
Write-off of deferred costs		—			—			203			—			203
Settlements		—			—			—			(337	)		(337	)
Reclassification to equity		—			—			(124,805	)		—			(124,805	)
As of December 31, 2022	$	6,191		$	311		$	—		$	1,833		$	8,335

Liberty Warrants and Liberty Advisory Fee Warrant

PIPE Warrant

Columbia Warrant

The Columbia Warrant is exercisable the earlier of 25 years from the effective date or the date in which the warrant is exercised in full.

$8.63 Warrants

Public Warrants to purchase 613,111 Class A ordinary shares were exercised during the year ended December 31, 2022.

Note 15 - Fair Value Measurement and Financial Instruments 1 (Details Textual) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022	Jan. 25, 2022	Jan. 24, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate		0.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate		0.00%
Sponsor Earnout [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term (Year)	3 years 3 months 18 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate	67.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	4.80%
PIPE Warrant, Liberty Warrants, and Liberty Advisory Fee Warrant [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term (Year)	3 years 4 months 24 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate	67.00%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	4.80%
The 8.63 Warrants [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 8.63	$ 8.63	$ 8.63	$ 11.5

Note 15 - Fair Value Measurements and Financial Instruments - Reconciliation of Level 3 Measurements (Details) - USD ($)
$ in Thousands

3 Months Ended

9 Months Ended

12 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Sep. 30, 2023

Sep. 30, 2022

Dec. 31, 2022

Dec. 31, 2021

Borrowings [Member]

$ 0

$ 7,522

$ 0

7,513

^[1]

489

^[1]

488

^[2]

(8,011)

^[3]

(8,010)

^[3]

7,522

Sponsor Earnout [Member]

504

3,111

1,353

8,022

(281)

(537)

(1,130)

^[1]

(5,448)

^[1]

(6,669)

^[2]

^[3]

Forfeiture Earnout [Member]

223

2,574

223

2,574

1,353

6,135

^[1]

(5,130)

^[1]

(5,130)

^[2]

(1,005)

^[3]

(1,005)

^[3]

Liberty Warrants and Liberty Advisory Fee Warrant [Member]

2,339

15,377

6,191

30,853

(1,157)

(4,026)

(5,009)

^[1]

(19,502)

^[1]

(24,662)

^[2]

^[3]

1,182

11,351

1,182

11,351

6,191

Pipe Warrant [Member]

109

952

311

1,312

(50)

(415)

(252)

^[1]

(775)

^[1]

(1,001)

^[2]

^[3]

Columbia Warrant [Member]

537

311

143,237

161,432

^[1]

(18,635)

^[1]

(18,635)

^[2]

(17,992)

^[2]

(203)

203

(124,805)

^[3]

(124,805)

^[3]

$ 0

$ 143,237

[1]	Recognized in the Condensed Consolidated Statements of Operations and Comprehensive Loss for the nine months ended September 30, 2023 and 2022, respectively.
[2]	Recognized in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2022 and 2021, respectively.
[3]	These liabilities were settled in connection with the Merger. See Note 4 (Recapitalization Transaction).

Note 4 - Reverse Recapitalization (Details Textual) $ / shares in Units, $ in Thousands				1 Months Ended	9 Months Ended	12 Months Ended
	Feb. 10, 2022 USD ($) $ / shares shares	Jan. 25, 2022 USD ($) $ / shares shares	Jan. 18, 2022 USD ($) $ / shares shares	Jul. 31, 2021 USD ($) $ / shares shares	Sep. 30, 2023	Dec. 31, 2022 USD ($)	Dec. 23, 2021 USD ($)
Proceeds From Reverse Recapitalization \| $		$ 168,000				$ 168,000
Conversion of Stock, Shares Issued (in shares)		2,140,340
Recapitalization Exchange Ratio					3.3028	3.3028
C F V [Member] \| Liberty Subscription Agreement [Member]
Proceeds from Issuance or Sale of Equity \| $			$ 150,000
Canter Loan [Member] \| Class A Common Stock Issued for Conversion of Promissory Note [Member]
Debt Conversion, Converted Instrument, Shares Issued (in shares)			788,021
Canter Loan [Member] \| CF Securities [Member]
Debt Instrument, Face Amount \| $							$ 7,500
Pipe Warrant [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)		2,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) \| $ / shares		$ 20
Proceeds from Issuance or Sale of Equity \| $		$ 58,200
Forward Purchase Warrant [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)				333,333
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) \| $ / shares				$ 11.5
Proceeds from Issuance or Sale of Equity \| $				$ 10,000
The 10 Dollar Liberty Warrant [Member] \| C F V [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)			5,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) \| $ / shares			$ 10
The 15 Dollar Liberty Warrant [Member] \| C F V [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)			15,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) \| $ / shares			$ 15
Advisory Fee Warrant [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)	2,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) \| $ / shares	$ 10
Class of Warrant or Right, Cash Portion of Advisory Fee \| $	$ 1,250					$ 7,500
Class of Warrant or Right, Anniversary Period (Year)	18 years
Common Class A [Member]
Stock Issued During Period, Shares, New Issues (in shares)		5,816,770		1,250,000
Stock Issued During Period, Shares, Conversion of Convertible Securities (in shares)				1,250,000
Conversion of Stock, Shares Issued (in shares)		2,140,340
Common Class A [Member] \| Transaction Fee Payment [Member]
Sale of Stock, Number of Shares Issued in Transaction (in shares)			2,058,229
Sale of Stock, Consideration Received on Transaction \| $			$ 5,000
Common Class A [Member] \| C F V [Member] \| Liberty Subscription Agreement [Member]
Sale of Stock, Number of Shares Issued in Transaction (in shares)			20,000,000
Series X Preferred Stock [Member]
Conversion of Stock, Shares Converted (in shares)		2,033,230
Conversion of Stock, Amount Converted \| $		$ 21,400

Note 8 - Property and Equipment

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Property, Plant and Equipment Disclosure [Text Block]

8. Property and Equipment

Property and equipment, net consists of the following:

	Estimated Useful Life (in years)			September 30, 2023			December 31, 2022
Satellites and other equipment	3	-	5	$	68,369		$	54,370
Satellites under construction	Not applicable				16,032			22,194
Leasehold improvements	5	-	10		7,601			6,433
Other property and equipment	3	-	10		4,227			4,146
Total property and equipment					96,229			87,143
Less: Accumulated depreciation					(53,501	)		(39,162	)
Property and equipment, net				$	42,728		$	47,981

Information related to the Company’s property and equipment and operating lease ROU assets by geography is as follows:

	September 30, 2023		December 31, 2022
Uruguay	$	37,991	$	43,134
Argentina		930		1,346
Spain		828		729
Netherlands		11,820		9,471
Other countries		490		1,472
Total ^{(1) (2) (3)}	$	52,059	$	56,152

⁽¹⁾	Non-current assets include property and equipment, net and operating lease right-of-use assets.

⁽²⁾	Presentation in the table is based on the geographic location of the entity that holds the assets.

⁽³⁾	We do not have any non-current assets in the country of incorporation of the holding company.

8. Property and Equipment

Property and equipment, net consists of the following:

				December 31,
	Estimated Useful Life (in years)			2022			2021
Satellites in orbit		3		$	54,370		$	43,716
Satellites under construction	Not applicable				22,194			10,558
Leasehold improvements	5	-	10		6,433			769
Other property and equipment	3	-	10		4,146			2,138
Total property and equipment					87,143			57,181
Less: Accumulated depreciation					(39,162	)		(24,651	)
Property and equipment, net				$	47,981		$	32,530

Provisions for depreciation are based on estimated useful lives of the assets using the straight-line method.

Information related to our property and equipment and operating lease ROU assets by geography is as follows:

	December 31,
	2022		2021
Uruguay	$	43,134	$	33,208
Argentina		1,346		1,250
Spain		729		791
Netherlands		9,471		—
Other countries		1,472		236
Total ⁽¹⁾ ⁽²⁾ ⁽³⁾	$	56,152	$	35,485

⁽¹⁾	Non-current assets include property and equipment, net and operating lease right-of-use assets.

⁽²⁾	The presentation in the table above is based on the geographic location of the entity that holds the assets.

⁽³⁾	We do not have any non-current assets in the country of incorporation of the holding company.

Note 9 - Additional Financial Statement Information - Schedule of Finance Costs, Net and Other Financial Income (Details) - USD ($)
$ in Thousands

3 Months Ended

9 Months Ended

12 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Sep. 30, 2023

Sep. 30, 2022

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Interest expense

$ (0)

$ 9

$ 3

$ 1,597

$ 1,596

$ 8,729

$ 43

Redeemable Series X preferred stock dividends

(97)

(974)

Other finance costs

(38)

(29)

(103)

(99)

(123)

(71)

Interest income

427

419

1,577

568

1,164

Total

$ 389

$ 381

$ 1,471

$ (1,225)

$ (652)

$ (9,738)

^[1],[2]

$ 35

^[1],[2]

[1]

[2]

Note 8 - Property and Equipment - Summary of Property and Equipment (Details) - USD ($)
$ in Thousands

Sep. 30, 2023

Dec. 31, 2022

Dec. 31, 2021

Less: Accumulated depreciation

$ 96,229

$ 87,143

$ 57,181

(53,501)

(39,162)

(24,651)

Property, Plant And Equipment And Operating Lease, Right-of-Use Assets

42,728

47,981

32,530

^[1],[3]

52,059

^[2]

56,152

^[2],[4]

35,485

^[4]

URUGUAY

Property, Plant And Equipment And Operating Lease, Right-of-Use Assets

37,991

43,134

33,208

ARGENTINA

Property, Plant And Equipment And Operating Lease, Right-of-Use Assets

930

1,346

1,250

SPAIN

Property, Plant And Equipment And Operating Lease, Right-of-Use Assets

828

729

791

NETHERLANDS

Property, Plant And Equipment And Operating Lease, Right-of-Use Assets

11,820

9,471

Other Countries [Member]

Property, Plant And Equipment And Operating Lease, Right-of-Use Assets

490

$ 1,472

236

Satellites in Orbit [Member]

3 years

Satellites Under Construction [Member]

$ 54,370

43,716

Leasehold Improvements [Member]

16,032

22,194

10,558

Leasehold Improvements [Member] | Minimum [Member]

$ 7,601

$ 6,433

769

Leasehold Improvements [Member] | Maximum [Member]

5 years

Property, Plant and Equipment, Other Types [Member]

10 years

Property, Plant and Equipment, Other Types [Member] | Minimum [Member]

$ 4,227

$ 4,146

$ 2,138

Property, Plant and Equipment, Other Types [Member] | Maximum [Member]

3 years

10 years

[1]	Non-current assets include property and equipment, net and operating lease right-of-use assets.
[2]	Presentation in the table is based on the geographic location of the entity that holds the assets.
[3]	We do not have any non-current assets in the country of incorporation of the holding company.
[4]	The presentation in the table above is based on the geographic location of the entity that holds the assets.

Note 6 - Warrant Liabilities 1 (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Schedule Of Warrant Liability [Table Text Block]

	Liberty Warrants and Liberty Advisory Fee Warrant			PIPE Warrant			*$8.63* Warrants			Total Warrants
As of December 31, 2022	$	6,191		$	311		$	1,833		$	8,335
Warrants issued	$	—		$	—		$	—		$	—
Change in fair value of financial instruments		(5,009	)		(252	)		(1,129	)		(6,390	)
As of September 30, 2023	$	1,182		$	59		$	704		$	1,945

	Liberty Warrants and Liberty Advisory Fee Warrant			PIPE Warrant			Columbia Warrant			$8.63 Warrants			Total Warrant Liabilities
As of December 31, 2021	$	—		$	—		$	143,237		$	—		$	143,237
Warrants issued	$	30,853		$	1,312		$	—		$	4,872		$	37,037
Change in fair value of financial instruments		(24,662	)		(1,001	)		(18,635	)		(2,702	)		(47,000	)
Write-off of deferred costs		—			—			203			—			203
Settlements		—			—			—			(337	)		(337	)
Reclassification to equity		—			—			(124,805	)		—			(124,805	)
As of December 31, 2022	$	6,191		$	311		$	—		$	1,833		$	8,335

Note 12 - Stock-based Compensation - Schedule of Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Payment Arrangement, Expense	$ 1,414	$ 2,139	$ 4,254	$ 6,624	$ 8,368	$ 10,881	$ 1,732
General and Administrative Expense [Member]
Share-Based Payment Arrangement, Expense	884	554	2,714	2,240	2,406	5,274	1,235
Research and Development Expense [Member]
Share-Based Payment Arrangement, Expense	312	781	933	1,753	3,631	1,968	382
Other Operating Income (Expense) [Member]
Share-Based Payment Arrangement, Expense	$ 218	$ 804	$ 607	$ 2,631	$ 2,331	$ 3,639	$ 115

Note 4 - Reverse Recapitalization 1 (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Schedule Of Reverse Recapitalization [Table Text Block]

Company stockholders	Shares
Class A stockholders immediately prior to merger		17,215,336
Series A preferred stockholders		7,968,316
Series B preferred stockholders		4,597,928
Series B-1 preferred stockholders		2,171,399
2018 convertible noteholders		5,581,416
2019 convertible noteholders		7,846,333
2020 convertible noteholders		4,553,205
Redeemable Series X preferred stockholders		2,140,340
Liberty investors		20,000,000
PIPE investors		5,816,770
Shares issued for Cantor loan repayment		788,021
Shares issued to Sponsor under Forward Purchase Securities Agreement		1,250,000
Issuance of shares for transaction fees		2,058,229
CF V shares		6,837,354
		88,824,647

Company stockholders	Shares
Class A stockholders immediately prior to merger		17,215,336
Series A preferred stockholders		7,968,316
Series B preferred stockholders		4,597,928
Series B-1 preferred stockholders		2,171,399
2018 convertible noteholders		5,581,416
2019 convertible noteholders		7,846,333
2020 convertible noteholders		4,553,205
Redeemable Series X preferred stockholders		2,140,340
Liberty investors		20,000,000
PIPE investors		5,816,770
Shares issued for Cantor loan repayment		788,021
Shares issued to Sponsor under Forward Purchase Securities Agreement		1,250,000
Issuance of shares for transaction fees		2,058,229
CF V shares		6,837,354
		88,824,647

Note 12 - Stock-based Compensation

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Share-Based Payment Arrangement [Text Block]

12. Stock-based Compensation

A summary of stock option activity for the nine months ended September 30, 2023 was as follows:

	Number of Options			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (years)		Intrinsic Value (in thousands)
Balance as of December 31, 2022		6,067,313		$	1.83		2.07
Forfeited		(425,178	)		3.98
Exercised		(186,307	)		1.13
Expired		(177,430	)		2.27
Outstanding at September 30, 2023		5,278,398		$	1.61		1.78	$	1,041
Exercisable at September 30, 2023		4,594,898		$	1.40		1.71	$	1,000

A summary of RSU activity for the nine months ended September 30, 2023 is as follows:

	Number of RSUs			Intrinsic value (in thousands)
Outstanding unvested RSUs at December 31, 2022		1,459,280
Granted during the year		3,369,167
Forfeited during the year		(559,809	)
Vested during the year		(494,287	)
Outstanding unvested RSUs at September 30, 2023		3,774,351		$	4,416

Stock-based Compensation Expense

	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
General and administrative expenses	$	884	$	554	$	2,714	$	2,240
Research and development expenses		312		781		933		1,753
Other operating expenses		218		804		607		2,631
Total	$	1,414	$	2,139	$	4,254	$	6,624

12. Stock-based Compensation

A summary of stock option activity for the year ended December 31, 2022 is as follows:

	Number of Options			Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (years)		Intrinsic Value (in thousands)
Balance as of December 31, 2021		6,864,563		$	2.05		2.36
Granted		—			—
Forfeited		(574,299	)		4.56
Exercised		(102,825	)		1.12
Expired		(120,126	)		2.60
Outstanding at December 31, 2022		6,067,313		$	1.83		2.07	$	10,818
Exercisable at December 31, 2022		4,449,152		$	1.31		1.92	$	8,832

The following table lists the inputs used under the Black-Scholes model for stock-option awards during the years ended December 31, 2022, 2021, and 2020, respectively:

	Year Ended December 31,
	2022			2021			2020
Weighted-average fair value of options at the measurement date (grant date)	$	—			$23.36			$6.31
Dividend yield (%)		—			—			—
Expected volatility (%)		—	%	61	-	72	59	-	61
Risk-free interest rate (%)		—	%	0.5	-	1.4	0.4	-	0.5
Weighted average share price	$	—			$6.79			$2.75

A summary of RSU activity for the year ended December 31, 2022 is as follows:

	Number of RSUs			Intrinsic Value (in thousands)
Outstanding unvested RSUs at December 31, 2021		—
Granted during the year		1,640,496
Forfeited during the year		(60,823	)
Vested during the year		(120,393	)
Expired during the year		—
Outstanding unvested RSUs at December 31, 2022		1,459,280		$	1,940

The weighted-average exercise price of RSUs at December 31, 2022 was $4.38. The number of shares vested is net of 56,649 options forfeited for payment of withholding taxes.

Stock-based Compensation Expense

	Year Ended December 31,
	2022		2021		2020
General and administrative expenses	$	2,406	$	5,274	$	1,235
Research and development		3,631		1,968		382
Other operating expenses		2,331		3,639		115
Total	$	8,368	$	10,881	$	1,732

Note 8 - Property and Equipment 1

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Property, Plant and Equipment Disclosure [Text Block]

8. Property and Equipment

Property and equipment, net consists of the following:

	Estimated Useful Life (in years)			September 30, 2023			December 31, 2022
Satellites and other equipment	3	-	5	$	68,369		$	54,370
Satellites under construction	Not applicable				16,032			22,194
Leasehold improvements	5	-	10		7,601			6,433
Other property and equipment	3	-	10		4,227			4,146
Total property and equipment					96,229			87,143
Less: Accumulated depreciation					(53,501	)		(39,162	)
Property and equipment, net				$	42,728		$	47,981

Information related to the Company’s property and equipment and operating lease ROU assets by geography is as follows:

	September 30, 2023		December 31, 2022
Uruguay	$	37,991	$	43,134
Argentina		930		1,346
Spain		828		729
Netherlands		11,820		9,471
Other countries		490		1,472
Total ^{(1) (2) (3)}	$	52,059	$	56,152

⁽¹⁾	Non-current assets include property and equipment, net and operating lease right-of-use assets.

⁽²⁾	Presentation in the table is based on the geographic location of the entity that holds the assets.

⁽³⁾	We do not have any non-current assets in the country of incorporation of the holding company.

8. Property and Equipment

Property and equipment, net consists of the following:

				December 31,
	Estimated Useful Life (in years)			2022			2021
Satellites in orbit		3		$	54,370		$	43,716
Satellites under construction	Not applicable				22,194			10,558
Leasehold improvements	5	-	10		6,433			769
Other property and equipment	3	-	10		4,146			2,138
Total property and equipment					87,143			57,181
Less: Accumulated depreciation					(39,162	)		(24,651	)
Property and equipment, net				$	47,981		$	32,530

Provisions for depreciation are based on estimated useful lives of the assets using the straight-line method.

Information related to our property and equipment and operating lease ROU assets by geography is as follows:

	December 31,
	2022		2021
Uruguay	$	43,134	$	33,208
Argentina		1,346		1,250
Spain		729		791
Netherlands		9,471		—
Other countries		1,472		236
Total ⁽¹⁾ ⁽²⁾ ⁽³⁾	$	56,152	$	35,485

⁽¹⁾	Non-current assets include property and equipment, net and operating lease right-of-use assets.

⁽²⁾	The presentation in the table above is based on the geographic location of the entity that holds the assets.

⁽³⁾	We do not have any non-current assets in the country of incorporation of the holding company.

Note 17 - Commitments and Contingencies

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Commitments and Contingencies Disclosure [Text Block]

17. Commitments and Contingencies

Contingencies

20. Commitments and Contingencies

Contingencies

Note 14 - Net Loss Per Share (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	Three Months Ended September						Nine Months Ended September
	2023			2022			2023			2022
Net loss attributable to common stockholders	$	(17,619	)	$	(14,823	)	$	(47,470	)	$	(22,944	)
Basic weighted-average common shares outstanding		89,739,310			89,002,430			89,476,065			81,221,550
Basic net loss per share for the period attributable to common stockholders	$	(0.20	)	$	(0.17	)	$	(0.53	)	$	(0.28	)

Effect of dilutive securities:
Net loss attributable to common stockholders	$	(17,619	)	$	(14,823	)	$	(47,470	)	$	(22,944	)
Adjustment to numerator - Change in fair value of Columbia Warrant liability		—			(18,635	)	$	—		$	(18,635	)
Dilutive numerator	$	(17,619	)	$	(33,458	)	$	(47,470	)	$	(41,579	)
Columbia Warrant		—			1,410,657			—			1,410,657
Diluted weighted-average common shares		89,739,310			90,413,087			89,476,065			82,632,207
Diluted net loss per share for the period attributable to common stockholders	$	(0.20	)	$	(0.37	)	$	(0.53	)	$	(0.50	)

	Year Ended December 31,
	2022			2021			2020
Net loss attributable to common stockholders	$	(36,641	)	$	(96,305	)	$	(21,529	)
Basic weighted-average common shares outstanding (1)		83,188,276			16,655,634			16,029,826
Basic loss per share for the period attributable to common stockholders	$	(0.44	)	$	(5.78	)	$	(1.34	)
Effect of dilutive securities:
Adjustment to numerator - Change in fair value of Columbia Warrant liability	$	(18,635	)	$	—		$	—
Dilutive numerator	$	(55,276	)	$	(96,305	)	$	(21,529	)
Columbia Warrant		609,873			—			—
Diluted weighted-average common shares outstanding		83,798,149			16,655,634			16,029,826
Diluted loss per share for the period attributable to common stockholders	$	(0.66	)	$	(5.78	)	$	(1.34	)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

	Year Ended December 31,
	2022		2021		2020
Warrants		49,184,868		15,931,360		—
Sponsor earnout shares		1,775,962		—		—
Stock options		6,067,313		6,864,563		4,694,314
Restricted stock units		1,459,280		—		—
Redeemable convertible preferred stock		—		6,645,215		8,740,398
Total		58,487,423		29,441,138		13,434,712

Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Accounts receivable, allowance	$ 3,317	$ 3,237	$ 1,794
Redeemable preferred shares par value (in dollars per share)		$ 0.0001	$ 0.0001
Preferred stock, par value (in dollars per share)	$ 0.0001	0.0001	0.0001
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001	$ 0.0001

Note 17 - Debt (Tables)

12 Months Ended

Dec. 31, 2022